(State or other jurisdiction of incorporation or organization) | (IRS Employer Identification No.) | ||||||||||||||||
| |||||||||||||||||
(Address of principal executive office) | (Zip Code) |
Securities registered pursuant to 12(b) of the Act: | ||||||||
Title of each class | Trading symbol | Name of each exchange on which registered | ||||||
Large accelerated filer | ☐ | ☒ | ||||||||||||
Non-accelerated filer | ☐ | Smaller reporting company | ||||||||||||
Emerging growth company |
PART I | ||||||||
ITEM 1. | ||||||||
ITEM 2. | ||||||||
ITEM 3. | ||||||||
ITEM 4. | ||||||||
PART II | ||||||||
ITEM 1. | ||||||||
ITEM 1A. | ||||||||
ITEM 2. | ||||||||
ITEM 3. | ||||||||
ITEM 4. | ||||||||
ITEM 5. | ||||||||
ITEM 6. | ||||||||
BANK OF MARIN BANCORP CONSOLIDATED STATEMENTS OF CONDITION |
(in thousands, except share data; unaudited) | March 31, 2022 | December 31, 2021 | ||||||
Assets | ||||||||
Cash, cash equivalents and restricted cash | $ | $ | ||||||
Investment securities | ||||||||
Held-to-maturity, at amortized cost (net of | ||||||||
Available-for-sale, at fair value (net of | ||||||||
Total investment securities | ||||||||
Loans, at amortized cost | ||||||||
Allowance for credit losses on loans | ( | ( | ||||||
Loans, net of allowance for credit losses on loans | ||||||||
Goodwill | ||||||||
Bank-owned life insurance | ||||||||
Operating lease right-of-use assets | ||||||||
Bank premises and equipment, net | ||||||||
Core deposit intangible, net | ||||||||
Other real estate owned | ||||||||
Interest receivable and other assets | ||||||||
Total assets | $ | $ | ||||||
Liabilities and Stockholders' Equity | ||||||||
Liabilities | ||||||||
Deposits | ||||||||
Non-interest bearing | $ | $ | ||||||
Interest bearing | ||||||||
Transaction accounts | ||||||||
Savings accounts | ||||||||
Money market accounts | ||||||||
Time accounts | ||||||||
Total deposits | ||||||||
Borrowings and other obligations | ||||||||
Operating lease liabilities | ||||||||
Interest payable and other liabilities | ||||||||
Total liabilities | ||||||||
Commitments and contingent liabilities (Note 8) | ||||||||
Stockholders' Equity | ||||||||
Preferred stock, no par value, Authorized - | ||||||||
Common stock, no par value, Authorized - | ||||||||
Retained earnings | ||||||||
Accumulated other comprehensive loss, net of taxes | ( | ( | ||||||
Total stockholders' equity | ||||||||
Total liabilities and stockholders' equity | $ | $ |
BANK OF MARIN BANCORP CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME |
Three months ended | |||||||||||
(in thousands, except per share amounts; unaudited) | March 31, 2022 | December 31, 2021 | March 31, 2021 | ||||||||
Interest income | |||||||||||
Interest and fees on loans | $ | $ | |||||||||
Interest on investment securities | |||||||||||
Interest on federal funds sold and due from banks | |||||||||||
Total interest income | |||||||||||
Interest expense | |||||||||||
Interest on interest-bearing transaction accounts | |||||||||||
Interest on savings accounts | |||||||||||
Interest on money market accounts | |||||||||||
Interest on time accounts | |||||||||||
Interest on borrowings and other obligations | |||||||||||
Interest on subordinated debenture | |||||||||||
Total interest expense | |||||||||||
Net interest income | |||||||||||
(Reversal of) provision for credit losses on loans | ( | ( | |||||||||
(Reversal of) provision for credit losses on unfunded loan commitments | ( | ( | |||||||||
Net interest income after (reversal of) provision for credit losses | |||||||||||
Non-interest income | |||||||||||
Wealth Management and Trust Services | |||||||||||
Debit card interchange fees, net | |||||||||||
Service charges on deposit accounts | |||||||||||
Earnings on bank-owned life insurance, net | |||||||||||
Dividends on Federal Home Loan Bank stock | |||||||||||
Merchant interchange fees, net | |||||||||||
Losses on sale of investment securities, net | ( | ||||||||||
Other income | |||||||||||
Total non-interest income | |||||||||||
Non-interest expense | |||||||||||
Salaries and related benefits | |||||||||||
Occupancy and equipment | |||||||||||
Data processing | |||||||||||
Professional services | |||||||||||
Information technology | |||||||||||
Depreciation and amortization | |||||||||||
Amortization of core deposit intangible | |||||||||||
Directors' expense | |||||||||||
Federal Deposit Insurance Corporation insurance | |||||||||||
Charitable contributions | |||||||||||
Other expense | |||||||||||
Total non-interest expense | |||||||||||
Income before provision for income taxes | |||||||||||
Provision for income taxes | |||||||||||
Net income | $ | $ | $ | ||||||||
Net income per common share: | |||||||||||
Basic | $ | $ | $ | ||||||||
Diluted | $ | $ | $ | ||||||||
Weighted average shares: | |||||||||||
Basic | |||||||||||
Diluted | |||||||||||
Comprehensive income (loss): | |||||||||||
Net income | $ | $ | $ | ||||||||
Other comprehensive income (loss): | |||||||||||
Change in net unrealized (losses) gains on available-for-sale securities | ( | ( | ( | ||||||||
Reclassification adjustment for losses on available-for-sale securities included in net income | |||||||||||
Net unrealized losses on securities transferred from available-for-sale to held-to-maturity | ( | ||||||||||
Amortization of net unrealized losses on securities transferred from available-for-sale to held-to-maturity | |||||||||||
Other comprehensive loss, before tax | ( | ( | ( | ||||||||
Deferred tax benefit | ( | ( | ( | ||||||||
Other comprehensive loss, net of tax | ( | ( | ( | ||||||||
Total comprehensive (loss) income | $ | ( | $ | $ |
BANK OF MARIN BANCORP CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY | ||
For the three months ended March 31, 2022 and 2021 |
(in thousands, except share data; unaudited) | Common Stock | Retained Earnings | Accumulated Other Comprehensive (Loss) Income, Net of Taxes | Total | |||||||||||||
Shares | Amount | ||||||||||||||||
Three months ended March 31, 2022 | |||||||||||||||||
Balance at January 1, 2022 | $ | $ | $ | ( | $ | ||||||||||||
Net income | — | — | — | ||||||||||||||
Other comprehensive loss | — | — | — | ( | ( | ||||||||||||
Stock options exercised, net of shares surrendered for cashless exercises and tax withholdings | — | — | |||||||||||||||
Stock issued under employee stock ownership plan | — | — | |||||||||||||||
Restricted stock granted | — | — | — | — | |||||||||||||
Restricted stock surrendered for tax withholdings upon vesting | ( | ( | — | — | ( | ||||||||||||
Restricted stock forfeited / cancelled | ( | — | — | — | — | ||||||||||||
Stock-based compensation - stock options | — | — | — | ||||||||||||||
Stock-based compensation - restricted stock | — | — | — | ||||||||||||||
Cash dividends paid on common stock ($ | — | — | ( | — | ( | ||||||||||||
Stock issued in payment of director fees | — | — | |||||||||||||||
Stock repurchased, including commissions | ( | ( | — | — | ( | ||||||||||||
Balance at March 31, 2022 | $ | $ | $ | ( | $ | ||||||||||||
Three months ended March 31, 2021 | |||||||||||||||||
Balance at January 1, 2021 | $ | $ | $ | $ | |||||||||||||
Net income | — | — | — | ||||||||||||||
Other comprehensive loss | — | — | — | ( | ( | ||||||||||||
Stock options exercised, net of shares surrendered for cashless exercises and tax withholdings | — | — | |||||||||||||||
Stock issued under employee stock purchase plan | — | — | |||||||||||||||
Stock issued under employee stock ownership plan | — | — | |||||||||||||||
Restricted stock granted | — | — | — | — | |||||||||||||
Restricted stock surrendered for tax withholdings upon vesting | ( | ( | — | — | ( | ||||||||||||
Restricted stock forfeited / cancelled | ( | — | — | — | — | ||||||||||||
Stock-based compensation - stock options | — | — | — | ||||||||||||||
Stock-based compensation - restricted stock | — | — | — | ||||||||||||||
Cash dividends paid on common stock ($ | — | — | ( | — | ( | ||||||||||||
Stock purchased by directors under director stock plan | — | — | |||||||||||||||
Stock issued in payment of director fees | — | — | |||||||||||||||
Stock repurchased, including commissions | ( | ( | — | — | ( | ||||||||||||
Balance at March 31, 2021 | $ | $ | $ | $ |
BANK OF MARIN BANCORP CONSOLIDATED STATEMENTS OF CASH FLOWS | ||
For the three months ended March 31, 2022 and 2021 |
(in thousands; unaudited) | March 31, 2022 | March 31, 2021 | ||||||
Cash Flows from Operating Activities: | ||||||||
Net income | $ | $ | ||||||
Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||
(Reversal of) provision for credit losses on loans | ( | ( | ||||||
(Reversal of) provision for credit losses on unfunded loan commitments | ( | ( | ||||||
Noncash contribution expense to employee stock ownership plan | ||||||||
Noncash director compensation expense | ||||||||
Stock-based compensation expense | ||||||||
Amortization of core deposit intangible | ||||||||
Amortization of investment security premiums, net of accretion of discounts | ||||||||
Accretion of premiums (discounts) on acquired loans | ( | |||||||
Accretion of discount on subordinated debenture | ||||||||
Net change in deferred loan origination costs/fees | ( | |||||||
Depreciation and amortization | ||||||||
Earnings on bank-owned life insurance policies | ( | ( | ||||||
Net changes in interest receivable and other assets | ||||||||
Net changes in interest payable and other liabilities | ( | ( | ||||||
Total adjustments | ||||||||
Net cash provided by operating activities | ||||||||
Cash Flows from Investing Activities: | ||||||||
Purchase of held-to-maturity securities | ( | ( | ||||||
Purchase of available-for-sale securities | ( | ( | ||||||
Proceeds from paydowns/maturities of held-to-maturity securities | ||||||||
Proceeds from paydowns/maturities of available-for-sale securities | ||||||||
Loan principal collected, net of originations | ( | |||||||
Cash receipts from bank-owned life insurance policies | ||||||||
Purchase of premises and equipment | ( | ( | ||||||
Cash paid for low income housing tax credit investment | ( | ( | ||||||
Net cash used in investing activities | ( | ( | ||||||
Cash Flows from Financing Activities: | ||||||||
Net increase in deposits | ||||||||
Proceeds from stock options exercised | ||||||||
Restricted stock surrendered for tax withholdings upon vesting | ( | ( | ||||||
Proceeds from stock issued under employee and director stock purchase plans | ||||||||
Stock repurchased, including commissions | ( | ( | ||||||
Repayment of subordinated debenture including execution costs | ( | |||||||
Repayment of finance lease obligations | ( | ( | ||||||
Cash dividends paid on common stock | ( | ( | ||||||
Net cash provided by financing activities | ||||||||
Net decrease in cash, cash equivalents and restricted cash | ( | ( | ||||||
Cash, cash equivalents and restricted cash at beginning of period | ||||||||
Cash, cash equivalents and restricted cash at end of period | $ | $ | ||||||
Supplemental disclosure of cash flow information: | ||||||||
Cash paid in interest | $ | $ | ||||||
Cash paid in income taxes | $ | $ | ||||||
Supplemental disclosure of noncash investing and financing activities: | ||||||||
Change in net unrealized gain or loss on available-for-sale securities | $ | ( | $ | ( | ||||
Securities transferred from available-for-sale to held-to-maturity, at fair value | $ | $ | ||||||
Amortization of net unrealized loss on available-for-sale securities transferred to held-to-maturity | $ | $ | ||||||
Purchase of investment security not yet settled | $ | $ | ||||||
Stock issued to employee stock ownership plan | $ | $ | ||||||
Stock issued in payment of director fees | $ | $ | ||||||
Repurchase of stock not yet settled | $ | $ | ||||||
Restricted cash1 | $ | $ |
Three months ended | ||||||||
(in thousands, except per share data) | March 31, 2022 | March 31, 2021 | ||||||
Weighted average basic common shares outstanding | ||||||||
Potentially dilutive common shares related to: | ||||||||
Stock options | ||||||||
Unvested restricted stock awards | ||||||||
Weighted average diluted shares outstanding | ||||||||
Net income | $ | $ | ||||||
Basic EPS | $ | $ | ||||||
Diluted EPS | $ | $ | ||||||
Weighted average anti-dilutive common shares not included in the calculation of diluted EPS |
(in thousands) Description of Financial Instruments | Carrying Value | Quoted Prices in Active Markets for Identical Assets (Level 1) | Significant Other Observable Inputs (Level 2) | Significant Unobservable Inputs (Level 3) | Measurement Categories: Changes in Fair Value Recorded In1 | ||||||||||||
March 31, 2022 | |||||||||||||||||
Securities available-for-sale: | |||||||||||||||||
Mortgage-backed securities and collateralized mortgage obligations issued by U.S. government-sponsored agencies | $ | $ | $ | $ | OCI | ||||||||||||
SBA-backed securities | $ | $ | $ | $ | OCI | ||||||||||||
Debentures of government sponsored agencies | $ | $ | $ | $ | OCI | ||||||||||||
U.S. Treasury securities | $ | $ | $ | $ | OCI | ||||||||||||
Obligations of state and political subdivisions | $ | $ | $ | $ | OCI | ||||||||||||
Corporate bonds | $ | $ | $ | $ | OCI | ||||||||||||
Asset-backed securities | $ | $ | $ | $ | OCI | ||||||||||||
Derivative financial assets (interest rate contracts) | $ | $ | $ | $ | NI | ||||||||||||
Derivative financial liabilities (interest rate contracts) | $ | $ | $ | $ | NI | ||||||||||||
December 31, 2021 | |||||||||||||||||
Securities available-for-sale: | |||||||||||||||||
Mortgage-backed securities and collateralized mortgage obligations issued by U.S. government-sponsored agencies | $ | $ | $ | $ | OCI | ||||||||||||
SBA-backed securities | $ | $ | $ | $ | OCI | ||||||||||||
Debentures of government sponsored agencies | $ | $ | $ | $ | OCI | ||||||||||||
U.S. Treasury securities | $ | $ | $ | $ | OCI | ||||||||||||
Obligations of state and political subdivisions | $ | $ | $ | $ | OCI | ||||||||||||
Corporate bonds | $ | $ | $ | $ | OCI | ||||||||||||
Asset-backed securities | $ | $ | $ | $ | OCI | ||||||||||||
Derivative financial liabilities (interest rate contracts) | $ | $ | $ | $ | NI |
(in thousands) | Carrying Value | Quoted Prices in Active Markets for Identical Assets (Level 1) | Significant Other Observable Inputs (Level 2) | Significant Unobservable Inputs (Level 3) | ||||||||||
March 31, 2022 | ||||||||||||||
Other real estate owned | $ | $ | $ | $ | ||||||||||
December 31, 2021 | ||||||||||||||
Other real estate owned | $ | $ | $ | $ |
March 31, 2022 | December 31, 2021 | ||||||||||||||||||||||
(in thousands) | Carrying Amounts | Fair Value | Fair Value Hierarchy | Carrying Amounts | Fair Value | Fair Value Hierarchy | |||||||||||||||||
Financial assets (recorded at amortized cost): | |||||||||||||||||||||||
Cash and cash equivalents | $ | $ | Level 1 | $ | $ | Level 1 | |||||||||||||||||
Investment securities held-to-maturity | Level 2 | Level 2 | |||||||||||||||||||||
Loans, net | Level 3 | Level 3 | |||||||||||||||||||||
Interest receivable | Level 2 | Level 2 | |||||||||||||||||||||
Financial liabilities (recorded at amortized cost): | |||||||||||||||||||||||
Time deposits | Level 2 | Level 2 | |||||||||||||||||||||
Interest payable | Level 2 | Level 2 |
Held-to-maturity: | Amortized Cost 1 | Allowance for Credit Losses | Net Carrying Amount | Gross Unrealized | Fair Value | |||||||||||||||
(in thousands) | Gains | (Losses) | ||||||||||||||||||
March 31, 2022 | ||||||||||||||||||||
Securities of U.S. government-sponsored enterprises: | ||||||||||||||||||||
MBS pass-through securities issued by FHLMC, FNMA and GNMA | $ | $ | $ | $ | $ | ( | $ | |||||||||||||
CMOs issued by FHLMC | ( | |||||||||||||||||||
CMOs issued by FNMA | ( | |||||||||||||||||||
CMOs issued by GNMA | ( | |||||||||||||||||||
SBA-backed securities | ( | |||||||||||||||||||
Debentures of government-sponsored agencies | ( | |||||||||||||||||||
Obligations of state and political subdivisions | ( | |||||||||||||||||||
Corporate bonds | ||||||||||||||||||||
Total held-to-maturity | $ | $ | $ | $ | $ | ( | $ | |||||||||||||
December 31, 2021 | ||||||||||||||||||||
Securities of U.S. government-sponsored enterprises: | ||||||||||||||||||||
MBS pass-through securities issued by FHLMC, FNMA and GNMA | $ | $ | $ | $ | $ | ( | $ | |||||||||||||
CMOs issued by FHLMC | ( | |||||||||||||||||||
CMOs issued by FNMA | ||||||||||||||||||||
SBA-backed securities | ||||||||||||||||||||
Debentures of government-sponsored agencies | ( | |||||||||||||||||||
Obligations of state and political subdivisions | ( | |||||||||||||||||||
Total held-to-maturity | $ | $ | $ | $ | $ | ( | $ | |||||||||||||
1 Amortized cost and fair values exclude accrued interest receivable of $ | ||||||||||||||||||||
Obligations of state and political subdivisions | Corporate bonds | |||||||||||||
(in thousands) | March 31, 2022 | December 31, 2021 | March 31, 2022 | December 31, 2021 | ||||||||||
AAA / Aaa | $ | $ | $ | $ | ||||||||||
AA / Aa | ||||||||||||||
A2 / A | ||||||||||||||
Total | $ | $ | $ | $ |
Available-for-sale: | Amortized Cost 1 | Gross Unrealized | Allowance for Credit Losses | Fair Value | |||||||||||||
(in thousands) | Gains | (Losses) | |||||||||||||||
March 31, 2022 | |||||||||||||||||
Securities of U.S. government-sponsored enterprises: | |||||||||||||||||
MBS pass-through securities issued by FHLMC, FNMA and GNMA | $ | $ | $ | ( | $ | $ | |||||||||||
CMOs issued by FHLMC | ( | ||||||||||||||||
CMOs issued by FNMA | ( | ||||||||||||||||
CMOs issued by GNMA | ( | ||||||||||||||||
SBA-backed securities | ( | ||||||||||||||||
Debentures of government- sponsored agencies | ( | ||||||||||||||||
U.S. Treasury securities | ( | ||||||||||||||||
Obligations of state and political subdivisions | ( | ||||||||||||||||
Corporate bonds | ( | ||||||||||||||||
Asset-backed securities | ( | ||||||||||||||||
Total available-for-sale | $ | $ | $ | ( | $ | $ | |||||||||||
December 31, 2021 | |||||||||||||||||
Securities of U.S. government-sponsored enterprises: | |||||||||||||||||
MBS pass-through securities issued by FHLMC, FNMA and GNMA | $ | $ | $ | ( | $ | $ | |||||||||||
CMOs issued by FHLMC | ( | ||||||||||||||||
CMOs issued by FNMA | ( | ||||||||||||||||
CMOs issued by GNMA | ( | ||||||||||||||||
SBA-backed securities | ( | ||||||||||||||||
Debentures of government- sponsored agencies | ( | ||||||||||||||||
U.S. Treasury securities | ( | ||||||||||||||||
Obligations of state and political subdivisions | ( | ||||||||||||||||
Corporate bonds | ( | ||||||||||||||||
Asset-backed securities | ( | ||||||||||||||||
Total available-for-sale | $ | $ | $ | ( | $ | $ | |||||||||||
1 Amortized cost and fair value exclude accrued interest receivable of $ |
March 31, 2022 | December 31, 2021 | ||||||||||||||||||||||||||||||||||
Held-to-Maturity | Available-for-Sale | Held-to-Maturity | Available-for-Sale | ||||||||||||||||||||||||||||||||
(in thousands) | Amortized Cost | Fair Value | Amortized Cost | Fair Value | Amortized Cost | Fair Value | Amortized Cost | Fair Value | |||||||||||||||||||||||||||
Within one year | $ | $ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||
After one but within five years | |||||||||||||||||||||||||||||||||||
After five years through ten years | |||||||||||||||||||||||||||||||||||
After ten years | |||||||||||||||||||||||||||||||||||
Total | $ | $ | $ | $ | $ | $ | $ | $ |
Three months ended | ||||||||
(in thousands) | March 31, 2022 | December 31, 2021 | ||||||
Pledged to the State of California: | ||||||||
Secure public deposits in compliance with the Local Agency Security Program | $ | $ | ||||||
Collateral for trust deposits | ||||||||
Collateral for Wealth Management and Trust Services checking account | ||||||||
Total investment securities pledged to the State of California | ||||||||
Bankruptcy trustee deposits pledged with Federal Reserve Bank | ||||||||
Total pledged investment securities | $ | $ |
March 31, 2022 | < 12 continuous months | ≥ 12 continuous months | Total securities in a loss position | |||||||||||||||||||||||
(in thousands) | Fair value | Unrealized loss | Fair value | Unrealized loss | Fair value | Unrealized loss | ||||||||||||||||||||
Held-to-maturity: | ||||||||||||||||||||||||||
MBS pass-through securities issued by FHLMC, FNMA and GNMA | $ | $ | ( | $ | $ | $ | $ | ( | ||||||||||||||||||
CMOs issued by FHLMC | ( | ( | ( | |||||||||||||||||||||||
CMOs issued by FNMA | ( | ( | ||||||||||||||||||||||||
CMOs issued by GNMA | ( | ( | ||||||||||||||||||||||||
SBA-backed securities | ( | $ | ( | |||||||||||||||||||||||
Debentures of government-sponsored agencies | ( | ( | $ | ( | ||||||||||||||||||||||
Obligations of state and political subdivisions | ( | ( | ||||||||||||||||||||||||
Total held-to-maturity | ( | ( | ( | |||||||||||||||||||||||
Available-for-sale: | ||||||||||||||||||||||||||
MBS pass-through securities issued by FHLMC, FNMA and GNMA | ( | ( | ||||||||||||||||||||||||
CMOs issued by FHLMC | ( | ( | ( | |||||||||||||||||||||||
CMOs issued by FNMA | ( | ( | ||||||||||||||||||||||||
CMOs issued by GNMA | ( | ( | ||||||||||||||||||||||||
SBA-backed securities | ( | ( | ( | |||||||||||||||||||||||
Debentures of government- sponsored agencies | ( | ( | ( | |||||||||||||||||||||||
U.S. Treasury securities | ( | ( | ||||||||||||||||||||||||
Obligations of state and political subdivisions | ( | ( | ( | |||||||||||||||||||||||
Corporate bonds | ( | ( | ( | |||||||||||||||||||||||
Asset-backed securities | ( | ( | ||||||||||||||||||||||||
Total available-for-sale | ( | ( | ( | |||||||||||||||||||||||
Total securities at loss position | $ | $ | ( | $ | $ | ( | $ | $ | ( |
December 31, 2021 | < 12 continuous months | ≥ 12 continuous months | Total securities in a loss position | |||||||||||||||||||||||
(in thousands) | Fair value | Unrealized loss | Fair value | Unrealized loss | Fair value | Unrealized loss | ||||||||||||||||||||
Held-to-maturity: | ||||||||||||||||||||||||||
MBS pass-through securities issued by FHLMC and FNMA | $ | $ | ( | $ | $ | $ | ( | |||||||||||||||||||
CMOs issued by FHLMC | ( | ( | ||||||||||||||||||||||||
Obligations of state and political subdivisions | ( | ( | ||||||||||||||||||||||||
Debentures of government-sponsored agencies | ( | ( | ||||||||||||||||||||||||
Total held-to-maturity | ( | ( | ||||||||||||||||||||||||
Available-for-sale: | ||||||||||||||||||||||||||
MBS pass-through securities issued by FHLMC and FNMA | ( | ( | ||||||||||||||||||||||||
SBA-backed securities | ( | ( | ( | |||||||||||||||||||||||
CMOs issued by FHLMC | ( | ( | ( | |||||||||||||||||||||||
CMOs issued by GNMA | $ | $ | ( | $ | $ | $ | $ | ( | ||||||||||||||||||
CMOs issued by FNMA | ( | ( | ||||||||||||||||||||||||
Debentures of government- sponsored agencies | ( | ( | ( | |||||||||||||||||||||||
U.S. Treasury securities | ( | ( | ||||||||||||||||||||||||
Obligations of state and political subdivisions | ( | ( | ||||||||||||||||||||||||
Corporate Bonds | ( | ( | ||||||||||||||||||||||||
Asset-backed securities | ( | ( | ||||||||||||||||||||||||
Total available-for-sale | ( | ( | ( | |||||||||||||||||||||||
Total securities at loss position | $ | $ | ( | $ | $ | ( | $ | $ | ( |
(in thousands) | March 31, 2022 | December 31, 2021 | ||||||
Commercial and industrial | $ | $ | ||||||
Real estate: | ||||||||
Commercial owner-occupied | ||||||||
Commercial investor-owned | ||||||||
Construction | ||||||||
Home equity | ||||||||
Other residential | ||||||||
Installment and other consumer loans | ||||||||
Total loans, at amortized cost 1 | ||||||||
Allowance for credit losses on loans | ( | ( | ||||||
Total loans, net of allowance for credit losses on loans | $ | $ |
(in thousands) | Term Loans - Amortized Cost by Origination Year | Revolving Loans Amortized Cost | ||||||||||||||||||||||||
March 31, 2022 | 2022 | 2021 | 2020 | 2019 | 2018 | Prior | Total | |||||||||||||||||||
Commercial and industrial: | ||||||||||||||||||||||||||
Pass and Watch | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
Special Mention | ||||||||||||||||||||||||||
Substandard | ||||||||||||||||||||||||||
Total commercial and industrial | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
Commercial real estate, owner-occupied: | ||||||||||||||||||||||||||
Pass and Watch | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
Special Mention | ||||||||||||||||||||||||||
Substandard | ||||||||||||||||||||||||||
Doubtful | ||||||||||||||||||||||||||
Total commercial real estate, owner-occupied | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
(in thousands) | Term Loans - Amortized Cost by Origination Year | Revolving Loans Amortized Cost | ||||||||||||||||||||||||
March 31, 2022 | 2022 | 2021 | 2020 | 2019 | 2018 | Prior | Total | |||||||||||||||||||
Commercial real estate, investor-owned: | ||||||||||||||||||||||||||
Pass and Watch | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
Special Mention | ||||||||||||||||||||||||||
Substandard | ||||||||||||||||||||||||||
Total commercial real estate, investor-owned | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
Construction: | ||||||||||||||||||||||||||
Pass and Watch | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
Total construction | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
Home equity: | ||||||||||||||||||||||||||
Pass and Watch | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
Special Mention | ||||||||||||||||||||||||||
Substandard | ||||||||||||||||||||||||||
Total home equity | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
Other residential: | ||||||||||||||||||||||||||
Pass and Watch | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
Total other residential | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
Installment and other consumer: | ||||||||||||||||||||||||||
Pass and Watch | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
Substandard | ||||||||||||||||||||||||||
Total installment and other consumer | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
Gross current period charge-offs | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
Total loans: | ||||||||||||||||||||||||||
Pass and Watch | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
Total Special Mention | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
Total Substandard | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
Total Doubtful | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
Totals | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
Total gross current period charge-offs | $ | $ | $ | $ | $ | $ | $ | $ |
(in thousands) | Term Loans - Amortized Cost by Origination Year | Revolving Loans Amortized Cost | ||||||||||||||||||||||||
December 31, 2021 | 2021 | 2020 | 2019 | 2018 | 2017 | Prior | Total | |||||||||||||||||||
Commercial and industrial: | ||||||||||||||||||||||||||
Pass and Watch | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
Special Mention | ||||||||||||||||||||||||||
Substandard | ||||||||||||||||||||||||||
Total commercial and industrial | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
Commercial real estate, owner-occupied: | ||||||||||||||||||||||||||
Pass and Watch | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
Special Mention | ||||||||||||||||||||||||||
Substandard | ||||||||||||||||||||||||||
Doubtful | ||||||||||||||||||||||||||
Total commercial real estate, owner-occupied | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
Commercial real estate, investor-owned: | ||||||||||||||||||||||||||
Pass and Watch | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
Special Mention | ||||||||||||||||||||||||||
Substandard | ||||||||||||||||||||||||||
Total commercial real estate, investor-owned | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
Construction: | ||||||||||||||||||||||||||
Pass and Watch | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
Total construction | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
Home equity: | ||||||||||||||||||||||||||
Pass and Watch | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
Substandard | ||||||||||||||||||||||||||
Total home equity | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
Other residential: | ||||||||||||||||||||||||||
Pass and Watch | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
Total other residential | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
Installment and other consumer: | ||||||||||||||||||||||||||
Pass and Watch | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
Total installment and other consumer | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
Total loans: | ||||||||||||||||||||||||||
Pass and Watch | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
Total Special Mention | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
Total Substandard | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
Doubtful | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
Totals | $ | $ | $ | $ | $ | $ | $ | $ |
Loan Aging Analysis by Class | ||||||||||||||||||||||||||
(in thousands) | Commercial and industrial | Commercial real estate, owner-occupied | Commercial real estate, investor-owned | Construction | Home equity | Other residential | Installment and other consumer | Total | ||||||||||||||||||
March 31, 2022 | ||||||||||||||||||||||||||
30-59 days past due | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
60-89 days past due | ||||||||||||||||||||||||||
90 days or more past due | ||||||||||||||||||||||||||
Total past due | ||||||||||||||||||||||||||
Current | ||||||||||||||||||||||||||
Total loans 1 | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
Non-accrual loans 2 | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
Non-accrual loans with no allowance | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
December 31, 2021 | ||||||||||||||||||||||||||
30-59 days past due | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
60-89 days past due | ||||||||||||||||||||||||||
90 days or more past due | ||||||||||||||||||||||||||
Total past due | ||||||||||||||||||||||||||
Current | ||||||||||||||||||||||||||
Total loans 1 | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
Non-accrual loans 2 | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
Non-accrual loans with no allowance | $ | $ | $ | $ | $ | $ | $ | $ |
Amortized Cost by Collateral Type | |||||||||||||||||
(in thousands) | Commercial Real Estate | Residential Real Estate | Other | Total | Allowance for Credit Losses | ||||||||||||
March 31, 2022 | |||||||||||||||||
Commercial real estate, owner-occupied | $ | $ | $ | $ | $ | ||||||||||||
Home equity | |||||||||||||||||
Installment and other consumer | $ | ||||||||||||||||
Total | $ | $ | $ | $ | $ | ||||||||||||
December 31, 2021 | |||||||||||||||||
Commercial real estate, owner-occupied | $ | $ | $ | $ | $ | ||||||||||||
Commercial real estate, investor-owned | |||||||||||||||||
Home equity | |||||||||||||||||
Total | $ | $ | $ | $ | $ |
(in thousands) | March 31, 2022 | December 31, 2021 | ||||||
Commercial and industrial | $ | $ | ||||||
Commercial real estate, owner-occupied | ||||||||
Commercial real estate, investor-owned | ||||||||
Home equity | ||||||||
Installment and other consumer | ||||||||
Total 1 | $ | $ |
Allowance for Credit Losses on Loans Rollforward | |||||||||||||||||||||||||||||
(in thousands) | Commercial and industrial | Commercial real estate, owner-occupied | Commercial real estate, investor-owned | Construction | Home equity | Other residential | Installment and other consumer | Unallocated | Total | ||||||||||||||||||||
Three months ended March 31, 2022 | |||||||||||||||||||||||||||||
Beginning balance | $ | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||
Provision (reversal) | ( | ( | ( | ( | ( | ||||||||||||||||||||||||
Charge-offs | ( | ( | |||||||||||||||||||||||||||
Recoveries | |||||||||||||||||||||||||||||
Ending balance | $ | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||
Three months ended March 31, 2021 | |||||||||||||||||||||||||||||
Beginning balance | $ | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||
Provision (reversal) | ( | ( | ( | ( | ( | ( | ( | ( | |||||||||||||||||||||
Charge-offs | |||||||||||||||||||||||||||||
Recoveries | |||||||||||||||||||||||||||||
Ending balance | $ | $ | $ | $ | $ | $ | $ | $ | $ |
(in thousands) | March 31, 2022 | December 31, 2021 | ||||||
Commercial lines of credit | $ | $ | ||||||
Revolving home equity lines | ||||||||
Undisbursed construction loans | ||||||||
Personal and other lines of credit | ||||||||
Standby letters of credit | ||||||||
Total commitments and standby letters of credit | $ | $ |
(in thousands) | March 31, 2022 | December 31, 2021 | ||||||
Operating leases: | ||||||||
Operating lease right-of-use assets | $ | $ | ||||||
Operating lease liabilities | $ | $ | ||||||
Finance leases: | ||||||||
$ | $ | |||||||
Accumulated amortization | ( | ( | ||||||
Finance lease right-of-use assets, net1 | $ | $ | ||||||
Finance lease liabilities2 | $ | $ | ||||||
1 Included in premises and equipment in the consolidated statements of condition. | ||||||||
2 Included in borrowings and other obligations in the consolidated statements of condition. |
Three months ended | ||||||||
(in thousands) | March 31, 2022 | March 31, 2021 | ||||||
Right-of-use assets obtained in exchange for operating lease liabilities | $ | $ | ||||||
Three months ended | ||||||||
(in thousands) | March 31, 2022 | March 31, 2021 | ||||||
Operating lease cost | $ | $ | ||||||
Variable lease cost | ||||||||
Total operating lease cost1 | $ | $ | ||||||
Finance lease cost: | ||||||||
Amortization of right-of-use assets2 | $ | $ | ||||||
Interest on finance lease liabilities3 | ||||||||
Total finance lease cost | ||||||||
Total lease cost | $ | $ | ||||||
1 Included in occupancy and equipment expense in the consolidated statements of comprehensive income. | ||||||||
2 Included in depreciation and amortization in the consolidated statements of comprehensive income. | ||||||||
3 Included in interest on borrowings and other obligations in the consolidated statements of comprehensive income. |
(in thousands) | March 31, 2022 | |||||||
Year | Operating Leases | Finance Leases | ||||||
2022 | $ | $ | ||||||
2023 | ||||||||
2024 | ||||||||
2025 | ||||||||
2026 | ||||||||
Thereafter | ||||||||
Total minimum lease payments | ||||||||
Amounts representing interest (present value discount) | ( | ( | ||||||
Present value of net minimum lease payments (lease liability) | $ | $ | ||||||
Weighted average remaining term (in years) | ||||||||
Weighted average discount rate | % | % |
Asset Derivatives | Liability Derivatives | ||||||||||||||||
(in thousands) | March 31, 2022 | December 31, 2021 | March 31, 2022 | December 31, 2021 | |||||||||||||
Fair value hedges: | |||||||||||||||||
Interest rate contracts notional amount | $ | $ | $ | $ | |||||||||||||
Interest rate contracts fair value1 | $ | $ | $ | $ |
Carrying Amounts of Hedged Assets | Cumulative Amount of Fair Value Hedging Adjustment Included in the Carrying Amount of the Hedged Loans | ||||||||||||||||
(in thousands) | March 31, 2022 | December 31, 2021 | March 31, 2022 | December 31, 2021 | |||||||||||||
Loans | $ | $ | $ | $ |
Three months ended | ||||||||
(in thousands) | March 31, 2022 | March 31, 2021 | ||||||
Interest and fees on loans 1 | $ | $ | ||||||
Increase in fair value of designated interest rate swaps due to LIBOR interest rate movements | $ | $ | ||||||
Payment on interest rate swaps | ( | ( | ||||||
Decrease in fair value hedging adjustment of hedged loans | ( | ( | ||||||
Decrease in value of yield maintenance agreement | ( | ( | ||||||
Net losses on fair value hedging relationships recognized in interest income | $ | ( | $ | ( |
Offsetting of Financial Assets and Derivative Assets | ||||||||||||||||||||
Gross Amounts | Net Amounts of | Gross Amounts Not Offset in | ||||||||||||||||||
Gross Amounts | Offset in the | Assets Presented | the Statements of Condition | |||||||||||||||||
of Recognized | Statements of | in the Statements | Financial | Cash Collateral | ||||||||||||||||
(in thousands) | Assets | Condition | of Condition | Instruments | Received | Net Amount | ||||||||||||||
March 31, 2022 | ||||||||||||||||||||
Derivatives by Counterparty: | ||||||||||||||||||||
Counterparty A | $ | $ | $ | $ | ( | $ | $ | |||||||||||||
December 31, 2021 | ||||||||||||||||||||
Derivatives by Counterparty: | ||||||||||||||||||||
Counterparty A | $ | $ | $ | $ | $ | $ | ||||||||||||||
Offsetting of Financial Liabilities and Derivative Liabilities | ||||||||||||||||||||
Gross Amounts | Net Amounts of | Gross Amounts Not Offset in | ||||||||||||||||||
Gross Amounts | Offset in the | Liabilities Presented | the Statements of Condition | |||||||||||||||||
of Recognized | Statements of | in the Statements | Financial | Cash Collateral | ||||||||||||||||
(in thousands) | Liabilities1 | Condition | of Condition1 | Instruments | Pledged | Net Amount | ||||||||||||||
March 31, 2022 | ||||||||||||||||||||
Derivatives by Counterparty: | ||||||||||||||||||||
Counterparty A | $ | $ | $ | $ | ( | $ | ( | $ | ||||||||||||
December 31, 2021 | ||||||||||||||||||||
Derivatives by Counterparty: | ||||||||||||||||||||
Counterparty A | $ | $ | $ | $ | $ | ( | $ | |||||||||||||
(in thousands) | Merger Consideration | ||||
Value of common stock consideration paid to shareholders ( | $ | ||||
Cash consideration for stock options | |||||
Cash paid in lieu of fractional shares | |||||
Total merger consideration | $ |
Three months ended | ||||||||
(in thousands, unaudited) | March 31, 2022 | March 31, 2021 | ||||||
Personnel and severance | $ | $ | ||||||
Professional services | ||||||||
Data processing | ||||||||
Other expense | ||||||||
Total merger-related one-time and conversion costs | $ | $ |
Three months ended | |||||||||||
(in thousands, unaudited) | March 31, 2022 | December 31, 2021 | March 31, 2021 | ||||||||
Net income | |||||||||||
Net income (GAAP) | $ | 10,465 | $ | 9,714 | $ | 8,947 | |||||
Merger-related one-time and conversion costs: | |||||||||||
Personnel and severance | 335 | 336 | — | ||||||||
Professional services | 67 | — | — | ||||||||
Data processing | 48 | 695 | — | ||||||||
Other | 97 | 67 | — | ||||||||
Total merger costs before tax benefits | 547 | 1,098 | — | ||||||||
Income tax benefit of merger-related expenses | (162) | (307) | — | ||||||||
Total merger-related one-time and conversion costs, net of tax benefits | 385 | 791 | — | ||||||||
Comparable net income (non-GAAP) | $ | 10,850 | $ | 10,505 | $ | 8,947 | |||||
Diluted earnings per share | |||||||||||
Weighted average diluted shares | 15,946 | 16,027 | 13,469 | ||||||||
Diluted earnings per share (GAAP) | $ | 0.66 | $ | 0.61 | $ | 0.66 | |||||
Merger-related one-time and conversion costs, net of tax benefits | 0.02 | 0.05 | — | ||||||||
Comparable diluted earnings per share (non-GAAP) | $ | 0.68 | $ | 0.66 | $ | 0.66 | |||||
Return on average assets | |||||||||||
Average assets | $ | 4,345,258 | $ | 4,298,766 | $ | 2,966,006 | |||||
Return on average assets (GAAP) | 0.98 | % | 0.90 | % | 1.21 | % | |||||
Comparable return on average assets (non-GAAP) | 1.01 | % | 0.97 | % | 1.21 | % | |||||
Return on average equity | |||||||||||
Average stockholders' equity | $ | 441,626 | $ | 453,468 | $ | 355,022 | |||||
Return on average equity (GAAP) | 9.61 | % | 8.50 | % | 10.22 | % | |||||
Comparable return on average equity (non-GAAP) | 9.96 | % | 9.19 | % | 10.22 | % | |||||
Efficiency ratio | |||||||||||
Non-interest expense (GAAP) | $ | 19,375 | $ | 18,984 | $ | 15,412 | |||||
Merger-related expenses | (547) | (1,098) | — | ||||||||
Non-interest expense (non-GAAP) | $ | 18,828 | $ | 17,886 | $ | 15,412 | |||||
Net interest income | $ | 29,898 | $ | 30,633 | $ | 22,031 | |||||
Non-interest income | $ | 2,867 | $ | 2,719 | $ | 1,826 | |||||
Efficiency ratio (GAAP) | 59.13 | % | 56.92 | % | 64.60 | % | |||||
Comparable efficiency ratio (non-GAAP) | 57.46 | % | 53.63 | % | 64.60 | % |
Three months ended | |||||||||||
(dollars in thousands, except per share data) | March 31, 2022 | December 31, 2021 | March 31, 2021 | ||||||||
Selected operating data: | |||||||||||
Net interest income | $ | 29,898 | $ | 30,633 | $ | 22,031 | |||||
(Reversal of) provision for credit losses on loans | (485) | 600 | (2,929) | ||||||||
(Reversal of) provision for credit losses on unfunded loan commitments | (318) | 210 | (590) | ||||||||
Non-interest income | 2,867 | 2,719 | 1,826 | ||||||||
Non-interest expense | 19,375 | 18,984 | 15,412 | ||||||||
Net income | 10,465 | 9,714 | 8,947 | ||||||||
Net income per common share: | |||||||||||
Basic | $ | 0.66 | $ | 0.61 | $ | 0.67 | |||||
Diluted | $ | 0.66 | $ | 0.61 | $ | 0.66 | |||||
Performance and other financial ratios: | |||||||||||
Return on average assets | 0.98 | % | 0.90 | % | 1.21 | % | |||||
Return on average equity | 9.61 | % | 8.50 | % | 10.22 | % | |||||
Tax-equivalent net interest margin 1 | 2.96 | % | 3.03 | % | 3.19 | % | |||||
Cost of deposits | 0.06 | % | 0.06 | % | 0.07 | % | |||||
Efficiency ratio | 59.13 | % | 56.92 | % | 64.60 | % | |||||
Cash dividend payout ratio on common stock 2 | 36.36 | % | 39.34 | % | 34.33 | % |
(dollars in thousands, except per share data) | March 31, 2022 | December 31, 2021 | ||||||
Selected financial condition data: | ||||||||
Total assets | $ | 4,330,424 | $ | 4,314,209 | ||||
Loans, net | 2,179,307 | 2,232,622 | ||||||
Deposits | 3,861,342 | 3,808,550 | ||||||
Borrowings and other obligations | 388 | 419 | ||||||
Stockholders' equity | 420,408 | 450,368 | ||||||
Book value per share | 26.27 | 28.27 | ||||||
Asset quality ratios: | ||||||||
Allowance for credit losses on loans to total loans | 1.02 | % | 1.02 | % | ||||
Allowance for credit losses on loans to total loans, excluding SBA PPP loans 3 | 1.04 | % | 1.07 | % | ||||
Allowance for credit losses on loans to non-accrual loans | 2.94x | 2.75x | ||||||
Non-accrual loans to total loans | 0.35 | % | 0.37 | % | ||||
Capital ratios: | ||||||||
Equity to total assets ratio | 9.71 | % | 10.44 | % | ||||
Tangible common equity to tangible assets 4 | 8.03 | % | 8.76 | % | ||||
Total capital (to risk-weighted assets) | 14.35 | % | 14.58 | % | ||||
Tier 1 capital (to risk-weighted assets) | 13.52 | % | 13.70 | % | ||||
Tier 1 capital (to average assets) | 8.90 | % | 8.85 | % | ||||
Common equity Tier 1 capital (to risk weighted assets) | 13.52 | % | 13.70 | % | ||||
1 Tax-equivalent net interest margin is computed by dividing taxable equivalent net interest income, which is adjusted for taxable equivalent income on tax-exempt loans and securities based on Federal statutory rate of 21 percent, by total average interest-earning assets. | ||||||||
2 Calculated as dividends on common shares divided by basic net income per common share. | ||||||||
3 The allowance for credit losses on loans to total loans, excluding SBA-guaranteed PPP loans, is considered a meaningful non-GAAP financial measure, as it represents only those loans that were considered in the calculation of the allowance for credit losses on loans. SBA PPP loans at March 31, 2022 and December 31, 2021 totaled $40.6 million and $111.2 million, respectively. | ||||||||
4 Tangible common equity to tangible assets is considered to be a meaningful non-GAAP financial measure of capital adequacy and is useful for investors to assess Bancorp's ability to absorb potential losses. Tangible common equity of $341 million and $371 million at March 31, 2022 and December 31, 2021, respectively, includes common stock, retained earnings and unrealized gains (losses) on available-for sale securities, net of tax, less goodwill and intangible assets. Tangible assets exclude goodwill and intangible assets of $79.0 million and $79.4 million at March 31, 2022 and December 31, 2021, respectively. |
Three months ended | Three months ended | Three months ended | ||||||||||||||||||||||||||||||
March 31, 2022 | December 31, 2021 | March 31, 2021 | ||||||||||||||||||||||||||||||
Interest | Interest | Interest | ||||||||||||||||||||||||||||||
Average | Income/ | Yield/ | Average | Income/ | Yield/ | Average | Income/ | Yield/ | ||||||||||||||||||||||||
(dollars in thousands) | Balance | Expense | Rate | Balance | Expense | Rate | Balance | Expense | Rate | |||||||||||||||||||||||
Assets | ||||||||||||||||||||||||||||||||
Interest-earning deposits with banks 1 | $ | 231,555 | $ | 106 | 0.18 | % | $ | 330,894 | $ | 125 | 0.15 | % | $ | 165,788 | $ | 42 | 0.10 | % | ||||||||||||||
Investment securities 2, 3 | 1,626,537 | 6,871 | 1.69 | % | 1,410,383 | 5,801 | 1.65 | % | 540,970 | 3,282 | 2.43 | % | ||||||||||||||||||||
Loans 1, 3, 4 | 2,227,495 | 23,881 | 4.29 | % | 2,269,785 | 25,711 | 4.43 | % | 2,099,847 | 20,836 | 3.97 | % | ||||||||||||||||||||
Total interest-earning assets 1 | 4,085,587 | 30,858 | 3.02 | % | 4,011,062 | 31,637 | 3.09 | % | 2,806,605 | 24,160 | 3.44 | % | ||||||||||||||||||||
Cash and non-interest-bearing due from banks | 69,019 | 85,869 | 50,931 | |||||||||||||||||||||||||||||
Bank premises and equipment, net | 7,430 | 7,777 | 4,777 | |||||||||||||||||||||||||||||
Interest receivable and other assets, net | 183,222 | 194,058 | 133,693 | |||||||||||||||||||||||||||||
Total assets | $ | 4,345,258 | $ | 4,298,766 | $ | 2,996,006 | ||||||||||||||||||||||||||
Liabilities and Stockholders' Equity | ||||||||||||||||||||||||||||||||
Interest-bearing transaction accounts | $ | 295,183 | $ | 56 | 0.08 | % | $ | 290,394 | $ | 53 | 0.07 | % | $ | 174,135 | $ | 39 | 0.09 | % | ||||||||||||||
Savings accounts | 343,327 | 29 | 0.03 | % | 336,715 | 28 | 0.03 | % | 214,049 | 19 | 0.04 | % | ||||||||||||||||||||
Money market accounts | 1,122,215 | 478 | 0.17 | % | 1,102,943 | 505 | 0.18 | % | 703,577 | 286 | 0.16 | % | ||||||||||||||||||||
Time accounts including CDARS | 147,707 | 14 | 0.04 | % | 144,993 | 25 | 0.07 | % | 96,349 | 96 | 0.40 | % | ||||||||||||||||||||
Borrowings and other obligations 1 | 399 | 1 | 0.62 | % | 430 | 1 | 0.62 | % | 36 | — | 1.99 | % | ||||||||||||||||||||
Subordinated debenture 1, 5 | — | — | — | % | — | — | — | % | 2,164 | 1,361 | 251.54 | % | ||||||||||||||||||||
Total interest-bearing liabilities | 1,908,831 | 578 | 0.12 | % | 1,875,475 | 612 | 0.13 | % | 1,190,310 | 1,801 | 0.61 | % | ||||||||||||||||||||
Demand accounts | 1,942,804 | 1,915,309 | 1,406,123 | |||||||||||||||||||||||||||||
Interest payable and other liabilities | 51,997 | 54,514 | 44,551 | |||||||||||||||||||||||||||||
Stockholders' equity | 441,626 | 453,468 | 355,022 | |||||||||||||||||||||||||||||
Total liabilities & stockholders' equity | $ | 4,345,258 | $ | 4,298,766 | $ | 2,996,006 | ||||||||||||||||||||||||||
Tax-equivalent net interest income/margin 1 | $ | 30,280 | 2.96 | % | $ | 31,025 | 3.03 | % | $ | 22,359 | 3.19 | % | ||||||||||||||||||||
Reported net interest income/margin 1 | $ | 29,898 | 2.93 | % | $ | 30,633 | 2.99 | % | $ | 22,031 | 3.14 | % | ||||||||||||||||||||
Tax-equivalent net interest rate spread | 2.90 | % | 2.96 | % | 2.83 | % |
1 Interest income/expense is divided by actual number of days in the period times 360 days to correspond to stated interest rate terms, where applicable. | ||||||||||||||||||||||||||
2 Yields on available-for-sale securities are calculated based on amortized cost balances rather than fair value, as changes in fair value are reflected as a component of stockholders' equity. Investment security interest is earned on 30/360 day basis monthly. | ||||||||||||||||||||||||||
3 Yields and interest income on tax-exempt securities and loans are presented on a taxable-equivalent basis using the Federal statutory rate of 21 percent in 2022 and 2021. | ||||||||||||||||||||||||||
4 Average balances on loans outstanding include non-performing loans. The amortized portion of net loan origination fees is included in interest income on loans, representing an adjustment to the yield. | ||||||||||||||||||||||||||
5 2021 interest on subordinated debenture included $1.3 million in accelerated discount accretion from the early redemption of our last subordinated debenture on March 15, 2021. | ||||||||||||||||||||||||||
Three Months Ended March 31, 2022 Compared to Three Months Ended December 31, 2021 | Three Months Ended March 31, 2022 Compared to Three Months Ended March 31, 2021 | ||||||||||||||||||||||||||||
(in thousands) | Volume | Yield/Rate | Mix | Total | Volume | Yield/Rate | Mix | Total | |||||||||||||||||||||
Interest-earning deposits with banks | $ | (38) | $ | 30 | $ | (11) | $ | (19) | $ | 17 | $ | 35 | $ | 12 | $ | 64 | |||||||||||||
Investment securities 1 | 888 | 158 | 24 | 1,070 | 6,586 | (997) | (2,000) | 3,589 | |||||||||||||||||||||
Loans 1 | (479) | (835) | (516) | (1,830) | 1,267 | 1,676 | 102 | 3,045 | |||||||||||||||||||||
Total interest-earning assets | 371 | (647) | (503) | (779) | 7,870 | 714 | (1,886) | 6,698 | |||||||||||||||||||||
Interest-bearing transaction accounts | 1 | 3 | (1) | 3 | 27 | (6) | (4) | 17 | |||||||||||||||||||||
Savings accounts | 1 | — | — | 1 | 11 | (1) | — | 10 | |||||||||||||||||||||
Money market accounts | 9 | (24) | (12) | (27) | 170 | 14 | 8 | 192 | |||||||||||||||||||||
Time accounts, including CDARS | — | (10) | (1) | (11) | 51 | (87) | (46) | (82) | |||||||||||||||||||||
Borrowings and other obligations | — | — | — | — | — | — | 1 | 1 | |||||||||||||||||||||
Subordinated debenture 2 | — | — | — | — | (1,361) | (1,361) | 1,361 | (1,361) | |||||||||||||||||||||
Total interest-bearing liabilities | 11 | (31) | (14) | (34) | (1,102) | (1,441) | 1,320 | (1,223) | |||||||||||||||||||||
Changes in tax-equivalent net interest income | $ | 360 | $ | (616) | $ | (489) | $ | (745) | $ | 8,972 | $ | 2,155 | $ | (3,206) | $ | 7,921 | |||||||||||||
1 Yields and interest income on tax-exempt securities and loans are presented on a taxable-equivalent basis using the federal statutory rate of 21%. | |||||||||||||||||||||||||||||
2 Three months ended March 31, 2021 includes $1.3 million in accelerated discount accretion from the early redemption of our last subordinated debenture on March 15, 2021. |
Three months ended | |||||||||||
(dollars in thousands) | March 31, 2022 | December 31, 2021 | March 31, 2021 | ||||||||
(Reversal of) provision for credit losses on loans | $ | (485) | $ | 600 | $ | (2,929) |
Three months ended | Quarter over quarter | Year over year | |||||||||||||||||||||
(dollars in thousands) | March 31, 2022 | December 31, 2021 | March 31, 2021 | Amount Change | Percent Change | Amount Change | Percent Change | ||||||||||||||||
Wealth Management and Trust Services | $ | 600 | $ | 607 | $ | 488 | $ | (7) | (1.2) | % | $ | 112 | 23.0 | % | |||||||||
Debit card interchange fees, net | 505 | 544 | 366 | (39) | (7.2) | % | 139 | 38.0 | % | ||||||||||||||
Service charges on deposit accounts | 488 | 531 | 281 | (43) | (8.1) | % | 207 | 73.7 | % | ||||||||||||||
Earnings on bank-owned life insurance, net | 413 | 302 | 257 | 111 | 36.8 | % | 156 | 60.7 | % | ||||||||||||||
Dividends on Federal Home Loan Bank stock | 259 | 255 | 149 | 4 | 1.6 | % | 110 | 73.8 | % | ||||||||||||||
Merchant interchange fees, net | 140 | 175 | 57 | (35) | (20.0) | % | 83 | 145.6 | % | ||||||||||||||
Losses on sale of investment securities, net | — | (17) | — | 17 | NM | — | NM | ||||||||||||||||
Other income | 462 | 322 | 228 | 140 | 43.5 | % | 234 | 102.6 | % | ||||||||||||||
Total non-interest income | $ | 2,867 | $ | 2,719 | $ | 1,826 | $ | 148 | 5.4 | % | $ | 1,041 | 57.0 | % | |||||||||
NM - not meaningful |
Three months ended | Quarter over quarter | Year over year | |||||||||||||||||||||
(dollars in thousands) | March 31, 2022 | December 31, 2021 | March 31, 2021 | Amount Change | Percent Change | Amount Change | Percent Change | ||||||||||||||||
Salaries and related benefits | $ | 11,548 | $ | 10,716 | $ | 9,208 | $ | 832 | 7.8 | % | $ | 2,340 | 25.4 | % | |||||||||
Occupancy and equipment | 1,909 | 1,929 | 1,751 | (20) | (1.0) | % | 158 | 9.0 | % | ||||||||||||||
Data processing | 1,277 | 1,887 | 819 | (610) | (32.3) | % | 458 | 55.9 | % | ||||||||||||||
Professional services | 913 | 653 | 863 | 260 | 39.8 | % | 50 | 5.8 | % | ||||||||||||||
Information technology | 478 | 445 | 313 | 33 | 7.4 | % | 165 | 52.7 | % | ||||||||||||||
Depreciation and amortization | 452 | 461 | 459 | (9) | (2.0) | % | (7) | (1.5) | % | ||||||||||||||
Amortization of core deposit intangible | 380 | 393 | 204 | (13) | (3.3) | % | 176 | 86.3 | % | ||||||||||||||
Directors' expense | 311 | 297 | 175 | 14 | 4.7 | % | 136 | 77.7 | % | ||||||||||||||
Federal Deposit Insurance Corporation insurance | 290 | 292 | 179 | (2) | (0.7) | % | 111 | 62.0 | % | ||||||||||||||
Charitable contributions | 45 | 90 | 31 | (45) | (50.0) | % | 14 | 45.2 | % | ||||||||||||||
Other non-interest expense | |||||||||||||||||||||||
Advertising | 347 | 305 | 239 | 42 | 13.8 | % | 108 | 45.2 | % | ||||||||||||||
Other expense | 1,425 | 1,516 | 1,171 | (91) | (6.0) | % | 254 | 21.7 | % | ||||||||||||||
Total other non-interest expense | 1,772 | 1,821 | 1,410 | (49) | (2.7) | % | 362 | 25.7 | % | ||||||||||||||
Total non-interest expense | $ | 19,375 | $ | 18,984 | $ | 15,412 | $ | 391 | 2.1 | % | $ | 3,963 | 25.7 | % | |||||||||
March 31, 2022 | December 31, 2021 | |||||||||||||||||||||||||
(dollars in thousands) | Amortized Cost | Fair Value | % of Total State and Political Subdivisions | Amortized Cost | Fair Value | % of Total State and Political Subdivisions | ||||||||||||||||||||
Within California: | ||||||||||||||||||||||||||
General obligation bonds | $ | 26,023 | $ | 23,757 | 14.4 | % | $ | 25,036 | $ | 25,020 | 14.2 | % | ||||||||||||||
Revenue bonds | 5,245 | 4,911 | 2.9 | 5,249 | 5,185 | 3.0 | ||||||||||||||||||||
Tax allocation bonds | 502 | 505 | 0.3 | 503 | 510 | 0.3 | ||||||||||||||||||||
Total within California | 31,770 | 29,173 | 17.6 | 30,788 | 30,715 | 17.5 | ||||||||||||||||||||
Outside California: | ||||||||||||||||||||||||||
General obligation bonds | 120,546 | 114,862 | 66.8 | 117,278 | 121,303 | 66.5 | ||||||||||||||||||||
Revenue bonds | 28,091 | 26,689 | 15.6 | 28,146 | 29,272 | 16.0 | ||||||||||||||||||||
Total outside California | 148,637 | 141,551 | 82.4 | 145,424 | 150,575 | 82.5 | ||||||||||||||||||||
Total obligations of state and political subdivisions | $ | 180,407 | $ | 170,724 | 100.0 | % | $ | 176,212 | $ | 181,290 | 100.0 | % | ||||||||||||||
Percent of investment portfolio | 10.1 | % | 10.0 | % | 11.7 | % | 12.0 | % |
Capital Ratios for Bancorp (dollars in thousands) | Actual Ratio | Adequately Capitalized Threshold | Ratio to be a Well Capitalized Bank Holding Company | |||||||||||||||||
March 31, 2022 | Amount | Ratio | Amount | Ratio | Amount | Ratio | ||||||||||||||
Total Capital (to risk-weighted assets) | $ | 404,039 | 14.35 | % | ≥ $ | 295,720 | ≥ 10.50 | % | ≥ $ | 281,638 | ≥ 10.00 | % | ||||||||
Tier 1 Capital (to risk-weighted assets) | $ | 380,876 | 13.52 | % | ≥ $ | 239,392 | ≥ 8.50 | % | ≥ $ | 225,310 | ≥ 8.00 | % | ||||||||
Tier 1 Capital (to average assets) | $ | 380,876 | 8.90 | % | ≥ $ | 171,200 | ≥ 4.00 | % | ≥ $ | 214,000 | ≥ 5.00 | % | ||||||||
Common Equity Tier 1 (to risk-weighted assets) | $ | 380,876 | 13.52 | % | ≥ $ | 197,147 | ≥ 7.00 | % | ≥ $ | 183,065 | ≥ 6.50 | % | ||||||||
December 31, 2021 | ||||||||||||||||||||
Total Capital (to risk-weighted assets) | $ | 397,101 | 14.58 | % | ≥ $ | 286,035 | ≥ 10.50 | % | ≥ $ | 272,414 | ≥ 10.00 | % | ||||||||
Tier 1 Capital (to risk-weighted assets) | $ | 373,286 | 13.70 | % | ≥ $ | 231,552 | ≥ 8.50 | % | ≥ $ | 217,931 | ≥ 8.00 | % | ||||||||
Tier 1 Capital (to average assets) | $ | 373,286 | 8.85 | % | ≥ $ | 168,750 | ≥ 4.00 | % | ≥ $ | 210,937 | ≥ 5.00 | % | ||||||||
Common Equity Tier 1 (to risk-weighted assets) | $ | 373,286 | 13.70 | % | ≥ $ | 190,690 | ≥ 7.00 | % | ≥ $ | 177,069 | ≥ 6.50 | % |
Capital Ratios for the Bank (dollars in thousands) | Actual Ratio | Adequately Capitalized Threshold | Ratio to be Well Capitalized under Prompt Corrective Action Provisions | |||||||||||||||||
March 31, 2022 | Amount | Ratio | Amount | Ratio | Amount | Ratio | ||||||||||||||
Total Capital (to risk-weighted assets) | $ | 402,918 | 14.31 | % | ≥ $ | 295,688 | ≥ 10.50 | % | ≥ $ | 281,607 | ≥ 10.00 | % | ||||||||
Tier 1 Capital (to risk-weighted assets) | $ | 379,755 | 13.49 | % | ≥ $ | 239,366 | ≥ 8.50 | % | ≥ $ | 225,286 | ≥ 8.00 | % | ||||||||
Tier 1 Capital (to average assets) | $ | 379,755 | 8.87 | % | ≥ $ | 171,192 | ≥ 4.00 | % | ≥ $ | 213,989 | ≥ 5.00 | % | ||||||||
Common Equity Tier 1 (to risk-weighted assets) | $ | 379,755 | 13.49 | % | ≥ $ | 197,125 | ≥ 7.00 | % | ≥ $ | 183,045 | ≥ 6.50 | % | ||||||||
December 31, 2021 | ||||||||||||||||||||
Total Capital (to risk-weighted assets) | $ | 390,924 | 14.35 | % | ≥ $ | 286,009 | ≥ 10.50 | % | ≥ $ | 272,390 | ≥ 10.00 | % | ||||||||
Tier 1 Capital (to risk-weighted assets) | $ | 367,109 | 13.48 | % | ≥ $ | 231,531 | ≥ 8.50 | % | ≥ $ | 217,912 | ≥ 8.00 | % | ||||||||
Tier 1 Capital (to average assets) | $ | 367,109 | 8.70 | % | ≥ $ | 168,724 | ≥ 4.00 | % | ≥ $ | 210,905 | ≥ 5.00 | % | ||||||||
Common Equity Tier 1 (to risk-weighted assets) | $ | 367,109 | 13.48 | % | ≥ $ | 190,673 | ≥ 7.00 | % | ≥ $ | 177,053 | ≥ 6.50 | % |
Immediate and Parallel Shift in Interest Rates (in basis points) | Estimated Change in Net Interest Income in Year 1, as percent of Net Interest Income | Estimated Change in Net Interest Income in Year 2, as percent of Net Interest Income | ||||||
up 400 | (6.7) | % | 4.9 | % | ||||
up 300 | (4.8) | % | 4.2 | % | ||||
up 200 | (3.0) | % | 3.1 | % | ||||
up 100 | (1.4) | % | 1.8 | % | ||||
down 100 | (2.2) | % | (5.2) | % | ||||
(in thousands, except per share data) | Total Number of Shares Purchased | Average Price Paid per Share 1 | Total Number of Shares Purchased as Part of Publicly Announced Programs | Approximate Dollar Value That May yet Be Purchased Under the Program | ||||||||||
Period | ||||||||||||||
January 1-31, 2022 | 23,275 | $ | 37.64 | 23,275 | $ | 34,664 | ||||||||
February 1-28, 2022 | — | — | — | $ | 34,664 | |||||||||
March 1-31, 2022 | — | — | — | $ | 34,664 | |||||||||
Total | 23,275 | $ | 37.64 | 23,275 | ||||||||||
1 Average price paid per share excludes commission. |
Incorporated by Reference | ||||||||||||||||||||
Exhibit Number | Exhibit Description | Form | File No. | Exhibit | Filing Date | Herewith | ||||||||||||||
2.01 | 8-K | 001-33572 | 2.1 | April 19, 2021 | ||||||||||||||||
3.01 | S-4 | 333-257025 | 3.01 | June 11, 2021 | ||||||||||||||||
3.02 | S-4 | 333-257025 | 3.02 | June 11, 2021 | ||||||||||||||||
4.01 | 8-A12B | 001-33572 | 4.1 | July 7, 2017 | ||||||||||||||||
4.02 | 10-K | 001-33572 | 4.02 | March 13, 2020 | ||||||||||||||||
10.01 | S-8 | 333-218274 | 4.1 | May 26, 2017 | ||||||||||||||||
10.02 | S-8 | 333-221219 | 4.1 | October 30, 2017 | ||||||||||||||||
10.03 | S-8 | 333-227840 | 4.1 | October 15, 2018 | ||||||||||||||||
10.04 | S-8 | 333-239555 | 4.1 | June 30, 2020 | ||||||||||||||||
10.05 | 10-Q | 001-33572 | 10.06 | November 7, 2007 | ||||||||||||||||
10.06 | 10-K | 001-33572 | 10.07 | March 15, 2021 | ||||||||||||||||
10.07 | 8-K | 001-33572 | 10.2 | November 4, 2014 | ||||||||||||||||
10.08 | 8-K | 001-33572 | 10.3 | November 4, 2014 | ||||||||||||||||
10.09 | 8-K | 001-33572 | 10.1 | October 31, 2007 | ||||||||||||||||
10.10 | 10-Q | 001-33572 | 10.12 | November 6, 2020 | ||||||||||||||||
10.11 | 10-K | 001-33572 | 10.13 | March 15, 2021 | ||||||||||||||||
10.12 | 8-K | 001-33572 | 10.1 | September 24, 2021 | ||||||||||||||||
31.01 | Filed | |||||||||||||||||||
31.02 | Filed | |||||||||||||||||||
32.01 | Filed | |||||||||||||||||||
101.INS | Inline XBRL Instance Document | Filed | ||||||||||||||||||
101.SCH | Inline XBRL Taxonomy Extension Schema Document | Filed | ||||||||||||||||||
101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document | Filed | ||||||||||||||||||
101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document | Filed | ||||||||||||||||||
101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document | Filed | ||||||||||||||||||
101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document | Filed |
Bank of Marin Bancorp | |||||||||||
(registrant) | |||||||||||
May 9, 2022 | /s/ Timothy D. Myers | ||||||||||
Date | Timothy D. Myers | ||||||||||
President and Chief Executive Officer | |||||||||||
(Principal Executive Officer) | |||||||||||
May 9, 2022 | /s/ Tani Girton | ||||||||||
Date | Tani Girton | ||||||||||
Executive Vice President & | |||||||||||
Chief Financial Officer | |||||||||||
(Principal Financial Officer) | |||||||||||
May 9, 2022 | /s/ David A. Merck | ||||||||||
Date | David A. Merck | ||||||||||
First Vice President & Controller | |||||||||||
(Principal Accounting Officer) |
May 9, 2022 | /s/ Timothy D. Myers | |||||||
Date | Timothy D. Myers | |||||||
President & | ||||||||
Chief Executive Officer |
May 9, 2022 | /s/ Tani Girton | |||||||
Date | Tani Girton | |||||||
Executive Vice President & | ||||||||
Chief Financial Officer |
May 9, 2022 | /s/ Timothy D. Myers | |||||||
Date | Timothy D. Myers | |||||||
President & | ||||||||
Chief Executive Officer |
May 9, 2022 | /s/ Tani Girton | |||||||
Date | Tani Girton | |||||||
Executive Vice President & | ||||||||
Chief Financial Officer |
CONSOLIDATED STATEMENTS OF CONDITION (Parenthetical) - USD ($) |
Mar. 31, 2022 |
Dec. 31, 2021 |
---|---|---|
Investment securities | ||
Held-to-maturity, allowance for credit Loss | $ 0 | $ 0 |
Available-for-sale, allowance for credit loss | $ 0 | $ 0 |
Stockholders' Equity | ||
Preferred stock, authorized (in shares) | 5,000,000 | 5,000,000 |
Preferred stock, issued (in shares) | 0 | 0 |
Common stock, authorized (in shares) | 30,000,000 | 30,000,000 |
Common stock, issued (in shares) | 16,003,847 | 15,929,243 |
Common stock, outstanding (in shares) | 16,003,847 | 15,929,243 |
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Parenthetical) - $ / shares |
3 Months Ended | |
---|---|---|
Mar. 31, 2022 |
Mar. 31, 2021 |
|
Statement of Stockholders' Equity [Abstract] | ||
Cash dividends paid on common stock (in dollars per share) | $ 0.24 | $ 0.23 |
Basis of Presentation |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Basis of Presentation | Basis of Presentation The consolidated financial statements include the accounts of Bancorp, a bank holding company, and its wholly-owned bank subsidiary, Bank of Marin, a California state-chartered commercial bank. Effective August 6, 2021 (the "merger date"), American River Bankshares ("AMRB") merged with and into Bank of Marin Bancorp ("Bancorp"), with Bank of Marin Bancorp surviving, followed thereafter at 12:05 AM on August 7, 2021, by the merger of American River Bank ("ARB") with and into Bank of Marin, with Bank of Marin (the "Bank") surviving, (collectively the "Merger"). The Merger was accounted for under ASC 805, Business Combinations. See Note 10, Merger, for further detail. References to “we,” “our,” “us” mean Bancorp and the Bank that are consolidated for financial reporting purposes. The accompanying unaudited consolidated interim financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC"). Certain information and note disclosures normally included in annual financial statements prepared in accordance with U.S. generally accepted accounting principles ("GAAP") have been condensed or omitted pursuant to those rules and regulations. Certain items in prior financial statements were reclassified to conform to the current presentation, including the reclassification of the provision for credit losses on unfunded commitments in the second quarter of 2021 from non-interest expense to a separate line item under the provision for credit losses on loans in the consolidated statements of comprehensive income. This reclassification had no impact to net income or stockholders' equity. Although we believe that the disclosures are adequate and the information presented is not misleading, we suggest that these interim financial statements be read in conjunction with the annual financial statements and the notes thereto included in our 2021 Annual Report on Form 10-K. In the opinion of management, the unaudited consolidated financial statements reflect all adjustments, which are necessary for a fair presentation of the consolidated financial position, the results of operations, changes in comprehensive income, changes in stockholders’ equity, and cash flows for the periods presented. All material intercompany transactions have been eliminated. The results of these interim periods may not be indicative of the results for the full year or for any other period. The following table shows: 1) weighted average basic shares, 2) potentially dilutive weighted average common shares related to stock options and unvested restricted stock awards, and 3) weighted average diluted shares. Basic earnings per share (“EPS”) are calculated by dividing net income by the weighted average number of common shares outstanding during each period, excluding unvested restricted stock awards. Diluted EPS are calculated using the weighted average number of potentially dilutive common shares. The number of potentially dilutive common shares included in the quarterly diluted EPS is computed using the average market prices during the three months included in the reporting period under the treasury stock method. The number of potentially dilutive common shares included in year-to-date diluted EPS is a year-to-date weighted average of potentially dilutive common shares included in each quarterly diluted EPS computation. In computing diluted EPS, we exclude anti-dilutive shares such as options whose exercise prices exceed the current common stock price, as they would not reduce EPS under the treasury method. We have two forms of outstanding common stock: common stock and unvested restricted stock awards. Holders of unvested restricted stock awards receive non-forfeitable dividends at the same rate as common shareholders and they both share equally in undistributed earnings. Under the two-class method, the difference in EPS is nominal for these participating securities.
|
Recently Adopted and Issued Accounting Standards |
3 Months Ended |
---|---|
Mar. 31, 2022 | |
Accounting Policies [Abstract] | |
Recently Adopted and Issued Accounting Standards | Recently Adopted and Issued Accounting Standards Accounting Standards Not Yet Effective In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848). The amendments in this ASU are elective and provide optional guidance for a limited period of time to ease the potential burden of accounting for, or recognizing the effects of reference rate reform. The amendments in this ASU provide optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. The amendments in this ASU may be elected as of March 12, 2020 through December 31, 2022. An entity may choose to elect the amendments in this update at an interim period subsequent to March 12, 2020 with adoption methods varying based on transaction type. We have not elected to apply amendments at this time and will assess the applicability of this ASU to us as we continue to monitor guidance for reference rate reform from FASB and its impact on our financial condition and results of operations. In January 2021, the FASB issued ASU No. 2021-01, Reference Rate Reform (Topic 848). The main amendments in this ASU are intended to clarify certain optional expedients and scope of derivative instruments. The amendments are elective and effective immediately upon issuance of this ASU. Amendments may be elected through December 31, 2022. As of March 31, 2022, we had four interest rate swap contracts with notional values totaling $12.8 million indexed to LIBOR that will either be subject to the fall-back index rate stipulated by the ISDA protocol or modified to other reference rates such as Prime or SOFR as mutually agreed by us and our counterparty. We have not elected to apply the amendments at this time and will continue to assess the applicability of this ASU to us as we monitor guidance for reference rate reform from FASB and its impact on our financial condition and results of operations. In October 2021, the FASB issued ASU No. 2021-08, Accounting for Contract Assets and Contract Liabilities From Contracts With Customers (Topic 805). The amendments address diversity in accounting practices and requires acquiring companies to apply ASC 606, Revenue from Contracts with Customers to recognize and measure contract assets and contract liabilities from contracts with customers acquired in a business combination, as opposed to other methods such as fair value. The amendments improve comparability after the business combination by providing consistent recognition and measurement guidance for revenue contracts with customers acquired in a business combination. The amendments are to be applied prospectively to business combinations occurring on or after December 15, 2022 and early adoption is permitted. In the event of a future business combination, we will assess the impact of the ASU on our financial condition and results of operations. In March 2022, the FASB issued ASU No. 2022-02, Financial Instruments - Credit Losses (Topic 326): Troubled Debt Restructurings and Vintage Disclosures. The amendment eliminates the recognition measurement guidance for troubled debt restructured ("TDR") loans, and instead requires an entity to evaluate whether a modification represents a new loan or a continuation of an existing loan in accordance with ASC Topic 310-20, Receivables - Nonrefundable Fees and Other Costs. In addition, the amendment requires that an entity include in its vintage disclosures the current period-gross loan charge-offs by year of origination. The amendments are effective for years beginning after December 15, 2022, and should be applied prospectively, except that an entity has the option to apply a modified retrospective method for TDR loans, resulting in a cumulative-effect adjustment to retained earnings in the period of adoption. An entity may elect to early adopt each of the amendments separately. As such, we early adopted the current period charge-off disclosures in the first quarter of 2022 and intend to adopt the loan modification amendments when effective in the first quarter of 2023. Neither the early adoption of the amendments related to gross charge-off disclosures nor the future adoption of the TDR amendments had or will have a material impact on our financial condition or results of operations. In March 2022, the FASB issued ASU No. 2022-01, Derivatives and Hedging (Topic 815): Fair Value Hedging - Portfolio Layer Method. Among other things, the ASU renames the "last-of-layer" method to the "portfolio layer" method and makes fair value hedging more accessible for hedge accounting of interest rate risk for portfolios and financial assets. For example, the guidance permits an entity to apply the same portfolio hedging method to both prepayable and non-prepayable financial assets, thereby providing for consistency between accounting for similar hedges. The amendments are effective for years beginning after December 15, 2022. The adoption of the amendments will not impact our existing hedge accounting, disclosures, financial condition or results of operations.
|
Fair Value of Assets and Liabilities |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value of Assets and Liabilities | Fair Value of Assets and Liabilities Fair Value Hierarchy and Fair Value Measurement We group our assets and liabilities that are measured at fair value into three levels within the fair value hierarchy, based on the markets in which the assets and liabilities are traded and the reliability of the assumptions used to determine fair value. These levels are: Level 1: Valuations are based on unadjusted quoted prices in active markets for identical assets or liabilities. Level 2: Valuations are based on quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active and model-based valuations for which all significant assumptions are observable or can be corroborated by observable market data. Level 3: Valuations are based on unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. Values are determined using pricing models and discounted cash flow models and may include significant management judgment and estimation. Transfers between levels of the fair value hierarchy are recognized through our monthly and/or quarterly valuation process in the reporting period during which the event or circumstances that caused the transfer occurred. No such transfers occurred in the years presented. The following table summarizes our assets and liabilities that were required to be recorded at fair value on a recurring basis.
1 Other comprehensive income ("OCI") or net income ("NI"). Available-for-sale securities are recorded at fair value on a recurring basis. When available, quoted market prices (Level 1) are used to determine the fair value of available-for-sale securities. Level 1 securities include U.S. Treasury securities. If quoted market prices are not available, we obtain pricing information from a reputable third-party service provider, who may utilize valuation techniques that use current market-based or independently sourced parameters, such as bid/ask prices, dealer-quoted prices, interest rates, benchmark yield curves, prepayment speeds, probability of default, loss severity and credit spreads (Level 2). Level 2 securities include asset-backed securities, obligations of state and political subdivisions, U.S. agencies or government-sponsored agencies' debt securities, mortgage-backed securities, government agency-issued, and corporate bonds. As of March 31, 2022 and December 31, 2021, there were no Level 3 securities. Held-to-maturity securities may be written down to fair value as a result of an other-than-temporary impairment, and we did not record any write-downs during the three months ended March 31, 2022 or March 31, 2021. Fair value of held-to-maturity securities is determined using the same techniques discussed above for available-for-sale securities. On a recurring basis, derivative financial instruments are recorded at fair value, which is based on the income approach using observable Level 2 market inputs, reflecting market expectations of future interest rates as of the measurement date. Standard valuation techniques are used to calculate the present value of the future expected cash flows assuming an orderly transaction. Valuation adjustments may be made to reflect both our own credit risk and the counterparties’ credit risk in determining the fair value of the derivatives. Level 2 inputs for the valuations are limited to observable market prices for London Interbank Offered Rate ("LIBOR") and Overnight Index Swap ("OIS") rates (for the very short term), quoted prices for LIBOR futures contracts, observable market prices for LIBOR and OIS swap rates, and one-month and three-month LIBOR basis spreads at commonly quoted intervals. Mid-market pricing of the inputs is used as a practical expedient in the fair value measurements. We project spot rates at reset days specified by each swap contract to determine future cash flows, then discount to present value using OIS curves as of the measurement date. When the value of any collateral placed with counterparties is less than the interest rate derivative liability, a credit valuation adjustment ("CVA") is applied to reflect the credit risk we pose to counterparties. We have used the spread between the Standard & Poor's BBB rated U.S. Bank Composite rate and LIBOR for the closest maturity term corresponding to the duration of the swaps to derive the CVA. A similar credit risk adjustment, correlated to the credit standing of the counterparty, is made when collateral posted by the counterparty does not fully cover their liability to us. For further discussion on our methodology in valuing our derivative financial instruments, refer to Note 9, Derivative Financial Instruments and Hedging Activities. Certain financial assets may be measured at fair value on a non-recurring basis. These assets are subject to fair value adjustments that result from the application of the lower of cost or fair value accounting or write-downs of individual assets, such as individually analyzed loans that are collateral dependent and other real estate owned ("OREO"). OREO represents collateral acquired through foreclosure and is initially recorded at fair value as established by a current appraisal of the collateral. Subsequent to foreclosure, OREO is carried at the lower of cost or fair value, less estimated costs to sell. OREO values are reviewed on an ongoing basis and any subsequent decline in fair value is recorded as a foreclosed asset expense in the current period. The value of OREO is classified as Level 3. Our current OREO resulted from the ARB Merger. The following table presents the carrying value of assets measured at fair value on a non-recurring basis and that were held in the consolidated statements of condition at each respective period end, by level within the fair value hierarchy as of March 31, 2022 and December 31, 2021.
Disclosures about Fair Value of Financial Instruments The table below is a summary of fair value estimates for financial instruments as of March 31, 2022 and December 31, 2021, excluding financial instruments recorded at fair value on a recurring basis (summarized in the first table in this note). The carrying amounts in the following table are recorded in the consolidated statements of condition under the indicated captions. Further, we have not disclosed the fair value of financial instruments specifically excluded from disclosure requirements such as bank-owned life insurance policies ("BOLI") and non-maturity deposit liabilities. Additionally, we held shares of Federal Home Loan Bank ("FHLB") of San Francisco stock and Visa Inc. Class B common stock, both recorded at cost, as there was no impairment or changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer as of March 31, 2022 or December 31, 2021. The values are discussed in Note 4, Investment Securities.
Fair value of loans is based on exit price techniques and obtained from an independent third-party that uses its proprietary valuation model and methodology and may differ from actual price from a prospective buyer. The discounted cash flow valuation approach reflects key inputs and assumptions that are unobservable, such as loan probability of default, loss given default, prepayment speed, and market discount rates. Fair value of fixed-rate time deposits is estimated by discounting future contractual cash flows using discount rates that reflect the current observable market rates offered for time deposits of similar remaining maturities. The value of off-balance-sheet financial instruments is estimated based on the fee income associated with the commitments which, in the absence of credit exposure, is considered to approximate their settlement value. The fair value of commitment fees was not material as of March 31, 2022 or December 31, 2021.
|
Investment Securities |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investments, Debt and Equity Securities [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment Securities | Investment Securities Our investment securities portfolio consists of U.S. Treasury securities, obligations of state and political subdivisions, U.S. federal government agencies such as Government National Mortgage Association ("GNMA") and Small Business Administration ("SBA"), U.S. government-sponsored enterprises ("GSEs"), such as Federal National Mortgage Association ("FNMA"), Federal Home Loan Mortgage Corporation ("FHLMC"), Federal Farm Credit Banks Funding Corporation and FHLB, U.S. Corporations and one asset-backed security collateralized by student loan pools. We also invest in residential and commercial mortgage-backed securities (“MBS”/"CMBS") and collateralized mortgage obligations (“CMOs”) issued or guaranteed by the GSEs, as reflected in the following table. A summary of the amortized cost, fair value and allowance for credit losses related to securities held-to-maturity as of March 31, 2022 and December 31, 2021 is presented below.
Management measures expected credit losses on held-to-maturity securities on a collective basis by major security type with each type sharing similar risk characteristics, and considers historical credit loss information that is adjusted for current conditions and reasonable and supportable forecasts. With regard to MBSs and CMOs issued or guaranteed by the GSEs, and SBA-backed securities, we expect to receive all the contractual principal and interest on these securities as such securities are backed by the full faith and credit of and/or guaranteed by the U.S. government. Accordingly, no allowance for credit losses has been recorded for these securities. With regard to securities issued by states and political subdivisions, management considers (i) issuer and/or guarantor credit ratings, (ii) historical probability of default and loss given default rates for given bond ratings and remaining maturity,(iii) whether issuers continue to make timely principal and interest payments under the contractual terms of the securities, (iv) internal credit review of the financial information, and (v) whether or not such securities have credit enhancements such as guarantees, contain a defeasance clause, or are pre-refunded by the issuers. Based on the comprehensive analysis, no credit losses are expected. The following table summarizes the amortized cost of our portfolio of held-to-maturity securities issued by states and political subdivisions and corporate bonds by Moody's and/or Standard & Poor's bond ratings as of March 31, 2022.
A summary of the amortized cost, fair value and allowance for credit losses related to securities available-for-sale as of March 31, 2022 and December 31, 2021 is presented below.
As part of our ongoing review of our investment securities portfolio, we reassessed the classification of certain securities issued by government sponsored agencies. In March 2022, we transferred $357.5 million of these securities from available-for-sale to held-to-maturity at fair value. We intend and have the ability to hold these securities to maturity. The net unrealized pre-tax loss of $14.8 million remained in accumulated other comprehensive loss and is accreted over the remaining lives of the securities. The amortized cost and fair value of investment debt securities by contractual maturity at March 31, 2022 and December 31, 2021 are shown below. Expected maturities may differ from contractual maturities if the issuers of the securities have the right to call or prepay obligations with or without call or prepayment penalties.
There were no sales of investment securities in the first quarter of 2022 or 2021.
Pledged investment securities are shown in the following table:
There were 354 and 217 securities in unrealized loss positions at March 31, 2022 and December 31, 2021, respectively. Those securities are summarized and classified according to the duration of the loss period in the tables below:
As of March 31, 2022, the investment portfolio included 17 investment securities that had been in a continuous loss position for twelve months or more and 337 investment securities that had been in a loss position for less than twelve months. Securities issued by government-sponsored agencies, such as FNMA and FHLMC, usually have implicit credit support by the U.S. federal government. However, since 2008, FNMA and FHLMC have been under government conservatorship and, therefore, contractual cash flows for these investments carry explicit guarantees by the U.S. federal government. Securities issued by the SBA and GNMA have explicit credit guarantees by the U.S. federal government, which protects us from credit losses on the contractual cash flows of the securities. Our investment in obligations of state and political subdivisions bonds are deemed credit worthy after our comprehensive analysis of the issuers' latest financial information, credit ratings by major credit agencies, and/or credit enhancements. At March 31, 2022, management determined that it did not intend to sell any investment securities with unrealized losses, and it is more likely than not that we will not be required to sell securities with unrealized losses before recovery of their amortized cost. No allowances for credit losses have been recognized on available-for-sale securities in an unrealized loss position as management does not believe any of the securities are impaired due to reasons of credit quality at March 31, 2022. Non-Marketable Securities Included in Other Assets FHLB Capital Stock As a member of the FHLB, we are required to maintain a minimum investment in FHLB capital stock determined by the Board of Directors of the FHLB. The minimum investment requirements can increase in the event we increase our total asset size or borrowings with the FHLB. Shares cannot be purchased or sold except between the FHLB and its members at the $100 per share par value. We held $16.7 million of FHLB stock included in other assets on the consolidated statements of condition at both March 31, 2022 and December 31, 2021. The carrying amounts of these investments are reasonable estimates of fair value because the securities are restricted to member banks and they do not have a readily determinable market value. Based on our analysis of FHLB's financial condition and certain qualitative factors, we determined that the FHLB stock was not impaired at March 31, 2022 and December 31, 2021. On April 28, 2022, FHLB announced a cash dividend for the first quarter of 2022 at an annualized dividend rate of 6.00% to be distributed in mid-May 2022. Cash dividends paid on FHLB capital stock are recorded as non-interest income. VISA Inc. Class B Common Stock As a member bank of Visa U.S.A., we held 10,439 shares of Visa Inc. Class B common stock at March 31, 2022 and December 31, 2021. These shares have a carrying value of zero and are restricted from resale to non-member banks of Visa U.S.A. until their conversion into Class A (voting) shares upon the termination of Visa Inc.'s Covered Litigation escrow account. Because of the restriction and the uncertainty on the conversion rate to Class A shares, these shares lack a readily determinable fair value. When converting this Class B common stock to Class A common stock based on the estimated conversion rate of 1.6181 both at March 31, 2022 and December 31, 2021, and the closing stock price of Class A shares at those respective dates, the converted value of our shares of Class B common stock would have been $3.7 million at both March 31, 2022 and December 31, 2021. The conversion rate is subject to further adjustment upon the final settlement of the covered litigation against Visa Inc. and its member banks. As such, the fair value of these Class B shares can differ significantly from their converted values. For further information, refer to Note 8, Commitments and Contingencies. Low Income Housing Tax Credits We invest in low-income housing tax credit funds as a limited partner, which totaled $2.9 million and $3.0 million recorded in other assets as of March 31, 2022 and December 31, 2021, respectively. In the first three months of 2022, we recognized $159 thousand of low-income housing tax credits and other tax benefits, offset by $134 thousand of amortization expense of low-income housing tax credit investment, as a component of income tax expense. As of March 31, 2022, our unfunded commitments for these low-income housing tax credit funds totaled $419 thousand. We did not recognize any impairment losses on these low-income housing tax credit investments during the first three months of 2022 or 2021, as the value of the future tax benefits exceeds the carrying value of the investments.
|
Loans and Allowance for Credit Losses on Loans |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Receivables [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loans and Allowance for Credit Losses on Loans | Loans and Allowance for Credit Losses on Loans The following table presents the amortized cost of loans by class as of March 31, 2022 and December 31, 2021.
1 Amortized cost includes net deferred loan origination costs (fees) of $690 thousand and $(901) thousand at March 31, 2022 and December 31, 2021, respectively. Amounts are also net of unrecognized purchase discounts of $2.6 million and $2.5 million at March 31, 2022 and December 31, 2021, respectively. Amortized cost excludes accrued interest, which totaled $6.2 million and $7.1 million at March 31, 2022 and December 31, 2021, respectively, and is included in interest receivable and other assets in the consolidated statements of condition. Lending Risks Commercial and Industrial Loans - Commercial loans are generally made to established small and mid-sized businesses to provide financing for their growth and working capital needs, equipment purchases and acquisitions. Management examines historical, current, and projected cash flows to determine the ability of the borrower to repay obligations as agreed. Commercial loans are made based primarily on the identified cash flows of the borrower and secondarily on the underlying collateral and guarantor support. The cash flows of borrowers, however, may not occur as expected, and the collateral securing these loans may fluctuate in value. Most commercial and industrial loans are secured by the assets being financed, such as accounts receivable and inventory, and typically include personal guarantees. We target stable businesses with guarantors who provide additional sources of repayment and have proven to be resilient in periods of economic stress. A weakened economy, and resultant decreased consumer and/or business spending, may have an effect on the credit quality of commercial loans. Pursuant to the 2020 CARES Act, Bank of Marin originated 2,876 guaranteed loans totaling $444.1 million in two rounds of the Small Business Administration's ("SBA") Paycheck Protection Program ("PPP"). Additionally in 2021, Bank of Marin assumed 113 PPP loans totaling $18.6 million from ARB as of the merger date. As of March 31, 2022, there were 191 PPP loans outstanding totaling $40.6 million (net of $993 thousand in unrecognized fees and costs), compared to 368 loans outstanding at December 31, 2021 totaling $111.2 million (net of $2.5 million in unrecognized fees and costs) included in commercial and industrial loan balances. PPP loans have terms of two to five years and earn interest at 1%. In addition, the SBA paid the Bank a fee of 1%-5% depending on the loan amount, which was netted with loan origination costs and accreted/amortized into interest income using the effective yield method over the contractual life of each loan. The recognition of fees and costs is accelerated when the SBA forgives the loan and/or the loan is paid off prior to maturity. PPP loans are fully guaranteed by the SBA if they meet the requirements of the program. As expected, the vast majority of the PPP loans have been fully forgiven by the SBA and we expect the majority of remaining loans to be forgiven as well. Commercial Real Estate Loans - Commercial real estate loans, which include income producing investment properties and owner-occupied real estate used for business purposes, are subject to underwriting standards and processes similar to commercial loans discussed above. We underwrite these loans to be repaid from cash flow from either the business or investment property and supported by real property collateral. Underwriting standards for commercial real estate loans include, but are not limited to, debt coverage and loan-to-value ratios. Furthermore, a large majority of our loans are guaranteed by the owners of the properties. Conditions in the real estate markets or downturn in the general economy may adversely affect our commercial real estate loans. In the event of a vacancy, we expect guarantors to carry the loans until they find a replacement tenant. The owner's substantial equity investment provides a strong economic incentive to continue to support the commercial real estate projects. As such, we have generally experienced a relatively low level of loss and delinquencies in this portfolio. Construction Loans - Construction loans are generally made to developers and builders to finance construction, renovation and occasionally land acquisitions in anticipation of near-term development. Construction loans include interest reserves that are used for the payment of interest during the development and marketing periods and are capitalized as part of the loan balance. When a construction loan is placed on nonaccrual status before the depletion of the interest reserve, we apply the interest funded by the interest reserve against the loan's principal balance. These loans are underwritten after evaluation of the borrower's financial strength, reputation, prior track record, and independent appraisals. We monitor all construction projects to determine whether they are on schedule, completed as planned and in accordance with the approved construction budgets. Significant events can affect the construction industry, including: the inherent volatility of real estate markets and vulnerability to delays due to weather, change orders, inability to obtain construction permits, labor or material shortages, and price changes. Estimates of construction costs and value associated with the completed project may be inaccurate. Repayment of construction loans is largely dependent on the ultimate success of the project. Consumer Loans - Consumer loans primarily consist of home equity lines of credit, other residential loans, floating homes, and indirect luxury auto loans, along with a small number of installment loans. Our other residential loans include tenancy-in-common fractional interest loans ("TIC") located almost entirely in San Francisco County. We originate consumer loans utilizing credit score information, debt-to-income ratio and loan-to-value ratio analysis. Diversification among consumer loan types, coupled with relatively small loan amounts that are spread across many individual borrowers, mitigates risk. We do not originate sub-prime residential mortgage loans, nor is it our practice to underwrite loans commonly referred to as "Alt-A mortgages," the characteristics of which are reduced documentation, borrowers with low FICO scores or collateral with high loan-to-value ratios. Credit Quality Indicators We use a risk rating system to evaluate asset quality, and to identify and monitor credit risk in individual loans, and in the loan portfolio. Our definitions of “Special Mention” risk graded loans, or worse, are consistent with those used by the Federal Deposit Insurance Corporation ("FDIC"). Our internally assigned grades are as follows: Pass and Watch - Loans to borrowers of acceptable or better credit quality. Borrowers in this category demonstrate fundamentally sound financial positions, repayment capacity, credit history and management expertise. Loans in this category must have an identifiable and stable source of repayment and meet the Bank’s policy regarding debt-service-coverage ratios. These borrowers are capable of sustaining normal economic, market or operational setbacks without significant financial consequences. Negative external industry factors are generally not present. The loan may be secured, unsecured or supported by non-real estate collateral for which the value is more difficult to determine and/or marketability is more uncertain. This category also includes “Watch” loans, where the primary source of repayment has been delayed. “Watch” is intended to be a transitional grade, with either an upgrade or downgrade within a reasonable period. Special Mention - Potential weaknesses that deserve close attention. If left uncorrected, those potential weaknesses may result in deterioration of the payment prospects for the asset. Special Mention assets do not present sufficient risk to warrant adverse classification. Substandard - Inadequately protected by either the current sound worth and paying capacity of the obligor or the collateral pledged, if any. A Substandard asset has a well-defined weakness or weaknesses that jeopardize(s) the liquidation of the debt. Substandard assets are characterized by the distinct possibility that we will sustain some loss if such weaknesses or deficiencies are not corrected. Well-defined weaknesses include adverse trends or developments of the borrower’s financial condition, managerial weaknesses and/or significant collateral deficiencies. Doubtful - Critical weaknesses that make collection or liquidation in full improbable. There may be specific pending events that work to strengthen the asset; however, the amount or timing of the loss may not be determinable. Pending events generally occur within one year of the asset being classified as Doubtful. Examples include: merger, acquisition, or liquidation; capital injection; guarantee; perfecting liens on additional collateral; and refinancing. Such loans are placed on non-accrual status and usually are collateral-dependent. We regularly review our credits for accuracy of risk grades whenever we receive new information. Borrowers are generally required to submit financial information at regular intervals. Typically, commercial borrowers with lines of credit are required to submit financial information with reporting intervals ranging from monthly to annually depending on credit size, risk and complexity. In addition, investor commercial real estate borrowers with loans exceeding a certain dollar threshold are usually required to submit rent rolls or property income statements annually. We monitor construction loans monthly. We review home equity and other consumer loans based on delinquency. We also review loans graded “Watch” or worse, regardless of loan type, no less than quarterly. The following tables present the loan portfolio by loan class, origination year and internal risk rating as of March 31, 2022 and December 31, 2021. We early adopted the vintage disclosure requirements of ASU 2022-02 prospectively as described in Note 2 beginning with the first quarter of 2022. Accordingly, the 2022 vintage table reflects gross charge-offs by loan class and year of origination. Generally, existing term loans that were re-underwritten are reflected in the table in the year of renewal. Lines of credit that have a conversion feature at the time of origination, such as construction to perm loans, are presented by year of origination.
The following table shows the amortized cost of loans by class, payment aging and non-accrual status as of March 31, 2022 and December 31, 2021.
2 None of the non-accrual loans as of March 31, 2022 or December 31, 2021 were earning interest on a cash basis. We recognized no interest income on non-accrual loans for the three months ended March 31, 2022 and 2021. There was one loan with amortized cost of $16 thousand placed on non-accrual status during the three months ended March 31, 2022 for which we reversed less than one thousand in interest income at the time of change in status. There were no loans placed on non-accrual status during the three months ended March 31, 2021. Collateral Dependent Loans The following table presents the amortized cost basis of individually analyzed collateral-dependent non-accrual loans by class at March 31, 2022 and December 31, 2021.
No collateral-dependent loans were in process of foreclosure at March 31, 2022 or December 31, 2021. In addition, the weighted average loan-to-value of collateral dependent loans was approximately 69% at March 31, 2022 and 67% at December 31, 2021. Troubled Debt Restructuring Our loan portfolio includes certain loans modified in a troubled debt restructuring (“TDR”), where we have granted economic concessions to borrowers experiencing financial difficulties. These concessions typically result from our loss mitigation activities and could include reductions in the interest rate, payment extensions, forgiveness of principal, forbearance or other actions. TDRs on non-accrual status at the time of restructure may be returned to accruing status after management considers the borrower’s sustained repayment performance for a reasonable period, generally nine months, and obtains reasonable assurance of repayment and performance. We may remove a loan from TDR designation if it meets all of the following conditions: •The loan is subsequently refinanced or restructured at current market interest rates and the new terms are consistent with the treatment of creditworthy borrowers under regular underwriting standards; •The borrower is no longer considered to be in financial difficulty; •Performance on the loan is reasonably assured; and •Existing loan did not have any forgiveness of principal or interest. There were no loans removed from TDR designation during the three months ended March 31, 2022 and 2021. In accordance with section 4013 of the CARES Act, subsequently amended by section 541 of the 2020 Economic Aid Act, we elected to apply the temporary accounting relief provisions for loan modifications that met certain criteria, which would otherwise be designated as TDRs under existing GAAP. As of March 31, 2022, two borrowing relationships with three loans totaling $23.6 million were continuing to benefit from payment relief. The weighted average loan-to-value ratio of the remaining payment relief loans was approximately 44%. We accrue and recognize interest income on loans under payment relief based on the original contractual interest rates. When payments resume at the end of the relief period, the payments will generally be applied to accrued interest due until accrued interest is fully paid. We monitor the financial situation of these clients closely and expect them to resume payments as the economy continues to recover. The following table summarizes the amortized cost of TDR loans by loan class as of March 31, 2022 and December 31, 2021.
1TDR loans on non-accrual status totaled $7.4 million at both March 31, 2022 and December 31, 2021. Unfunded commitments for TDR loans totaled $241 thousand and $441 thousand as of March 31, 2022 and December 31, 2021, respectively. There were no loans modified in a TDR during the three months ended March 31, 2022 and 2021. During the three months ended March 31, 2022 and March 31, 2021, there were no defaults on loans that had been modified in a TDR within the prior twelve-month period. We report defaulted TDRs based on a payment default definition of more than ninety days past due. Allowance for Credit Losses on Loans Rollforward The following table discloses activity in the allowance for credit losses on loans for the periods presented.
Pledged Loans Our FHLB line of credit is secured under terms of a blanket collateral agreement by a pledge of certain qualifying loans with unpaid principal balances of $1.295 billion and $1.330 billion at March 31, 2022 and December 31, 2021, respectively. In addition, we pledge eligible TIC loans, which totaled $102.2 million and $106.2 million at March 31, 2022 and December 31, 2021, respectively, to secure our borrowing capacity with the Federal Reserve Bank ("FRB"). For additional information, see Note 6, Borrowings. Related Party Loans The Bank has, and expects to have in the future, banking transactions in the ordinary course of its business with directors, officers, principal shareholders and their businesses or associates. These transactions, including loans, are granted on substantially the same terms, including interest rates and collateral on loans, as those prevailing at the same time for comparable transactions with persons not related to us. Likewise, these transactions do not involve more than the normal risk of collectability or present other unfavorable features. Related party loans totaled $5.1 million at March 31, 2022 and $7.9 million at December 31, 2021. In addition, undisbursed commitments to related parties totaled $562 thousand at March 31, 2022 and $8.6 million at December 31, 2021. The decreases in both the outstanding amount and undisbursed commitment as of March 31, 2022 were primarily due to a Director retirement in the first quarter.
|
Borrowings and Other Obligations |
3 Months Ended |
---|---|
Mar. 31, 2022 | |
Debt Disclosure [Abstract] | |
Borrowings and Other Obligations | Borrowings and Other Obligations Federal Funds Purchased – The Bank had unsecured available lines of credit with correspondent banks for overnight borrowings totaling $150.0 million at March 31, 2022 and December 31, 2021. In general, interest rates on these lines approximate the federal funds target rate. We had no overnight borrowings under these credit facilities at March 31, 2022 or December 31, 2021. Federal Home Loan Bank Borrowings – As of March 31, 2022 and December 31, 2021, the Bank had available lines of credit with the FHLB totaling $799.5 million and $820.5 million, respectively, based on eligible collateral of certain loans. There were no FHLB overnight borrowings at March 31, 2022 or December 31, 2021. As part of our acquisition of ARB, we assumed FHLB advances in the amount of $13.8 million that we paid off on August 25, 2021. Federal Reserve Line of Credit – The Bank has an available line of credit with the Federal Reserve Bank of San Francisco ("FRBSF") secured by certain residential loans. At March 31, 2022 and December 31, 2021, the Bank had borrowing capacity under this line totaling $57.3 million and $70.8 million, respectively, and had no outstanding borrowings with the FRBSF. Subordinated Debenture – As part of an acquisition in 2013, Bancorp assumed a subordinated debenture with a contractual balance of $4.1 million due to NorCal Community Bancorp Trust II (the "Trust"), established for the sole purpose of issuing trust preferred securities. On March 15, 2021, Bancorp redeemed in full the $2.8 million (book value) subordinated debenture due to the Trust, which had a 251.5% effective rate for the first three months of 2021, and included accelerated accretion of the $1.3 million remaining purchase discount due to the early redemption. Other Obligations – Finance lease liabilities totaling $388 thousand and $419 thousand at March 31, 2022 and December 31, 2021, respectively, are included in borrowings and other obligations in the consolidated statements of condition. See Note 8, Commitments and Contingencies, for additional information.
|
Stockholders' Equity |
3 Months Ended |
---|---|
Mar. 31, 2022 | |
Equity [Abstract] | |
Stockholders' Equity | Stockholders' Equity Dividends On April 22, 2022, Bancorp declared a $0.24 per share cash dividend, payable on May 13, 2022 to shareholders of record at the close of business on May 6, 2022. Share-Based Payments The fair value of stock options as of the grant date is recorded as stock-based compensation expense in the consolidated statements of comprehensive income over the requisite service period, which is generally the vesting period, with a corresponding increase in common stock. Stock-based compensation also includes compensation expense related to the issuance of restricted stock awards. The grant-date fair value of the restricted stock awards, which equals the grant date price, is recorded as compensation expense over the requisite service period with a corresponding increase in common stock as the shares vest. Beginning in 2018, stock option and restricted stock awards issued include a retirement eligibility clause whereby the requisite service period is satisfied at the retirement eligibility date. For those awards, we accelerate the recording of stock-based compensation when the award holder is eligible to retire. However, retirement eligibility does not affect the vesting of restricted stock or the exercisability of the stock options, which are based on the scheduled vesting period. Performance-based stock awards (restricted stock) are issued to a selected group of employees. Stock award vesting is contingent upon the achievement of pre-established long-term performance goals set by the Compensation Committee of the Board of Directors. Performance is measured over a three-year period and cliff vested. These performance-based stock awards were granted at a maximum opportunity level, and based on the achievement of the pre-established goals, the actual payouts can range from 0% to 200% of the target award. For performance-based stock awards, an estimate is made of the number of shares expected to vest based on the probability that the performance criteria will be achieved to determine the amount of compensation expense to be recognized. The estimate is re-evaluated quarterly and total compensation expense is adjusted for any change in the current period. We record excess tax benefits (deficiencies) resulting from the exercise of non-qualified stock options, the disqualifying disposition of incentive stock options and vesting of restricted stock awards as income tax benefits (expense) in the consolidated statements of comprehensive income with a corresponding decrease (increase) to current taxes payable. The holders of unvested restricted stock awards are entitled to dividends on the same per-share ratio as holders of common stock. Tax benefits for dividends paid on unvested restricted stock awards are recorded as tax benefits in the consolidated statements of comprehensive income with a corresponding decrease to current taxes payable. Dividends on forfeited awards are included in stock-based compensation expense. Stock options and restricted stock may be net settled in a cashless exercise by a reduction in the number of shares otherwise deliverable upon exercise or vesting in satisfaction of the exercise payment and/or applicable tax withholding requirements. During the three months ended March 31, 2022, we withheld 8,003 shares totaling $278 thousand at a weighted-average price of $34.76 for cashless exercises. During the three months ended March 31, 2021, we withheld 27,547 shares totaling $1.1 million at a weighted-average price of $38.87 for cashless exercises. Shares withheld under net settlement arrangements are available for future grants. Share Repurchase Program On April 23, 2018, Bancorp announced that its Board of Directors approved a share repurchase program under which Bancorp may repurchase up to $25.0 million of its outstanding common stock through May 1, 2019. Bancorp's Board of Directors subsequently extended the share repurchase program through February 28, 2020. A new share repurchase program was approved by the Board of Directors on January 24, 2020, which began on March 1, 2020 and allowed Bancorp to repurchase up to $25.0 million of its outstanding common stock and ended May 2021. On July 16, 2021, Bancorp Board of Directors approved a share repurchase program under which Bancorp could repurchase up to $25.0 million of its outstanding common stock through July 31, 2023. On October 22, 2021, Bancorp's Board of Directors approved an amendment to the current share repurchase program, which increased the total authorization from $25.0 million to $57.0 million and left the expiration date unchanged. Under the share repurchase program, Bancorp may purchase shares of its common stock through various means such as open market transactions, including block purchases, and privately negotiated transactions. The number of shares repurchased and the timing, manner, price and amount of any repurchases will be determined at Bancorp's discretion. Factors include, but are not limited to, stock price, trading volume and general market conditions, along with Bancorp’s general business conditions. The program may be suspended or discontinued at any time and does not obligate Bancorp to acquire any specific number of shares of its common stock. As part of the share repurchase program, Bancorp entered into a trading plan adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The 10b5-1 trading plan permits common stock to be repurchased at times that might otherwise be prohibited under insider trading laws or self-imposed trading restrictions. The 10b5-1 trading plan is administered by an independent broker and is subject to price, market volume and timing restrictions. Bancorp repurchased 23,275 shares totaling $877 thousand in the first quarter of 2022. Cumulative shares repurchased under the current program totaled 618,991 shares as of March 31, 2022 at an average price of $36.04 per share.
|
Commitments and Contingencies |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitments and Contingencies Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitments and Contingencies | Commitments and Contingencies Financial Instruments with Off-Balance Sheet Risk We make commitments to extend credit in the normal course of business to meet the financing needs of our customers. These financial instruments include commitments to extend credit in the form of loans or through standby letters of credit. Commitments to extend credit are agreements to lend to a customer as long as there is no violation of any condition established in the contract. Commitments generally have fixed expiration dates or other termination clauses and may require payment of a fee. Because various commitments will expire without being fully drawn, the total commitment amount does not necessarily represent future cash requirements. Our credit loss exposure is equal to the contractual amount of the commitment in the event of nonperformance by the borrower. We use the same credit underwriting criteria for all credit exposure. The amount of collateral obtained, if deemed necessary by us, is based on management's credit evaluation of the borrower. Collateral types pledged may include accounts receivable, inventory, other personal property and real property. The contractual amount of unfunded loan commitments and standby letters of credit not reflected in the consolidated statements of condition are as follows:
We record an allowance for credit losses on unfunded loan commitments at the balance sheet date based on estimates of the probability that these commitments will be drawn upon according to historical utilization experience of the different types of commitments and expected loss rates determined for pooled funded loans. The allowance for credit losses on unfunded commitments totaled $1.5 million and 1.8 million as of March 31, 2022 and December 31, 2021, respectively, which is included in interest payable and other liabilities in the consolidated statements of condition. We recorded a reversals of the allowance for credit losses on unfunded commitments of $318 thousand and $590 thousand for the three months ended March 31, 2022 and 2021 due to improved economic forecasts. Leases We lease premises under long-term non-cancelable operating leases with remaining terms of 7 months to 11 years, most of which include escalation clauses and one or more options to extend the lease term, and some of which contain lease termination clauses. Lease terms may include certain renewal options that were considered reasonably certain to be exercised. We lease certain equipment under finance leases with initial terms of 3 years to 5 years. The equipment finance leases do not contain renewal options, bargain purchase options or residual value guarantees. The following table shows the balances of operating and finance lease right-of-use assets and lease liabilities.
The following table shows supplemental disclosures of noncash investing and financing activities for the period presented.
The following table shows components of operating and finance lease cost.
The following table shows the future minimum lease payments, weighted average remaining lease terms, and weighted average discount rates under operating and finance lease arrangements as of March 31, 2022. The discount rates used to calculate the present value of lease liabilities were based on the collateralized FHLB borrowing rates that were commensurate with lease terms and minimum payments on the later of the date we adopted the new lease accounting standards or lease commencement date.
Litigation Matters Bancorp may be party to legal actions that arise from time to time in the normal course of business. Bancorp's management is not aware of any pending legal proceedings to which either it or the Bank may be a party or has recently been a party that will have a material adverse effect on the financial condition or results of operations of Bancorp or the Bank. The Bank is responsible for a proportionate share of certain litigation indemnifications provided to Visa U.S.A. ("Visa") by its member banks in connection with Visa's lawsuits related to anti-trust charges and interchange fees ("Covered Litigation"). Our proportionate share of the litigation indemnification liability does not change or transfer upon the sale of our Class B Visa shares to member banks. Visa established an escrow account to pay for settlements or judgments in the Covered Litigation. Under the terms of the U.S. retrospective responsibility plan, when Visa funds the litigation escrow account, it triggers a conversion rate reduction of the Class B common stock to shares of Class A common stock, effectively reducing the aggregate value of the Class B common stock held by Visa's member banks like us. In 2012, Visa had reached a $4.0 billion interchange multidistrict litigation class settlement agreement with plaintiffs representing a class of U.S. retailers. The escrow balance of $882 million as of March 31, 2022, combined with funds previously deposited with the court, are expected to cover the settlement payment obligations. The outcome of the Covered Litigation affects the conversion rate of Visa Class B common stock held by us to Visa Class A common stock, as discussed above and in Note 4, Investment Securities. The final conversion rate is subject to change depending on the final settlement payments, and the full effect on member banks is still uncertain. Litigation is ongoing and until the court approval process is complete, there is no assurance that Visa will resolve the claims as contemplated by the amended class settlement agreement, and additional lawsuits may arise from individual merchants who opted out of the class settlement. However, until the escrow account is fully depleted and the conversion rate of Class B to Class A common stock is reduced to zero, no future cash settlement payments are required by the member banks, such as us, on the Covered Litigation. Therefore, we are not required to record any contingent liabilities for the indemnification related to the Covered Litigation, as we consider the probability of losses to be remote.
|
Derivative Financial Instruments and Hedging Activities |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Derivative Financial Instruments and Hedging Activities | Derivative Financial Instruments and Hedging Activities We entered into interest rate swap agreements, primarily as an asset/liability management strategy, in order to mitigate the changes in the fair value of specified long-term fixed-rate loans (or firm commitments to enter into long-term fixed-rate loans) caused by changes in interest rates. These hedges allow us to offer long-term fixed-rate loans to customers without assuming the interest rate risk of a long-term asset. Converting our fixed-rate interest payments to floating-rate interest payments, generally benchmarked to the one-month U.S. dollar LIBOR index, protects us against changes in the fair value of our loans associated with fluctuating interest rates. Our credit exposure, if any, on interest rate swap asset positions is limited to the fair value (net of any collateral pledged to us) and interest payments of all swaps by each counterparty. Conversely, when an interest rate swap is in a liability position exceeding a certain threshold, we may be required to post collateral to the counterparty in an amount determined by the agreements. Collateral levels are monitored and adjusted on a regular basis for changes in interest rate swap values. As of March 31, 2022, we had four interest rate swap agreements, which are scheduled to mature in June 2031, October 2031, July 2032, and October 2037. All of our derivatives are accounted for as fair value hedges. The notional amounts of the interest rate contracts are equal to the notional amounts of the hedged loans. Our interest rate swap payments are settled monthly with counterparties. Accrued interest on the swaps totaled $10 thousand at March 31, 2022 and $11 thousand at December 31, 2021. Information on our derivatives follows:
1 See Note 3, Fair Value of Assets and Liabilities, for valuation methodology. The following table presents the carrying amount and associated cumulative basis adjustment related to the application of fair value hedge accounting that is included in the carrying amount of hedged assets as of March 31, 2022 and December 31, 2021.
The following table presents the net losses recognized in interest income on loans on the consolidated statements of comprehensive income related to our derivatives designated as fair value hedges.
1 Represents the income line item in the statement of comprehensive income in which the effects of fair value hedges are recorded. Our derivative transactions with counterparties are under International Swaps and Derivative Association (“ISDA”) master agreements that include “right of set-off” provisions. “Right of set-off” provisions are legally enforceable rights to offset recognized amounts and there may be an intention to settle such amounts on a net basis. We do not offset such financial instruments for financial reporting purposes. Information on financial instruments that are eligible for offset in the consolidated statements of condition follows:
1 Amounts exclude accrued interest on swaps. For more information on how we account for our interest rate swaps, refer to Note 1 to the Consolidated Financial Statements included in our 2021 Form 10-K filed with the SEC on March 15, 2022.
|
Merger |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Business Combination and Asset Acquisition [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Merger | Merger As described in Note 1, Basis of Presentation, Bancorp completed its merger with American River Bankshares in August 2021. The Merger expanded Bank of Marin's presence throughout the Greater Sacramento, Amador and Sonoma County Regions where ARB had ten branches. The Merger added $297.8 million in investment securities, $419.4 million in loans and $790.0 million in deposits to Bank of Marin as of the merger date. Bancorp accounted for the Merger as a business combination under the acquisition method of accounting. The assets acquired and liabilities assumed, both tangible and intangible, were recorded at their fair values as of the merger date in accordance with ASC 805, Business Combinations. AMRB shareholders received 0.575 shares of Bancorp's common stock for each share of AMRB common stock outstanding immediately prior to the Merger resulting in the issuance of 3,441,235 shares of Bancorp common stock. In addition, merger consideration included cash paid for outstanding stock options and cash paid in lieu of fractional shares, as summarized in the following table.
We recorded $42.6 million in goodwill, which represents the excess of the total merger consideration paid over the fair value of the assets acquired, net of the fair values of liabilities assumed. Goodwill mainly reflects expected value created through the combined operations of AMRB and Bancorp and is evaluated for impairment annually. The core deposit intangible ("CDI") represents the estimated future benefits of acquired deposits and is recorded separately from the related deposits. We recorded a core deposit intangible asset of $3.9 million related to the ARB merger, of which $184 thousand was amortized in the first quarter of 2022 and no amortization was recognized in the comparable quarter of 2021. The CDI is amortized on an accelerated basis over an estimated ten-year life and is evaluated periodically for impairment. No impairment loss was recognized as of March 31, 2022. Merger-related one time and conversion costs are recognized as incurred and continue until all systems have been converted and operational functions are fully integrated. Bancorp's merger-related costs reflected in the consolidated statements of comprehensive income are summarized in the following table.
|
Basis of Presentation - (Policies) |
3 Months Ended |
---|---|
Mar. 31, 2022 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Basis of Presentation | The consolidated financial statements include the accounts of Bancorp, a bank holding company, and its wholly-owned bank subsidiary, Bank of Marin, a California state-chartered commercial bank. Effective August 6, 2021 (the "merger date"), American River Bankshares ("AMRB") merged with and into Bank of Marin Bancorp ("Bancorp"), with Bank of Marin Bancorp surviving, followed thereafter at 12:05 AM on August 7, 2021, by the merger of American River Bank ("ARB") with and into Bank of Marin, with Bank of Marin (the "Bank") surviving, (collectively the "Merger"). The Merger was accounted for under ASC 805, Business Combinations. See Note 10, Merger, for further detail. References to “we,” “our,” “us” mean Bancorp and the Bank that are consolidated for financial reporting purposes. The accompanying unaudited consolidated interim financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC"). Certain information and note disclosures normally included in annual financial statements prepared in accordance with U.S. generally accepted accounting principles ("GAAP") have been condensed or omitted pursuant to those rules and regulations. Certain items in prior financial statements were reclassified to conform to the current presentation, including the reclassification of the provision for credit losses on unfunded commitments in the second quarter of 2021 from non-interest expense to a separate line item under the provision for credit losses on loans in the consolidated statements of comprehensive income. This reclassification had no impact to net income or stockholders' equity. Although we believe that the disclosures are adequate and the information presented is not misleading, we suggest that these interim financial statements be read in conjunction with the annual financial statements and the notes thereto included in our 2021 Annual Report on Form 10-K. In the opinion of management, the unaudited consolidated financial statements reflect all adjustments, which are necessary for a fair presentation of the consolidated financial position, the results of operations, changes in comprehensive income, changes in stockholders’ equity, and cash flows for the periods presented. All material intercompany transactions have been eliminated. The results of these interim periods may not be indicative of the results for the full year or for any other period.
|
Earnings Per Share | Basic earnings per share (“EPS”) are calculated by dividing net income by the weighted average number of common shares outstanding during each period, excluding unvested restricted stock awards. Diluted EPS are calculated using the weighted average number of potentially dilutive common shares. The number of potentially dilutive common shares included in the quarterly diluted EPS is computed using the average market prices during the three months included in the reporting period under the treasury stock method. The number of potentially dilutive common shares included in year-to-date diluted EPS is a year-to-date weighted average of potentially dilutive common shares included in each quarterly diluted EPS computation. In computing diluted EPS, we exclude anti-dilutive shares such as options whose exercise prices exceed the current common stock price, as they would not reduce EPS under the treasury method. We have two forms of outstanding common stock: common stock and unvested restricted stock awards. Holders of unvested restricted stock awards receive non-forfeitable dividends at the same rate as common shareholders and they both share equally in undistributed earnings. Under the two-class method, the difference in EPS is nominal for these participating securities. |
Recently Adopted and Issued Accounting Standards | Recently Adopted and Issued Accounting Standards Accounting Standards Not Yet Effective In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848). The amendments in this ASU are elective and provide optional guidance for a limited period of time to ease the potential burden of accounting for, or recognizing the effects of reference rate reform. The amendments in this ASU provide optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. The amendments in this ASU may be elected as of March 12, 2020 through December 31, 2022. An entity may choose to elect the amendments in this update at an interim period subsequent to March 12, 2020 with adoption methods varying based on transaction type. We have not elected to apply amendments at this time and will assess the applicability of this ASU to us as we continue to monitor guidance for reference rate reform from FASB and its impact on our financial condition and results of operations. In January 2021, the FASB issued ASU No. 2021-01, Reference Rate Reform (Topic 848). The main amendments in this ASU are intended to clarify certain optional expedients and scope of derivative instruments. The amendments are elective and effective immediately upon issuance of this ASU. Amendments may be elected through December 31, 2022. As of March 31, 2022, we had four interest rate swap contracts with notional values totaling $12.8 million indexed to LIBOR that will either be subject to the fall-back index rate stipulated by the ISDA protocol or modified to other reference rates such as Prime or SOFR as mutually agreed by us and our counterparty. We have not elected to apply the amendments at this time and will continue to assess the applicability of this ASU to us as we monitor guidance for reference rate reform from FASB and its impact on our financial condition and results of operations. In October 2021, the FASB issued ASU No. 2021-08, Accounting for Contract Assets and Contract Liabilities From Contracts With Customers (Topic 805). The amendments address diversity in accounting practices and requires acquiring companies to apply ASC 606, Revenue from Contracts with Customers to recognize and measure contract assets and contract liabilities from contracts with customers acquired in a business combination, as opposed to other methods such as fair value. The amendments improve comparability after the business combination by providing consistent recognition and measurement guidance for revenue contracts with customers acquired in a business combination. The amendments are to be applied prospectively to business combinations occurring on or after December 15, 2022 and early adoption is permitted. In the event of a future business combination, we will assess the impact of the ASU on our financial condition and results of operations. In March 2022, the FASB issued ASU No. 2022-02, Financial Instruments - Credit Losses (Topic 326): Troubled Debt Restructurings and Vintage Disclosures. The amendment eliminates the recognition measurement guidance for troubled debt restructured ("TDR") loans, and instead requires an entity to evaluate whether a modification represents a new loan or a continuation of an existing loan in accordance with ASC Topic 310-20, Receivables - Nonrefundable Fees and Other Costs. In addition, the amendment requires that an entity include in its vintage disclosures the current period-gross loan charge-offs by year of origination. The amendments are effective for years beginning after December 15, 2022, and should be applied prospectively, except that an entity has the option to apply a modified retrospective method for TDR loans, resulting in a cumulative-effect adjustment to retained earnings in the period of adoption. An entity may elect to early adopt each of the amendments separately. As such, we early adopted the current period charge-off disclosures in the first quarter of 2022 and intend to adopt the loan modification amendments when effective in the first quarter of 2023. Neither the early adoption of the amendments related to gross charge-off disclosures nor the future adoption of the TDR amendments had or will have a material impact on our financial condition or results of operations. In March 2022, the FASB issued ASU No. 2022-01, Derivatives and Hedging (Topic 815): Fair Value Hedging - Portfolio Layer Method. Among other things, the ASU renames the "last-of-layer" method to the "portfolio layer" method and makes fair value hedging more accessible for hedge accounting of interest rate risk for portfolios and financial assets. For example, the guidance permits an entity to apply the same portfolio hedging method to both prepayable and non-prepayable financial assets, thereby providing for consistency between accounting for similar hedges. The amendments are effective for years beginning after December 15, 2022. The adoption of the amendments will not impact our existing hedge accounting, disclosures, financial condition or results of operations.
|
Fair Value Hierarchy and Fair Value Measurement | We group our assets and liabilities that are measured at fair value into three levels within the fair value hierarchy, based on the markets in which the assets and liabilities are traded and the reliability of the assumptions used to determine fair value. These levels are: Level 1: Valuations are based on unadjusted quoted prices in active markets for identical assets or liabilities. Level 2: Valuations are based on quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active and model-based valuations for which all significant assumptions are observable or can be corroborated by observable market data. Level 3: Valuations are based on unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. Values are determined using pricing models and discounted cash flow models and may include significant management judgment and estimation. Transfers between levels of the fair value hierarchy are recognized through our monthly and/or quarterly valuation process in the reporting period during which the event or circumstances that caused the transfer occurred. No such transfers occurred in the years presented. Available-for-sale securities are recorded at fair value on a recurring basis. When available, quoted market prices (Level 1) are used to determine the fair value of available-for-sale securities. Level 1 securities include U.S. Treasury securities. If quoted market prices are not available, we obtain pricing information from a reputable third-party service provider, who may utilize valuation techniques that use current market-based or independently sourced parameters, such as bid/ask prices, dealer-quoted prices, interest rates, benchmark yield curves, prepayment speeds, probability of default, loss severity and credit spreads (Level 2). Level 2 securities include asset-backed securities, obligations of state and political subdivisions, U.S. agencies or government-sponsored agencies' debt securities, mortgage-backed securities, government agency-issued, and corporate bonds.Held-to-maturity securities may be written down to fair value as a result of an other-than-temporary impairment, and weFair value of held-to-maturity securities is determined using the same techniques discussed above for available-for-sale securities.On a recurring basis, derivative financial instruments are recorded at fair value, which is based on the income approach using observable Level 2 market inputs, reflecting market expectations of future interest rates as of the measurement date. Standard valuation techniques are used to calculate the present value of the future expected cash flows assuming an orderly transaction. Valuation adjustments may be made to reflect both our own credit risk and the counterparties’ credit risk in determining the fair value of the derivatives. Level 2 inputs for the valuations are limited to observable market prices for London Interbank Offered Rate ("LIBOR") and Overnight Index Swap ("OIS") rates (for the very short term), quoted prices for LIBOR futures contracts, observable market prices for LIBOR and OIS swap rates, and one-month and three-month LIBOR basis spreads at commonly quoted intervals. Mid-market pricing of the inputs is used as a practical expedient in the fair value measurements. We project spot rates at reset days specified by each swap contract to determine future cash flows, then discount to present value using OIS curves as of the measurement date. When the value of any collateral placed with counterparties is less than the interest rate derivative liability, a credit valuation adjustment ("CVA") is applied to reflect the credit risk we pose to counterparties. We have used the spread between the Standard & Poor's BBB rated U.S. Bank Composite rate and LIBOR for the closest maturity term corresponding to the duration of the swaps to derive the CVA. A similar credit risk adjustment, correlated to the credit standing of the counterparty, is made when collateral posted by the counterparty does not fully cover their liability to us. For further discussion on our methodology in valuing our derivative financial instruments, refer to Note 9, Derivative Financial Instruments and Hedging Activities. Certain financial assets may be measured at fair value on a non-recurring basis. These assets are subject to fair value adjustments that result from the application of the lower of cost or fair value accounting or write-downs of individual assets, such as individually analyzed loans that are collateral dependent and other real estate owned ("OREO"). OREO represents collateral acquired through foreclosure and is initially recorded at fair value as established by a current appraisal of the collateral. Subsequent to foreclosure, OREO is carried at the lower of cost or fair value, less estimated costs to sell. OREO values are reviewed on an ongoing basis and any subsequent decline in fair value is recorded as a foreclosed asset expense in the current period. The value of OREO is classified as Level 3. Our current OREO resulted from the ARB Merger.Fair value of loans is based on exit price techniques and obtained from an independent third-party that uses its proprietary valuation model and methodology and may differ from actual price from a prospective buyer. The discounted cash flow valuation approach reflects key inputs and assumptions that are unobservable, such as loan probability of default, loss given default, prepayment speed, and market discount rates. Fair value of fixed-rate time deposits is estimated by discounting future contractual cash flows using discount rates that reflect the current observable market rates offered for time deposits of similar remaining maturities. The value of off-balance-sheet financial instruments is estimated based on the fee income associated with the commitments which, in the absence of credit exposure, is considered to approximate their settlement value.
|
Finance, Loan and Lease Receivables, Held-for-investment, Allowance and Nonperforming Loans | Commercial and Industrial Loans - Commercial loans are generally made to established small and mid-sized businesses to provide financing for their growth and working capital needs, equipment purchases and acquisitions. Management examines historical, current, and projected cash flows to determine the ability of the borrower to repay obligations as agreed. Commercial loans are made based primarily on the identified cash flows of the borrower and secondarily on the underlying collateral and guarantor support. The cash flows of borrowers, however, may not occur as expected, and the collateral securing these loans may fluctuate in value. Most commercial and industrial loans are secured by the assets being financed, such as accounts receivable and inventory, and typically include personal guarantees. We target stable businesses with guarantors who provide additional sources of repayment and have proven to be resilient in periods of economic stress. A weakened economy, and resultant decreased consumer and/or business spending, may have an effect on the credit quality of commercial loans. Pursuant to the 2020 CARES Act, Bank of Marin originated 2,876 guaranteed loans totaling $444.1 million in two rounds of the Small Business Administration's ("SBA") Paycheck Protection Program ("PPP"). Additionally in 2021, Bank of Marin assumed 113 PPP loans totaling $18.6 million from ARB as of the merger date. As of March 31, 2022, there were 191 PPP loans outstanding totaling $40.6 million (net of $993 thousand in unrecognized fees and costs), compared to 368 loans outstanding at December 31, 2021 totaling $111.2 million (net of $2.5 million in unrecognized fees and costs) included in commercial and industrial loan balances. PPP loans have terms of two to five years and earn interest at 1%. In addition, the SBA paid the Bank a fee of 1%-5% depending on the loan amount, which was netted with loan origination costs and accreted/amortized into interest income using the effective yield method over the contractual life of each loan. The recognition of fees and costs is accelerated when the SBA forgives the loan and/or the loan is paid off prior to maturity. PPP loans are fully guaranteed by the SBA if they meet the requirements of the program. As expected, the vast majority of the PPP loans have been fully forgiven by the SBA and we expect the majority of remaining loans to be forgiven as well. Commercial Real Estate Loans - Commercial real estate loans, which include income producing investment properties and owner-occupied real estate used for business purposes, are subject to underwriting standards and processes similar to commercial loans discussed above. We underwrite these loans to be repaid from cash flow from either the business or investment property and supported by real property collateral. Underwriting standards for commercial real estate loans include, but are not limited to, debt coverage and loan-to-value ratios. Furthermore, a large majority of our loans are guaranteed by the owners of the properties. Conditions in the real estate markets or downturn in the general economy may adversely affect our commercial real estate loans. In the event of a vacancy, we expect guarantors to carry the loans until they find a replacement tenant. The owner's substantial equity investment provides a strong economic incentive to continue to support the commercial real estate projects. As such, we have generally experienced a relatively low level of loss and delinquencies in this portfolio. Construction Loans - Construction loans are generally made to developers and builders to finance construction, renovation and occasionally land acquisitions in anticipation of near-term development. Construction loans include interest reserves that are used for the payment of interest during the development and marketing periods and are capitalized as part of the loan balance. When a construction loan is placed on nonaccrual status before the depletion of the interest reserve, we apply the interest funded by the interest reserve against the loan's principal balance. These loans are underwritten after evaluation of the borrower's financial strength, reputation, prior track record, and independent appraisals. We monitor all construction projects to determine whether they are on schedule, completed as planned and in accordance with the approved construction budgets. Significant events can affect the construction industry, including: the inherent volatility of real estate markets and vulnerability to delays due to weather, change orders, inability to obtain construction permits, labor or material shortages, and price changes. Estimates of construction costs and value associated with the completed project may be inaccurate. Repayment of construction loans is largely dependent on the ultimate success of the project. Consumer Loans - Consumer loans primarily consist of home equity lines of credit, other residential loans, floating homes, and indirect luxury auto loans, along with a small number of installment loans. Our other residential loans include tenancy-in-common fractional interest loans ("TIC") located almost entirely in San Francisco County. We originate consumer loans utilizing credit score information, debt-to-income ratio and loan-to-value ratio analysis. Diversification among consumer loan types, coupled with relatively small loan amounts that are spread across many individual borrowers, mitigates risk. We do not originate sub-prime residential mortgage loans, nor is it our practice to underwrite loans commonly referred to as "Alt-A mortgages," the characteristics of which are reduced documentation, borrowers with low FICO scores or collateral with high loan-to-value ratios. Credit Quality Indicators We use a risk rating system to evaluate asset quality, and to identify and monitor credit risk in individual loans, and in the loan portfolio. Our definitions of “Special Mention” risk graded loans, or worse, are consistent with those used by the Federal Deposit Insurance Corporation ("FDIC"). Our internally assigned grades are as follows: Pass and Watch - Loans to borrowers of acceptable or better credit quality. Borrowers in this category demonstrate fundamentally sound financial positions, repayment capacity, credit history and management expertise. Loans in this category must have an identifiable and stable source of repayment and meet the Bank’s policy regarding debt-service-coverage ratios. These borrowers are capable of sustaining normal economic, market or operational setbacks without significant financial consequences. Negative external industry factors are generally not present. The loan may be secured, unsecured or supported by non-real estate collateral for which the value is more difficult to determine and/or marketability is more uncertain. This category also includes “Watch” loans, where the primary source of repayment has been delayed. “Watch” is intended to be a transitional grade, with either an upgrade or downgrade within a reasonable period. Special Mention - Potential weaknesses that deserve close attention. If left uncorrected, those potential weaknesses may result in deterioration of the payment prospects for the asset. Special Mention assets do not present sufficient risk to warrant adverse classification. Substandard - Inadequately protected by either the current sound worth and paying capacity of the obligor or the collateral pledged, if any. A Substandard asset has a well-defined weakness or weaknesses that jeopardize(s) the liquidation of the debt. Substandard assets are characterized by the distinct possibility that we will sustain some loss if such weaknesses or deficiencies are not corrected. Well-defined weaknesses include adverse trends or developments of the borrower’s financial condition, managerial weaknesses and/or significant collateral deficiencies. Doubtful - Critical weaknesses that make collection or liquidation in full improbable. There may be specific pending events that work to strengthen the asset; however, the amount or timing of the loss may not be determinable. Pending events generally occur within one year of the asset being classified as Doubtful. Examples include: merger, acquisition, or liquidation; capital injection; guarantee; perfecting liens on additional collateral; and refinancing. Such loans are placed on non-accrual status and usually are collateral-dependent. We regularly review our credits for accuracy of risk grades whenever we receive new information. Borrowers are generally required to submit financial information at regular intervals. Typically, commercial borrowers with lines of credit are required to submit financial information with reporting intervals ranging from monthly to annually depending on credit size, risk and complexity. In addition, investor commercial real estate borrowers with loans exceeding a certain dollar threshold are usually required to submit rent rolls or property income statements annually. We monitor construction loans monthly. We review home equity and other consumer loans based on delinquency. We also review loans graded “Watch” or worse, regardless of loan type, no less than quarterly.
|
Troubled Debt Restructuring | Our loan portfolio includes certain loans modified in a troubled debt restructuring (“TDR”), where we have granted economic concessions to borrowers experiencing financial difficulties. These concessions typically result from our loss mitigation activities and could include reductions in the interest rate, payment extensions, forgiveness of principal, forbearance or other actions. TDRs on non-accrual status at the time of restructure may be returned to accruing status after management considers the borrower’s sustained repayment performance for a reasonable period, generally nine months, and obtains reasonable assurance of repayment and performance. We may remove a loan from TDR designation if it meets all of the following conditions: •The loan is subsequently refinanced or restructured at current market interest rates and the new terms are consistent with the treatment of creditworthy borrowers under regular underwriting standards; •The borrower is no longer considered to be in financial difficulty; •Performance on the loan is reasonably assured; and •Existing loan did not have any forgiveness of principal or interest.
|
Basis of Presentation - (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Earnings Per Share Reconciliation | The following table shows: 1) weighted average basic shares, 2) potentially dilutive weighted average common shares related to stock options and unvested restricted stock awards, and 3) weighted average diluted shares. Basic earnings per share (“EPS”) are calculated by dividing net income by the weighted average number of common shares outstanding during each period, excluding unvested restricted stock awards. Diluted EPS are calculated using the weighted average number of potentially dilutive common shares. The number of potentially dilutive common shares included in the quarterly diluted EPS is computed using the average market prices during the three months included in the reporting period under the treasury stock method. The number of potentially dilutive common shares included in year-to-date diluted EPS is a year-to-date weighted average of potentially dilutive common shares included in each quarterly diluted EPS computation. In computing diluted EPS, we exclude anti-dilutive shares such as options whose exercise prices exceed the current common stock price, as they would not reduce EPS under the treasury method. We have two forms of outstanding common stock: common stock and unvested restricted stock awards. Holders of unvested restricted stock awards receive non-forfeitable dividends at the same rate as common shareholders and they both share equally in undistributed earnings. Under the two-class method, the difference in EPS is nominal for these participating securities.
|
Fair Value of Assets and Liabilities - (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis | The following table summarizes our assets and liabilities that were required to be recorded at fair value on a recurring basis.
1 Other comprehensive income ("OCI") or net income ("NI").
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Fair Value Assets Measured on Non-recurring Basis | The following table presents the carrying value of assets measured at fair value on a non-recurring basis and that were held in the consolidated statements of condition at each respective period end, by level within the fair value hierarchy as of March 31, 2022 and December 31, 2021.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Fair Value by Balance Sheet Grouping | The table below is a summary of fair value estimates for financial instruments as of March 31, 2022 and December 31, 2021, excluding financial instruments recorded at fair value on a recurring basis (summarized in the first table in this note). The carrying amounts in the following table are recorded in the consolidated statements of condition under the indicated captions. Further, we have not disclosed the fair value of financial instruments specifically excluded from disclosure requirements such as bank-owned life insurance policies ("BOLI") and non-maturity deposit liabilities. Additionally, we held shares of Federal Home Loan Bank ("FHLB") of San Francisco stock and Visa Inc. Class B common stock, both recorded at cost, as there was no impairment or changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer as of March 31, 2022 or December 31, 2021. The values are discussed in Note 4, Investment Securities.
|
Investment Securities - (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investments, Debt and Equity Securities [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summary of Held-to-Maturity Investments | A summary of the amortized cost, fair value and allowance for credit losses related to securities held-to-maturity as of March 31, 2022 and December 31, 2021 is presented below.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Bond Ratings for Held-to-Maturity Securities | The following table summarizes the amortized cost of our portfolio of held-to-maturity securities issued by states and political subdivisions and corporate bonds by Moody's and/or Standard & Poor's bond ratings as of March 31, 2022.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summary of Available-for-Sale Investments | A summary of the amortized cost, fair value and allowance for credit losses related to securities available-for-sale as of March 31, 2022 and December 31, 2021 is presented below.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investments Classified by Contractual Maturity Date | The amortized cost and fair value of investment debt securities by contractual maturity at March 31, 2022 and December 31, 2021 are shown below. Expected maturities may differ from contractual maturities if the issuers of the securities have the right to call or prepay obligations with or without call or prepayment penalties.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Financial Instruments Owned and Pledged as Collateral | Pledged investment securities are shown in the following table:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Unrealized Loss on Investments | There were 354 and 217 securities in unrealized loss positions at March 31, 2022 and December 31, 2021, respectively. Those securities are summarized and classified according to the duration of the loss period in the tables below:
|
Loans and Allowance for Credit Losses on Loans - (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Receivables [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Loans by Class | The following table presents the amortized cost of loans by class as of March 31, 2022 and December 31, 2021.
1 Amortized cost includes net deferred loan origination costs (fees) of $690 thousand and $(901) thousand at March 31, 2022 and December 31, 2021, respectively. Amounts are also net of unrecognized purchase discounts of $2.6 million and $2.5 million at March 31, 2022 and December 31, 2021, respectively. Amortized cost excludes accrued interest, which totaled $6.2 million and $7.1 million at March 31, 2022 and December 31, 2021, respectively, and is included in interest receivable and other assets in the consolidated statements of condition.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financing Receivable Credit Quality Indicators | The following tables present the loan portfolio by loan class, origination year and internal risk rating as of March 31, 2022 and December 31, 2021. We early adopted the vintage disclosure requirements of ASU 2022-02 prospectively as described in Note 2 beginning with the first quarter of 2022. Accordingly, the 2022 vintage table reflects gross charge-offs by loan class and year of origination. Generally, existing term loans that were re-underwritten are reflected in the table in the year of renewal. Lines of credit that have a conversion feature at the time of origination, such as construction to perm loans, are presented by year of origination.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Past Due Financing Receivables | The following table shows the amortized cost of loans by class, payment aging and non-accrual status as of March 31, 2022 and December 31, 2021.
2 None of the non-accrual loans as of March 31, 2022 or December 31, 2021 were earning interest on a cash basis. We recognized no interest income on non-accrual loans for the three months ended March 31, 2022 and 2021. There was one loan with amortized cost of $16 thousand placed on non-accrual status during the three months ended March 31, 2022 for which we reversed less than one thousand in interest income at the time of change in status. There were no loans placed on non-accrual status during the three months ended March 31, 2021.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Collateral Dependent Loans | The following table presents the amortized cost basis of individually analyzed collateral-dependent non-accrual loans by class at March 31, 2022 and December 31, 2021.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Troubled Debt Restructurings on Financing Receivables | The following table summarizes the amortized cost of TDR loans by loan class as of March 31, 2022 and December 31, 2021.
1TDR loans on non-accrual status totaled $7.4 million at both March 31, 2022 and December 31, 2021. Unfunded commitments for TDR loans totaled $241 thousand and $441 thousand as of March 31, 2022 and December 31, 2021, respectively.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Allowance for Credit Losses on Financing Receivables | The following table discloses activity in the allowance for credit losses on loans for the periods presented.
|
Commitments and Contingencies - (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitments and Contingencies Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Undrawn Loan Commitments and Standby Letters of Credit | The contractual amount of unfunded loan commitments and standby letters of credit not reflected in the consolidated statements of condition are as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Operating and Finance Lease Right-of-Use Assets and Lease Liabilities | The following table shows the balances of operating and finance lease right-of-use assets and lease liabilities.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Components of Operating and Finance Lease Cost | The following table shows supplemental disclosures of noncash investing and financing activities for the period presented.
The following table shows components of operating and finance lease cost.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Operating Lease Liability Maturities | The following table shows the future minimum lease payments, weighted average remaining lease terms, and weighted average discount rates under operating and finance lease arrangements as of March 31, 2022. The discount rates used to calculate the present value of lease liabilities were based on the collateralized FHLB borrowing rates that were commensurate with lease terms and minimum payments on the later of the date we adopted the new lease accounting standards or lease commencement date.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Finance Lease Liability Maturities | The following table shows the future minimum lease payments, weighted average remaining lease terms, and weighted average discount rates under operating and finance lease arrangements as of March 31, 2022. The discount rates used to calculate the present value of lease liabilities were based on the collateralized FHLB borrowing rates that were commensurate with lease terms and minimum payments on the later of the date we adopted the new lease accounting standards or lease commencement date.
|
Derivative Financial Instruments and Hedging Activities - (Tables) |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2022 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Derivative Instruments and Hedging Activities Disclosure [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value | Information on our derivatives follows:
1 See Note 3, Fair Value of Assets and Liabilities, for valuation methodology. The following table presents the carrying amount and associated cumulative basis adjustment related to the application of fair value hedge accounting that is included in the carrying amount of hedged assets as of March 31, 2022 and December 31, 2021.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance | The following table presents the net losses recognized in interest income on loans on the consolidated statements of comprehensive income related to our derivatives designated as fair value hedges.
1 Represents the income line item in the statement of comprehensive income in which the effects of fair value hedges are recorded.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Offsetting Liabilities | Information on financial instruments that are eligible for offset in the consolidated statements of condition follows:
1 Amounts exclude accrued interest on swaps.
|
Merger (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Business Combination and Asset Acquisition [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Consideration Paid for AMRB | In addition, merger consideration included cash paid for outstanding stock options and cash paid in lieu of fractional shares, as summarized in the following table.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Merger-Related One-Time and Conversion Costs | Merger-related one time and conversion costs are recognized as incurred and continue until all systems have been converted and operational functions are fully integrated. Bancorp's merger-related costs reflected in the consolidated statements of comprehensive income are summarized in the following table.
|
Basis of Presentation - Reconciliation of Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands |
3 Months Ended | ||
---|---|---|---|
Mar. 31, 2022 |
Dec. 31, 2021 |
Mar. 31, 2021 |
|
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |||
Weighted average basic shares outstanding (in shares) | 15,876 | 15,948 | 13,363 |
Potentially dilutive common shares related to: | |||
Stock options (in shares) | 52 | 81 | |
Unvested restricted stock awards (in shares) | 18 | 25 | |
Weighted average diluted shares outstanding (in shares) | 15,946 | 16,027 | 13,469 |
Net income | $ 10,465 | $ 9,714 | $ 8,947 |
Basic EPS (in dollars per share) | $ 0.66 | $ 0.61 | $ 0.67 |
Diluted EPS (in dollars per share) | $ 0.66 | $ 0.61 | $ 0.66 |
Weighted average anti-dilutive shares not included in the calculation of diluted EPS (in shares) | 125 | 80 |
Recently Adopted and Issued Accounting Standards (Details) $ in Millions |
Mar. 31, 2022
USD ($)
contract
|
---|---|
Accounting Policies [Abstract] | |
Number of interest rate swap contract | contract | 4 |
Derivative, notional amount | $ | $ 12.8 |
Fair Value of Assets and Liabilities - Recorded on a Recurring Basis (Details) - USD ($) $ in Thousands |
Mar. 31, 2022 |
Dec. 31, 2021 |
---|---|---|
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale securities | $ 955,457 | $ 1,167,568 |
SBA-backed securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale securities | 54,652 | 33,478 |
Debentures of government- sponsored agencies | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale securities | 143,297 | 188,527 |
U.S. Treasury securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale securities | 10,973 | 11,630 |
Obligations of state and political subdivisions | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale securities | 124,690 | 134,000 |
Corporate bonds | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale securities | 34,860 | 38,495 |
Asset-backed securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale securities | 1,761 | 1,862 |
Carrying Value | Assets and liabilities at fair value measured on a recurring basis | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Derivative financial assets (interest rate contracts) | 42 | |
Derivative financial liabilities (interest rate contracts) | 370 | 1,085 |
Carrying Value | Assets and liabilities at fair value measured on a recurring basis | Mortgage-backed securities and collateralized mortgage obligations issued by U.S. government-sponsored agencies | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale securities | 585,224 | 759,576 |
Carrying Value | Assets and liabilities at fair value measured on a recurring basis | SBA-backed securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale securities | 54,652 | 33,478 |
Carrying Value | Assets and liabilities at fair value measured on a recurring basis | Debentures of government- sponsored agencies | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale securities | 143,297 | 188,527 |
Carrying Value | Assets and liabilities at fair value measured on a recurring basis | U.S. Treasury securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale securities | 10,973 | 11,630 |
Carrying Value | Assets and liabilities at fair value measured on a recurring basis | Obligations of state and political subdivisions | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale securities | 124,690 | 134,000 |
Carrying Value | Assets and liabilities at fair value measured on a recurring basis | Corporate bonds | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale securities | 34,860 | 38,495 |
Carrying Value | Assets and liabilities at fair value measured on a recurring basis | Asset-backed securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale securities | 1,761 | 1,862 |
Fair Value | Assets and liabilities at fair value measured on a recurring basis | Quoted Prices in Active Markets for Identical Assets (Level 1) | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Derivative financial assets (interest rate contracts) | 0 | |
Derivative financial liabilities (interest rate contracts) | 0 | 0 |
Fair Value | Assets and liabilities at fair value measured on a recurring basis | Significant Other Observable Inputs (Level 2) | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Derivative financial assets (interest rate contracts) | 42 | |
Derivative financial liabilities (interest rate contracts) | 370 | 1,085 |
Fair Value | Assets and liabilities at fair value measured on a recurring basis | Significant Unobservable Inputs (Level 3) | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Derivative financial assets (interest rate contracts) | 0 | |
Derivative financial liabilities (interest rate contracts) | 0 | 0 |
Fair Value | Assets and liabilities at fair value measured on a recurring basis | Mortgage-backed securities and collateralized mortgage obligations issued by U.S. government-sponsored agencies | Quoted Prices in Active Markets for Identical Assets (Level 1) | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale securities | 0 | 0 |
Fair Value | Assets and liabilities at fair value measured on a recurring basis | Mortgage-backed securities and collateralized mortgage obligations issued by U.S. government-sponsored agencies | Significant Other Observable Inputs (Level 2) | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale securities | 585,224 | 759,576 |
Fair Value | Assets and liabilities at fair value measured on a recurring basis | Mortgage-backed securities and collateralized mortgage obligations issued by U.S. government-sponsored agencies | Significant Unobservable Inputs (Level 3) | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale securities | 0 | 0 |
Fair Value | Assets and liabilities at fair value measured on a recurring basis | SBA-backed securities | Quoted Prices in Active Markets for Identical Assets (Level 1) | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale securities | 0 | 0 |
Fair Value | Assets and liabilities at fair value measured on a recurring basis | SBA-backed securities | Significant Other Observable Inputs (Level 2) | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale securities | 54,652 | 33,478 |
Fair Value | Assets and liabilities at fair value measured on a recurring basis | SBA-backed securities | Significant Unobservable Inputs (Level 3) | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale securities | 0 | 0 |
Fair Value | Assets and liabilities at fair value measured on a recurring basis | Debentures of government- sponsored agencies | Quoted Prices in Active Markets for Identical Assets (Level 1) | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale securities | 0 | 0 |
Fair Value | Assets and liabilities at fair value measured on a recurring basis | Debentures of government- sponsored agencies | Significant Other Observable Inputs (Level 2) | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale securities | 143,297 | 188,527 |
Fair Value | Assets and liabilities at fair value measured on a recurring basis | Debentures of government- sponsored agencies | Significant Unobservable Inputs (Level 3) | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale securities | 0 | 0 |
Fair Value | Assets and liabilities at fair value measured on a recurring basis | U.S. Treasury securities | Quoted Prices in Active Markets for Identical Assets (Level 1) | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale securities | 10,973 | 11,630 |
Fair Value | Assets and liabilities at fair value measured on a recurring basis | U.S. Treasury securities | Significant Other Observable Inputs (Level 2) | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale securities | 0 | 0 |
Fair Value | Assets and liabilities at fair value measured on a recurring basis | U.S. Treasury securities | Significant Unobservable Inputs (Level 3) | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale securities | 0 | 0 |
Fair Value | Assets and liabilities at fair value measured on a recurring basis | Obligations of state and political subdivisions | Quoted Prices in Active Markets for Identical Assets (Level 1) | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale securities | 0 | 0 |
Fair Value | Assets and liabilities at fair value measured on a recurring basis | Obligations of state and political subdivisions | Significant Other Observable Inputs (Level 2) | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale securities | 124,690 | 134,000 |
Fair Value | Assets and liabilities at fair value measured on a recurring basis | Obligations of state and political subdivisions | Significant Unobservable Inputs (Level 3) | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale securities | 0 | 0 |
Fair Value | Assets and liabilities at fair value measured on a recurring basis | Corporate bonds | Quoted Prices in Active Markets for Identical Assets (Level 1) | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale securities | 0 | 0 |
Fair Value | Assets and liabilities at fair value measured on a recurring basis | Corporate bonds | Significant Other Observable Inputs (Level 2) | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale securities | 34,860 | 38,495 |
Fair Value | Assets and liabilities at fair value measured on a recurring basis | Corporate bonds | Significant Unobservable Inputs (Level 3) | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale securities | 0 | 0 |
Fair Value | Assets and liabilities at fair value measured on a recurring basis | Asset-backed securities | Quoted Prices in Active Markets for Identical Assets (Level 1) | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale securities | 0 | 0 |
Fair Value | Assets and liabilities at fair value measured on a recurring basis | Asset-backed securities | Significant Other Observable Inputs (Level 2) | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale securities | 1,761 | 1,862 |
Fair Value | Assets and liabilities at fair value measured on a recurring basis | Asset-backed securities | Significant Unobservable Inputs (Level 3) | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale securities | $ 0 | $ 0 |
Fair Value of Assets and Liabilities - Narrative (Details) |
3 Months Ended | ||
---|---|---|---|
Mar. 31, 2022
USD ($)
security
|
Mar. 31, 2021
USD ($)
|
Dec. 31, 2021
security
|
|
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Write down of held to maturity securities | $ | $ 0 | $ 0 | |
Significant Unobservable Inputs (Level 3) | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Number of securities | security | 0 | 0 |
Fair Value of Assets and Liabilities - Fair Value Assets Measured on Non-recurring Basis (Details) - Assets and liabilities at fair value measured on a recurring basis - Other real estate owned - USD ($) $ in Thousands |
Mar. 31, 2022 |
Dec. 31, 2021 |
---|---|---|
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Debt securities, fair value | $ 800 | $ 800 |
Quoted Prices in Active Markets for Identical Assets (Level 1) | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Debt securities, fair value | 0 | 0 |
Significant Other Observable Inputs (Level 2) | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Debt securities, fair value | 0 | 0 |
Significant Unobservable Inputs (Level 3) | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Debt securities, fair value | $ 800 | $ 800 |
Fair Value of Assets and Liabilities - Fair Value of Financial Instruments (Details) - USD ($) $ in Thousands |
Mar. 31, 2022 |
Dec. 31, 2021 |
---|---|---|
Financial assets (recorded at amortized cost): | ||
Investment securities held-to-maturity | $ 744,512 | $ 342,755 |
Carrying Amounts | Level 1 | ||
Financial assets (recorded at amortized cost): | ||
Cash and cash equivalents | 170,901 | 347,641 |
Carrying Amounts | Level 2 | ||
Financial assets (recorded at amortized cost): | ||
Investment securities held-to-maturity | 790,264 | 342,222 |
Interest receivable | 11,298 | 11,889 |
Financial liabilities (recorded at amortized cost): | ||
Time deposits | 145,135 | 150,235 |
Interest payable | 71 | 81 |
Carrying Amounts | Level 3 | ||
Financial assets (recorded at amortized cost): | ||
Loans, net | 2,179,307 | 2,232,622 |
Fair Value | Level 1 | ||
Financial assets (recorded at amortized cost): | ||
Cash and cash equivalents | 170,901 | 347,641 |
Fair Value | Level 2 | ||
Financial assets (recorded at amortized cost): | ||
Investment securities held-to-maturity | 744,512 | 342,755 |
Interest receivable | 11,298 | 11,889 |
Financial liabilities (recorded at amortized cost): | ||
Time deposits | 145,553 | 150,475 |
Interest payable | 71 | 81 |
Fair Value | Level 3 | ||
Financial assets (recorded at amortized cost): | ||
Loans, net | $ 2,173,298 | $ 2,234,430 |
Investment Securities - Held-to-Maturity Amortized Cost and Fair Value (Details) - USD ($) |
Mar. 31, 2022 |
Dec. 31, 2021 |
---|---|---|
Schedule of Available-for-sale Securities and Held-to-maturity Securities [Line Items] | ||
Held to maturity, amortized cost | $ 790,264,000 | $ 342,222,000 |
Allowance for Credit Losses | 0 | 0 |
Net Carrying Amount | 790,264,000 | 342,222,000 |
Held-to-maturity, gross unrealized gains | 191,000 | 3,400,000 |
Held-to-maturity, gross unrealized losses | (45,943,000) | (2,867,000) |
Held to maturity, fair value | 744,512,000 | 342,755,000 |
Accrued interest | 1,800,000 | 1,100,000 |
MBS pass-through securities issued by FHLMC, FNMA and GNMA | ||
Schedule of Available-for-sale Securities and Held-to-maturity Securities [Line Items] | ||
Held to maturity, amortized cost | 339,149,000 | 126,990,000 |
Allowance for Credit Losses | 0 | 0 |
Net Carrying Amount | 339,149,000 | 126,990,000 |
Held-to-maturity, gross unrealized gains | 148,000 | 2,110,000 |
Held-to-maturity, gross unrealized losses | (18,528,000) | (712,000) |
Held to maturity, fair value | 320,769,000 | 128,388,000 |
CMOs issued by FHLMC | ||
Schedule of Available-for-sale Securities and Held-to-maturity Securities [Line Items] | ||
Held to maturity, amortized cost | 187,459,000 | 106,851,000 |
Allowance for Credit Losses | 0 | 0 |
Net Carrying Amount | 187,459,000 | 106,851,000 |
Held-to-maturity, gross unrealized gains | 42,000 | 668,000 |
Held-to-maturity, gross unrealized losses | (11,811,000) | (1,045,000) |
Held to maturity, fair value | 175,690,000 | 106,474,000 |
CMOs issued by FNMA | ||
Schedule of Available-for-sale Securities and Held-to-maturity Securities [Line Items] | ||
Held to maturity, amortized cost | 51,732,000 | 4,866,000 |
Allowance for Credit Losses | 0 | 0 |
Net Carrying Amount | 51,732,000 | 4,866,000 |
Held-to-maturity, gross unrealized gains | 0 | 128,000 |
Held-to-maturity, gross unrealized losses | (1,000,000) | 0 |
Held to maturity, fair value | 50,732,000 | 4,994,000 |
CMOs issued by GNMA | ||
Schedule of Available-for-sale Securities and Held-to-maturity Securities [Line Items] | ||
Held to maturity, amortized cost | 12,375,000 | |
Allowance for Credit Losses | 0 | |
Net Carrying Amount | 12,375,000 | |
Held-to-maturity, gross unrealized gains | 0 | |
Held-to-maturity, gross unrealized losses | (431,000) | |
Held to maturity, fair value | 11,944,000 | |
SBA-backed securities | ||
Schedule of Available-for-sale Securities and Held-to-maturity Securities [Line Items] | ||
Held to maturity, amortized cost | 3,245,000 | 4,840,000 |
Allowance for Credit Losses | 0 | 0 |
Net Carrying Amount | 3,245,000 | 4,840,000 |
Held-to-maturity, gross unrealized gains | 0 | 198,000 |
Held-to-maturity, gross unrealized losses | (29,000) | 0 |
Held to maturity, fair value | 3,216,000 | 5,038,000 |
Debentures of government- sponsored agencies | ||
Schedule of Available-for-sale Securities and Held-to-maturity Securities [Line Items] | ||
Held to maturity, amortized cost | 115,603,000 | 51,472,000 |
Allowance for Credit Losses | 0 | 0 |
Net Carrying Amount | 115,603,000 | 51,472,000 |
Held-to-maturity, gross unrealized gains | 0 | 0 |
Held-to-maturity, gross unrealized losses | (9,477,000) | (901,000) |
Held to maturity, fair value | 106,126,000 | 50,571,000 |
Obligations of state and political subdivisions | ||
Schedule of Available-for-sale Securities and Held-to-maturity Securities [Line Items] | ||
Held to maturity, amortized cost | 50,701,000 | 47,203,000 |
Allowance for Credit Losses | 0 | 0 |
Net Carrying Amount | 50,701,000 | 47,203,000 |
Held-to-maturity, gross unrealized gains | 1,000 | 296,000 |
Held-to-maturity, gross unrealized losses | (4,667,000) | (209,000) |
Held to maturity, fair value | 46,035,000 | 47,290,000 |
Corporate bonds | ||
Schedule of Available-for-sale Securities and Held-to-maturity Securities [Line Items] | ||
Held to maturity, amortized cost | 30,000,000 | $ 0 |
Allowance for Credit Losses | ||
Net Carrying Amount | 30,000,000 | |
Held-to-maturity, gross unrealized gains | 0 | |
Held-to-maturity, gross unrealized losses | 0 | |
Held to maturity, fair value | $ 30,000,000 |
Investment Securities - Narrative (Details) |
3 Months Ended | ||
---|---|---|---|
Mar. 31, 2022
USD ($)
security
|
Mar. 31, 2021
USD ($)
|
Dec. 31, 2021
USD ($)
security
|
|
Debt Securities, Available-for-sale [Line Items] | |||
Held-to-maturity, allowance for credit Loss | $ 0 | $ 0 | |
Transfer of securities from available-for-sale to held-to-maturity at fair value | 357,500,000 | ||
Net unrealized pre-tax loss | 41,059,000 | $ 13,026,000 | |
Sales of investment securities | $ 0 | $ 0 | |
Number of investment securities in unrealized loss position | security | 354 | 217 | |
Number of investment securities in unrealized loss position longer than 12 months | security | 17 | ||
Number of investment securities in unrealized loss position less than 12 months | security | 337 | ||
Debt securities, available-for-sale unrealized loss position, allowance for credit loss | $ 0 | ||
Accumulated Other Comprehensive Income (Loss), Net of Tax | |||
Debt Securities, Available-for-sale [Line Items] | |||
Net unrealized pre-tax loss | $ 14,800,000 |
Investment Securities - Schedule of Bond Ratings For Held-to-Maturity Securities (Details) - USD ($) $ in Thousands |
Mar. 31, 2022 |
Dec. 31, 2021 |
---|---|---|
Debt Securities, Held-to-maturity, Credit Quality Indicator [Line Items] | ||
Debt securities, held-to-maturity | $ 790,264 | $ 342,222 |
Obligations of state and political subdivisions | ||
Debt Securities, Held-to-maturity, Credit Quality Indicator [Line Items] | ||
Debt securities, held-to-maturity | 50,701 | 47,203 |
Corporate bonds | ||
Debt Securities, Held-to-maturity, Credit Quality Indicator [Line Items] | ||
Debt securities, held-to-maturity | 30,000 | 0 |
Moody's And/Or Standard & Poor's AAA Rating | Obligations of state and political subdivisions | ||
Debt Securities, Held-to-maturity, Credit Quality Indicator [Line Items] | ||
Debt securities, held-to-maturity | 37,735 | 34,229 |
Moody's And/Or Standard & Poor's AAA Rating | Corporate bonds | ||
Debt Securities, Held-to-maturity, Credit Quality Indicator [Line Items] | ||
Debt securities, held-to-maturity | 0 | 0 |
Moody's And/Or Standard & Poor's AA Rating | Obligations of state and political subdivisions | ||
Debt Securities, Held-to-maturity, Credit Quality Indicator [Line Items] | ||
Debt securities, held-to-maturity | 12,866 | 12,873 |
Moody's And/Or Standard & Poor's AA Rating | Corporate bonds | ||
Debt Securities, Held-to-maturity, Credit Quality Indicator [Line Items] | ||
Debt securities, held-to-maturity | 0 | 0 |
Moody's And/Or Standard & Poor's A Rating | Obligations of state and political subdivisions | ||
Debt Securities, Held-to-maturity, Credit Quality Indicator [Line Items] | ||
Debt securities, held-to-maturity | 100 | 101 |
Moody's And/Or Standard & Poor's A Rating | Corporate bonds | ||
Debt Securities, Held-to-maturity, Credit Quality Indicator [Line Items] | ||
Debt securities, held-to-maturity | $ 30,000 | $ 0 |
Investment Securities - Available-for-Sale Securities Amortized Cost and Fair Value (Details) - USD ($) |
Mar. 31, 2022 |
Dec. 31, 2021 |
---|---|---|
Debt Securities, Available-for-sale [Line Items] | ||
Available-for-sale, amortized cost | $ 995,637,000 | $ 1,169,520,000 |
Available-for-sale, gross unrealized gains | 879,000 | 11,074,000 |
Available-for-sale, gross unrealized losses | (41,059,000) | (13,026,000) |
Allowance for Credit Losses | 0 | 0 |
Available-for-sale securities | 955,457,000 | 1,167,568,000 |
Accrued interest | 3,300,000 | 3,700,000 |
Accumulated Other Comprehensive Income (Loss), Net of Tax | ||
Debt Securities, Available-for-sale [Line Items] | ||
Available-for-sale, gross unrealized losses | (14,800,000) | |
MBS pass-through securities issued by FHLMC, FNMA and GNMA | ||
Debt Securities, Available-for-sale [Line Items] | ||
Available-for-sale, amortized cost | 133,883,000 | 316,090,000 |
Available-for-sale, gross unrealized gains | 252,000 | 1,224,000 |
Available-for-sale, gross unrealized losses | (5,486,000) | (2,784,000) |
Allowance for Credit Losses | 0 | 0 |
Available-for-sale securities | 128,649,000 | 314,530,000 |
CMOs issued by FHLMC | ||
Debt Securities, Available-for-sale [Line Items] | ||
Available-for-sale, amortized cost | 390,501,000 | 343,047,000 |
Available-for-sale, gross unrealized gains | 103,000 | 3,209,000 |
Available-for-sale, gross unrealized losses | (14,756,000) | (4,829,000) |
Allowance for Credit Losses | 0 | 0 |
Available-for-sale securities | 375,848,000 | 341,427,000 |
CMOs issued by FNMA | ||
Debt Securities, Available-for-sale [Line Items] | ||
Available-for-sale, amortized cost | 43,750,000 | 48,187,000 |
Available-for-sale, gross unrealized gains | 9,000 | 152,000 |
Available-for-sale, gross unrealized losses | (2,258,000) | (611,000) |
Allowance for Credit Losses | 0 | 0 |
Available-for-sale securities | 41,501,000 | 47,728,000 |
CMOs issued by GNMA | ||
Debt Securities, Available-for-sale [Line Items] | ||
Available-for-sale, amortized cost | 40,948,000 | 56,345,000 |
Available-for-sale, gross unrealized gains | 3,000 | 99,000 |
Available-for-sale, gross unrealized losses | (1,725,000) | (553,000) |
Allowance for Credit Losses | 0 | 0 |
Available-for-sale securities | 39,226,000 | 55,891,000 |
SBA-backed securities | ||
Debt Securities, Available-for-sale [Line Items] | ||
Available-for-sale, amortized cost | 56,085,000 | 32,640,000 |
Available-for-sale, gross unrealized gains | 11,000 | 993,000 |
Available-for-sale, gross unrealized losses | (1,444,000) | (155,000) |
Allowance for Credit Losses | 0 | 0 |
Available-for-sale securities | 54,652,000 | 33,478,000 |
Debentures of government- sponsored agencies | ||
Debt Securities, Available-for-sale [Line Items] | ||
Available-for-sale, amortized cost | 150,091,000 | 191,449,000 |
Available-for-sale, gross unrealized gains | 3,000 | 25,000 |
Available-for-sale, gross unrealized losses | (6,797,000) | (2,947,000) |
Allowance for Credit Losses | 0 | 0 |
Available-for-sale securities | 143,297,000 | 188,527,000 |
U.S. Treasury securities | ||
Debt Securities, Available-for-sale [Line Items] | ||
Available-for-sale, amortized cost | 11,890,000 | 11,886,000 |
Available-for-sale, gross unrealized gains | 0 | 0 |
Available-for-sale, gross unrealized losses | (917,000) | (256,000) |
Allowance for Credit Losses | 0 | |
Available-for-sale securities | 10,973,000 | 11,630,000 |
Obligations of state and political subdivisions | ||
Debt Securities, Available-for-sale [Line Items] | ||
Available-for-sale, amortized cost | 129,706,000 | 129,009,000 |
Available-for-sale, gross unrealized gains | 498,000 | 5,372,000 |
Available-for-sale, gross unrealized losses | (5,514,000) | (381,000) |
Allowance for Credit Losses | 0 | 0 |
Available-for-sale securities | 124,690,000 | 134,000,000 |
Corporate bonds | ||
Debt Securities, Available-for-sale [Line Items] | ||
Available-for-sale, amortized cost | 36,988,000 | 39,001,000 |
Available-for-sale, gross unrealized gains | 0 | 0 |
Available-for-sale, gross unrealized losses | (2,128,000) | (506,000) |
Allowance for Credit Losses | 0 | 0 |
Available-for-sale securities | 34,860,000 | 38,495,000 |
Asset-backed securities | ||
Debt Securities, Available-for-sale [Line Items] | ||
Available-for-sale, amortized cost | 1,795,000 | 1,866,000 |
Available-for-sale, gross unrealized gains | 0 | 0 |
Available-for-sale, gross unrealized losses | (34,000) | (4,000) |
Allowance for Credit Losses | 0 | 0 |
Available-for-sale securities | $ 1,761,000 | $ 1,862,000 |
Investment Securities - Maturities (Details) - USD ($) $ in Thousands |
Mar. 31, 2022 |
Dec. 31, 2021 |
---|---|---|
Held-to-maturity Securities, Amortized Cost | ||
Within one year | $ 101 | $ 101 |
After one but within five years | 43,041 | 25,666 |
After five years through ten years | 244,649 | 182,604 |
After ten years | 502,473 | 133,851 |
Total | 790,264 | 342,222 |
Held-to-maturity Securities, Fair Value | ||
Within one year | 102 | 103 |
After one but within five years | 42,969 | 26,559 |
After five years through ten years | 227,772 | 182,303 |
After ten years | 473,669 | 133,790 |
Total | 744,512 | 342,755 |
Available-for-sale Securities, Amortized Cost | ||
Within one year | 5,605 | 10,785 |
After one but within five years | 260,143 | 219,474 |
After five years through ten years | 312,767 | 299,937 |
After ten years | 417,122 | 639,324 |
Available-for-sale, amortized cost | 995,637 | 1,169,520 |
Available-for-sale Securities, Fair Value | ||
Within one year | 5,618 | 10,841 |
After one but within five years | 251,904 | 219,957 |
After five years through ten years | 298,180 | 300,187 |
After ten years | 399,755 | 636,583 |
Total | $ 955,457 | $ 1,167,568 |
Investment Securities - Pledged and Transferred Securities (Details) - USD ($) $ in Thousands |
Mar. 31, 2022 |
Dec. 31, 2021 |
---|---|---|
Financial Instruments Owned and Pledged as Collateral [Line Items] | ||
Available-for-sale securities pledged as collateral | $ 211,874 | $ 217,849 |
Public deposits | ||
Financial Instruments Owned and Pledged as Collateral [Line Items] | ||
Available-for-sale securities pledged as collateral | 208,406 | 213,861 |
Trust deposits | ||
Financial Instruments Owned and Pledged as Collateral [Line Items] | ||
Available-for-sale securities pledged as collateral | 691 | 729 |
Internal checking account | ||
Financial Instruments Owned and Pledged as Collateral [Line Items] | ||
Available-for-sale securities pledged as collateral | 583 | 614 |
State of California | ||
Financial Instruments Owned and Pledged as Collateral [Line Items] | ||
Available-for-sale securities pledged as collateral | 209,680 | 215,204 |
Bankruptcy trustee deposits | ||
Financial Instruments Owned and Pledged as Collateral [Line Items] | ||
Available-for-sale securities pledged as collateral | $ 2,194 | $ 2,645 |
Investment Securities - Unrealized Loss Positions (Details) - USD ($) $ in Thousands |
Mar. 31, 2022 |
Dec. 31, 2021 |
---|---|---|
Debt Securities, Held-to-maturity, Continuous Unrealized Loss Position, Fair Value [Abstract] | ||
Less than 12 continuous months | $ 612,985 | $ 201,204 |
Greater than or equal to 12 continuous months | 44,628 | 0 |
Total Securities in a loss position | 657,613 | 201,204 |
Debt Securities, Held-to-maturity, Unrealized Loss Position, Accumulated Loss [Abstract] | ||
Less than 12 continuous months | (42,663) | (2,867) |
Greater than or equal to 12 continuous months | (3,280) | 0 |
Held-to-maturity, gross unrealized losses | (45,943) | (2,867) |
Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Fair Value [Abstract] | ||
Available-for-sale, less than 12 continuous months, fair value | 849,125 | 797,781 |
Available-for-sale, greater than 12 continuous months, fair value | 20,759 | 14,173 |
Available-for-sale, total securities in a loss position, fair value | 869,884 | 811,954 |
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss [Abstract] | ||
Available-for-sale, less than 12 continuous months, unrealized loss | (38,582) | (12,411) |
Available-for-sale, greater than 12 continuous months, unrealized loss | (2,477) | (615) |
Available-for-sale, total securities in a loss position, unrealized loss | (41,059) | (13,026) |
Marketable Securities, Continuous Unrealized Loss Position, Fair Value [Abstract] | ||
Marketable securities, less than 12 continuous months, fair value | 1,462,110 | 998,985 |
Marketable securities, greater than 12 continuous months, fair value | 65,387 | 14,173 |
Marketable securities, total securities in a loss position, fair value | 1,527,497 | 1,013,158 |
Marketable Securities, Continuous Unrealized Loss Position, Accumulated Loss [Abstract] | ||
Marketable securities, less than 12 continuous months, unrealized loss | (81,245) | (15,278) |
Marketable securities, greater than 12 continuous months, unrealized loss | (5,757) | (615) |
Marketable securities, total securities in a loss position, unrealized loss | (87,002) | (15,893) |
MBS pass-through securities issued by FHLMC, FNMA and GNMA | ||
Debt Securities, Held-to-maturity, Continuous Unrealized Loss Position, Fair Value [Abstract] | ||
Less than 12 continuous months | 299,200 | 76,619 |
Greater than or equal to 12 continuous months | 0 | 0 |
Total Securities in a loss position | 299,200 | 76,619 |
Debt Securities, Held-to-maturity, Unrealized Loss Position, Accumulated Loss [Abstract] | ||
Less than 12 continuous months | (18,528) | (712) |
Greater than or equal to 12 continuous months | 0 | 0 |
Held-to-maturity, gross unrealized losses | (18,528) | (712) |
Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Fair Value [Abstract] | ||
Available-for-sale, less than 12 continuous months, fair value | 108,982 | 263,474 |
Available-for-sale, greater than 12 continuous months, fair value | 0 | 0 |
Available-for-sale, total securities in a loss position, fair value | 108,982 | 263,474 |
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss [Abstract] | ||
Available-for-sale, less than 12 continuous months, unrealized loss | (5,486) | (2,784) |
Available-for-sale, greater than 12 continuous months, unrealized loss | 0 | 0 |
Available-for-sale, total securities in a loss position, unrealized loss | (5,486) | (2,784) |
CMOs issued by FHLMC | ||
Debt Securities, Held-to-maturity, Continuous Unrealized Loss Position, Fair Value [Abstract] | ||
Less than 12 continuous months | 165,101 | 54,811 |
Greater than or equal to 12 continuous months | 4,328 | 0 |
Total Securities in a loss position | 169,429 | 54,811 |
Debt Securities, Held-to-maturity, Unrealized Loss Position, Accumulated Loss [Abstract] | ||
Less than 12 continuous months | (11,498) | (1,045) |
Greater than or equal to 12 continuous months | (313) | 0 |
Held-to-maturity, gross unrealized losses | (11,811) | (1,045) |
Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Fair Value [Abstract] | ||
Available-for-sale, less than 12 continuous months, fair value | 359,856 | 226,175 |
Available-for-sale, greater than 12 continuous months, fair value | 4,107 | 4,415 |
Available-for-sale, total securities in a loss position, fair value | 363,963 | 230,590 |
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss [Abstract] | ||
Available-for-sale, less than 12 continuous months, unrealized loss | (14,357) | (4,677) |
Available-for-sale, greater than 12 continuous months, unrealized loss | (399) | (152) |
Available-for-sale, total securities in a loss position, unrealized loss | (14,756) | (4,829) |
CMOs issued by FNMA | ||
Debt Securities, Held-to-maturity, Continuous Unrealized Loss Position, Fair Value [Abstract] | ||
Less than 12 continuous months | 25,350 | |
Greater than or equal to 12 continuous months | 0 | |
Total Securities in a loss position | 25,350 | |
Debt Securities, Held-to-maturity, Unrealized Loss Position, Accumulated Loss [Abstract] | ||
Less than 12 continuous months | (1,000) | |
Greater than or equal to 12 continuous months | 0 | |
Held-to-maturity, gross unrealized losses | (1,000) | |
Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Fair Value [Abstract] | ||
Available-for-sale, less than 12 continuous months, fair value | 40,170 | 37,348 |
Available-for-sale, greater than 12 continuous months, fair value | 0 | 0 |
Available-for-sale, total securities in a loss position, fair value | 40,170 | 37,348 |
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss [Abstract] | ||
Available-for-sale, less than 12 continuous months, unrealized loss | (2,258) | (611) |
Available-for-sale, greater than 12 continuous months, unrealized loss | 0 | 0 |
Available-for-sale, total securities in a loss position, unrealized loss | (2,258) | (611) |
CMOs issued by GNMA | ||
Debt Securities, Held-to-maturity, Continuous Unrealized Loss Position, Fair Value [Abstract] | ||
Less than 12 continuous months | 11,944 | |
Greater than or equal to 12 continuous months | 0 | |
Total Securities in a loss position | 11,944 | |
Debt Securities, Held-to-maturity, Unrealized Loss Position, Accumulated Loss [Abstract] | ||
Less than 12 continuous months | (431) | |
Greater than or equal to 12 continuous months | 0 | |
Held-to-maturity, gross unrealized losses | (431) | |
Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Fair Value [Abstract] | ||
Available-for-sale, less than 12 continuous months, fair value | 37,732 | 44,790 |
Available-for-sale, greater than 12 continuous months, fair value | 0 | 0 |
Available-for-sale, total securities in a loss position, fair value | 37,732 | 44,790 |
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss [Abstract] | ||
Available-for-sale, less than 12 continuous months, unrealized loss | (1,725) | (553) |
Available-for-sale, greater than 12 continuous months, unrealized loss | 0 | 0 |
Available-for-sale, total securities in a loss position, unrealized loss | (1,725) | (553) |
SBA-backed securities | ||
Debt Securities, Held-to-maturity, Continuous Unrealized Loss Position, Fair Value [Abstract] | ||
Less than 12 continuous months | 3,216 | |
Greater than or equal to 12 continuous months | 0 | |
Total Securities in a loss position | 3,216 | |
Debt Securities, Held-to-maturity, Unrealized Loss Position, Accumulated Loss [Abstract] | ||
Less than 12 continuous months | (29) | |
Greater than or equal to 12 continuous months | 0 | |
Held-to-maturity, gross unrealized losses | (29) | |
Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Fair Value [Abstract] | ||
Available-for-sale, less than 12 continuous months, fair value | 43,665 | 7,478 |
Available-for-sale, greater than 12 continuous months, fair value | 1,124 | 1,209 |
Available-for-sale, total securities in a loss position, fair value | 44,789 | 8,687 |
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss [Abstract] | ||
Available-for-sale, less than 12 continuous months, unrealized loss | (1,400) | (112) |
Available-for-sale, greater than 12 continuous months, unrealized loss | (44) | (43) |
Available-for-sale, total securities in a loss position, unrealized loss | (1,444) | (155) |
Debentures of government- sponsored agencies | ||
Debt Securities, Held-to-maturity, Continuous Unrealized Loss Position, Fair Value [Abstract] | ||
Less than 12 continuous months | 65,826 | 50,571 |
Greater than or equal to 12 continuous months | 40,300 | 0 |
Total Securities in a loss position | 106,126 | 50,571 |
Debt Securities, Held-to-maturity, Unrealized Loss Position, Accumulated Loss [Abstract] | ||
Less than 12 continuous months | (6,510) | (901) |
Greater than or equal to 12 continuous months | (2,967) | 0 |
Held-to-maturity, gross unrealized losses | (9,477) | (901) |
Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Fair Value [Abstract] | ||
Available-for-sale, less than 12 continuous months, fair value | 114,450 | 148,979 |
Available-for-sale, greater than 12 continuous months, fair value | 7,845 | 8,549 |
Available-for-sale, total securities in a loss position, fair value | 122,295 | 157,528 |
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss [Abstract] | ||
Available-for-sale, less than 12 continuous months, unrealized loss | (5,673) | (2,527) |
Available-for-sale, greater than 12 continuous months, unrealized loss | (1,124) | (420) |
Available-for-sale, total securities in a loss position, unrealized loss | (6,797) | (2,947) |
U.S. Treasury securities | ||
Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Fair Value [Abstract] | ||
Available-for-sale, less than 12 continuous months, fair value | 10,973 | 11,629 |
Available-for-sale, greater than 12 continuous months, fair value | 0 | 0 |
Available-for-sale, total securities in a loss position, fair value | 10,973 | 11,629 |
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss [Abstract] | ||
Available-for-sale, less than 12 continuous months, unrealized loss | (917) | (256) |
Available-for-sale, greater than 12 continuous months, unrealized loss | 0 | 0 |
Available-for-sale, total securities in a loss position, unrealized loss | (917) | (256) |
Obligations of state and political subdivisions | ||
Debt Securities, Held-to-maturity, Continuous Unrealized Loss Position, Fair Value [Abstract] | ||
Less than 12 continuous months | 42,348 | 19,203 |
Greater than or equal to 12 continuous months | 0 | 0 |
Total Securities in a loss position | 42,348 | 19,203 |
Debt Securities, Held-to-maturity, Unrealized Loss Position, Accumulated Loss [Abstract] | ||
Less than 12 continuous months | (4,667) | (209) |
Greater than or equal to 12 continuous months | 0 | 0 |
Held-to-maturity, gross unrealized losses | (4,667) | (209) |
Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Fair Value [Abstract] | ||
Available-for-sale, less than 12 continuous months, fair value | 102,115 | 17,552 |
Available-for-sale, greater than 12 continuous months, fair value | 2,243 | 0 |
Available-for-sale, total securities in a loss position, fair value | 104,358 | 17,552 |
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss [Abstract] | ||
Available-for-sale, less than 12 continuous months, unrealized loss | (5,153) | (381) |
Available-for-sale, greater than 12 continuous months, unrealized loss | (361) | 0 |
Available-for-sale, total securities in a loss position, unrealized loss | (5,514) | (381) |
Corporate bonds | ||
Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Fair Value [Abstract] | ||
Available-for-sale, less than 12 continuous months, fair value | 29,421 | 38,495 |
Available-for-sale, greater than 12 continuous months, fair value | 5,440 | 0 |
Available-for-sale, total securities in a loss position, fair value | 34,861 | 38,495 |
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss [Abstract] | ||
Available-for-sale, less than 12 continuous months, unrealized loss | (1,579) | (506) |
Available-for-sale, greater than 12 continuous months, unrealized loss | (549) | 0 |
Available-for-sale, total securities in a loss position, unrealized loss | (2,128) | (506) |
Asset-backed securities | ||
Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Fair Value [Abstract] | ||
Available-for-sale, less than 12 continuous months, fair value | 1,761 | 1,861 |
Available-for-sale, greater than 12 continuous months, fair value | 0 | 0 |
Available-for-sale, total securities in a loss position, fair value | 1,761 | 1,861 |
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss [Abstract] | ||
Available-for-sale, less than 12 continuous months, unrealized loss | (34) | (4) |
Available-for-sale, greater than 12 continuous months, unrealized loss | 0 | 0 |
Available-for-sale, total securities in a loss position, unrealized loss | $ (34) | $ (4) |
Investment Securities - Non-Marketable Securities Included in Other Assets (Details) |
3 Months Ended | 12 Months Ended | ||
---|---|---|---|---|
Mar. 31, 2022
USD ($)
$ / shares
shares
|
Mar. 31, 2021
USD ($)
|
Dec. 31, 2021
USD ($)
shares
|
Apr. 28, 2022 |
|
Schedule of Equity Method Investments [Line Items] | ||||
Federal home loan bank stock, par value (in usd per share) | $ / shares | $ 100 | |||
Investments in low income housing tax credit funds | $ 2,900,000 | $ 3,000,000 | ||
Low income housing tax credits and other tax benefits | 159,000 | |||
Low income housing amortization expense | 134,000 | |||
Unfunded commitments for low income housing tax credit funds | $ 419,000 | |||
Subsequent event | ||||
Schedule of Equity Method Investments [Line Items] | ||||
Federal home loan bank, dividend rate percentage | 6.00% | |||
Visa Inc. Class B common stock | ||||
Schedule of Equity Method Investments [Line Items] | ||||
Number of shares of securities carried at cost (in shares) | shares | 10,439 | 10,439 | ||
Carrying value of securities carried at cost | $ 0 | $ 0 | ||
Fair value of Class B common stock | $ 3,700,000 | $ 3,700,000 | ||
Visa Inc. | Visa Inc. Class B common stock | ||||
Schedule of Equity Method Investments [Line Items] | ||||
Conversion rate on common stock | 1.6181 | 1.6181 | ||
Asset Derivatives | ||||
Schedule of Equity Method Investments [Line Items] | ||||
Federal home loan bank stock | $ 16,700,000 | |||
Low-income housing tax credit investment | ||||
Schedule of Equity Method Investments [Line Items] | ||||
Impairment losses | $ 0 | $ 0 |
Loans and Allowance for Credit Losses on Loans - Schedule of Loans by Class (Details) - USD ($) $ in Thousands |
Mar. 31, 2022 |
Dec. 31, 2021 |
Mar. 31, 2021 |
Dec. 31, 2020 |
---|---|---|---|---|
Financing Receivable, Allowance for Credit Loss [Line Items] | ||||
Loans at amortized cost | $ 2,201,854 | $ 2,255,645 | ||
Allowance for credit losses on loans | (22,547) | (23,023) | $ (19,958) | $ (22,874) |
Total loans, net of allowance for credit losses on loans | 2,179,307 | 2,232,622 | ||
Deferred loan fees | 690 | (901) | ||
Unrecognized purchase discounts on non-PCI loans | 2,600 | 2,500 | ||
Financing receivable, accrued interest, net | 6,200 | 7,100 | ||
Commercial loans | Commercial and industrial | ||||
Financing Receivable, Allowance for Credit Loss [Line Items] | ||||
Loans at amortized cost | 248,625 | 301,602 | ||
Allowance for credit losses on loans | (1,784) | (1,709) | (1,654) | (2,530) |
Commercial real estate loans | Commercial owner-occupied | ||||
Financing Receivable, Allowance for Credit Loss [Line Items] | ||||
Loans at amortized cost | 391,924 | 392,345 | ||
Allowance for credit losses on loans | (2,622) | (2,776) | (2,304) | (2,778) |
Commercial real estate loans | Commercial investor-owned | ||||
Financing Receivable, Allowance for Credit Loss [Line Items] | ||||
Loans at amortized cost | 1,176,918 | 1,189,021 | ||
Allowance for credit losses on loans | (12,301) | (12,739) | (10,856) | (12,682) |
Commercial real estate loans | Construction | ||||
Financing Receivable, Allowance for Credit Loss [Line Items] | ||||
Loans at amortized cost | 131,015 | 119,840 | ||
Allowance for credit losses on loans | (1,717) | (1,653) | (1,312) | (1,557) |
Residential loans | Home equity | ||||
Financing Receivable, Allowance for Credit Loss [Line Items] | ||||
Loans at amortized cost | 88,092 | 88,746 | ||
Allowance for credit losses on loans | (549) | (595) | (520) | (738) |
Residential loans | Other residential | ||||
Financing Receivable, Allowance for Credit Loss [Line Items] | ||||
Loans at amortized cost | 114,277 | 114,558 | ||
Allowance for credit losses on loans | (628) | (644) | (757) | (998) |
Consumer loans | Installment and other consumer loans | ||||
Financing Receivable, Allowance for Credit Loss [Line Items] | ||||
Loans at amortized cost | 51,003 | 49,533 | ||
Allowance for credit losses on loans | $ (641) | $ (621) | $ (255) | $ (291) |
Loans and Allowance for Credit Losses on Loans - CARES Act Narrative (Details) $ in Thousands |
Mar. 31, 2022
USD ($)
branch
loan
|
Dec. 31, 2021
USD ($)
loan
|
Aug. 06, 2021
USD ($)
branch
|
Jun. 30, 2021
USD ($)
loan
|
---|---|---|---|---|
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Loans at amortized cost | $ 2,201,854 | $ 2,255,645 | ||
SBA PPP | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Number of PPP participated | branch | 2 | |||
Commercial loans | Commercial and industrial | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Loans at amortized cost | $ 248,625 | $ 301,602 | ||
Commercial loans | Commercial and industrial | SBA PPP | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Number of loans | loan | 191 | 368 | 2,876 | |
Loans at amortized cost | $ 40,600 | $ 111,200 | $ 444,100 | |
Financing receivable, unamortized loan fee | $ 993 | $ 2,500 | ||
Commercial loans | Commercial and industrial | SBA PPP | American River Bank (ARB) | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Number of loans | branch | 113 | |||
Loans at amortized cost | $ 18,600 |
Loans and Allowance for Credit Losses on Loans - Schedule of Loans by Risk Grade and Origination Year (Details) - USD ($) $ in Thousands |
Mar. 31, 2022 |
Dec. 31, 2021 |
---|---|---|
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Financing receivable, originated, year one | $ 79,930 | $ 461,784 |
Financing receivable, originated, year two | 399,640 | 385,837 |
Financing receivable, originated, year three | 361,966 | 310,140 |
Financing receivable, originated, year four | 296,016 | 242,704 |
Financing receivable, originated, year five | 233,327 | 131,462 |
Prior | 622,830 | 539,868 |
Revolving Loans Amortized Cost | 208,145 | 183,850 |
Total | 2,201,854 | 2,255,645 |
Pass and Watch | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Financing receivable, originated, year one | 73,715 | 445,036 |
Financing receivable, originated, year two | 383,169 | 375,654 |
Financing receivable, originated, year three | 351,905 | 306,557 |
Financing receivable, originated, year four | 291,009 | 222,117 |
Financing receivable, originated, year five | 213,817 | 129,675 |
Prior | 586,603 | 486,821 |
Revolving Loans Amortized Cost | 201,918 | 180,287 |
Total | 2,102,136 | 2,146,147 |
Special Mention | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Financing receivable, originated, year one | 6,215 | 16,748 |
Financing receivable, originated, year two | 16,471 | 2,914 |
Financing receivable, originated, year three | 1,213 | 3,298 |
Financing receivable, originated, year four | 5,007 | 19,892 |
Financing receivable, originated, year five | 19,510 | 1,787 |
Prior | 14,773 | 26,536 |
Revolving Loans Amortized Cost | 69 | 2,088 |
Total | 63,258 | 73,263 |
Substandard | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Financing receivable, originated, year one | 0 | 0 |
Financing receivable, originated, year two | 0 | 7,155 |
Financing receivable, originated, year three | 8,738 | 285 |
Financing receivable, originated, year four | 0 | 695 |
Financing receivable, originated, year five | 0 | 0 |
Prior | 21,454 | 26,511 |
Revolving Loans Amortized Cost | 6,158 | 1,475 |
Total | 36,350 | 36,121 |
Doubtful | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Financing receivable, originated, year one | 0 | 0 |
Financing receivable, originated, year two | 0 | 114 |
Financing receivable, originated, year three | 110 | 0 |
Financing receivable, originated, year four | 0 | 0 |
Financing receivable, originated, year five | 0 | 0 |
Prior | 0 | 0 |
Revolving Loans Amortized Cost | 0 | 0 |
Total | 110 | 114 |
Gross current period charge-offs | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Financing receivable, originated, year one | 0 | |
Financing receivable, originated, year two | 0 | |
Financing receivable, originated, year three | 0 | |
Financing receivable, originated, year four | 0 | |
Financing receivable, originated, year five | 0 | |
Prior | 0 | |
Revolving Loans Amortized Cost | 2 | |
Total | 2 | |
Commercial loans | Commercial and industrial | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Financing receivable, originated, year one | 2,563 | 96,643 |
Financing receivable, originated, year two | 44,716 | 37,667 |
Financing receivable, originated, year three | 14,159 | 26,338 |
Financing receivable, originated, year four | 25,184 | 13,036 |
Financing receivable, originated, year five | 12,192 | 2,729 |
Prior | 30,950 | 31,280 |
Revolving Loans Amortized Cost | 118,861 | 93,909 |
Total | 248,625 | 301,602 |
Commercial loans | Commercial and industrial | Pass and Watch | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Financing receivable, originated, year one | 2,563 | 96,643 |
Financing receivable, originated, year two | 44,716 | 35,967 |
Financing receivable, originated, year three | 12,583 | 25,754 |
Financing receivable, originated, year four | 24,654 | 12,763 |
Financing receivable, originated, year five | 7,862 | 2,729 |
Prior | 30,950 | 31,280 |
Revolving Loans Amortized Cost | 112,839 | 90,744 |
Total | 236,167 | 295,880 |
Commercial loans | Commercial and industrial | Special Mention | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Financing receivable, originated, year one | 0 | 0 |
Financing receivable, originated, year two | 0 | 1,700 |
Financing receivable, originated, year three | 0 | 584 |
Financing receivable, originated, year four | 530 | 273 |
Financing receivable, originated, year five | 4,330 | 0 |
Prior | 0 | 0 |
Revolving Loans Amortized Cost | 3 | 2,088 |
Total | 4,863 | 4,645 |
Commercial loans | Commercial and industrial | Substandard | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Financing receivable, originated, year one | 0 | 0 |
Financing receivable, originated, year two | 0 | 0 |
Financing receivable, originated, year three | 1,576 | 0 |
Financing receivable, originated, year four | 0 | 0 |
Financing receivable, originated, year five | 0 | 0 |
Prior | 0 | 0 |
Revolving Loans Amortized Cost | 6,019 | 1,077 |
Total | 7,595 | 1,077 |
Commercial real estate loans | Commercial owner-occupied | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Financing receivable, originated, year one | 20,757 | 75,143 |
Financing receivable, originated, year two | 69,805 | 50,485 |
Financing receivable, originated, year three | 51,123 | 49,770 |
Financing receivable, originated, year four | 49,147 | 44,020 |
Financing receivable, originated, year five | 41,100 | 42,430 |
Prior | 159,992 | 130,497 |
Revolving Loans Amortized Cost | 0 | 0 |
Total | 391,924 | 392,345 |
Commercial real estate loans | Commercial owner-occupied | Pass and Watch | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Financing receivable, originated, year one | 14,542 | 58,395 |
Financing receivable, originated, year two | 53,334 | 43,216 |
Financing receivable, originated, year three | 43,851 | 49,485 |
Financing receivable, originated, year four | 47,384 | 36,174 |
Financing receivable, originated, year five | 35,681 | 42,430 |
Prior | 151,304 | 104,898 |
Revolving Loans Amortized Cost | 0 | 0 |
Total | 346,096 | 334,598 |
Commercial real estate loans | Commercial owner-occupied | Special Mention | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Financing receivable, originated, year one | 6,215 | 16,748 |
Financing receivable, originated, year two | 16,471 | 0 |
Financing receivable, originated, year three | 0 | 0 |
Financing receivable, originated, year four | 1,763 | 7,846 |
Financing receivable, originated, year five | 5,419 | 0 |
Prior | 5,152 | 16,996 |
Revolving Loans Amortized Cost | 0 | 0 |
Total | 35,020 | 41,590 |
Commercial real estate loans | Commercial owner-occupied | Substandard | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Financing receivable, originated, year one | 0 | 0 |
Financing receivable, originated, year two | 0 | 7,155 |
Financing receivable, originated, year three | 7,162 | 285 |
Financing receivable, originated, year four | 0 | 0 |
Financing receivable, originated, year five | 0 | 0 |
Prior | 3,536 | 8,603 |
Revolving Loans Amortized Cost | 0 | 0 |
Total | 10,698 | 16,043 |
Commercial real estate loans | Commercial owner-occupied | Doubtful | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Financing receivable, originated, year one | 0 | 0 |
Financing receivable, originated, year two | 0 | 114 |
Financing receivable, originated, year three | 110 | 0 |
Financing receivable, originated, year four | 0 | 0 |
Financing receivable, originated, year five | 0 | 0 |
Prior | 0 | 0 |
Revolving Loans Amortized Cost | 0 | 0 |
Total | 110 | 114 |
Commercial real estate loans | Commercial investor-owned | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Financing receivable, originated, year one | 42,615 | 225,722 |
Financing receivable, originated, year two | 222,832 | 187,428 |
Financing receivable, originated, year three | 178,290 | 190,132 |
Financing receivable, originated, year four | 180,191 | 155,496 |
Financing receivable, originated, year five | 151,205 | 77,206 |
Prior | 401,707 | 352,953 |
Revolving Loans Amortized Cost | 78 | 84 |
Total | 1,176,918 | 1,189,021 |
Commercial real estate loans | Commercial investor-owned | Pass and Watch | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Financing receivable, originated, year one | 42,615 | 225,722 |
Financing receivable, originated, year two | 222,832 | 186,214 |
Financing receivable, originated, year three | 177,077 | 187,418 |
Financing receivable, originated, year four | 177,477 | 143,028 |
Financing receivable, originated, year five | 141,444 | 75,419 |
Prior | 374,554 | 325,882 |
Revolving Loans Amortized Cost | 78 | 84 |
Total | 1,136,077 | 1,143,767 |
Commercial real estate loans | Commercial investor-owned | Special Mention | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Financing receivable, originated, year one | 0 | 0 |
Financing receivable, originated, year two | 0 | 1,214 |
Financing receivable, originated, year three | 1,213 | 2,714 |
Financing receivable, originated, year four | 2,714 | 11,773 |
Financing receivable, originated, year five | 9,761 | 1,787 |
Prior | 9,621 | 9,540 |
Revolving Loans Amortized Cost | 0 | 0 |
Total | 23,309 | 27,028 |
Commercial real estate loans | Commercial investor-owned | Substandard | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Financing receivable, originated, year one | 0 | 0 |
Financing receivable, originated, year two | 0 | 0 |
Financing receivable, originated, year three | 0 | 0 |
Financing receivable, originated, year four | 0 | 695 |
Financing receivable, originated, year five | 0 | 0 |
Prior | 17,532 | 17,531 |
Revolving Loans Amortized Cost | 0 | 0 |
Total | 17,532 | 18,226 |
Commercial real estate loans | Construction | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Financing receivable, originated, year one | 2,708 | 31,269 |
Financing receivable, originated, year two | 30,721 | 70,528 |
Financing receivable, originated, year three | 79,544 | 8,935 |
Financing receivable, originated, year four | 8,933 | 9,108 |
Financing receivable, originated, year five | 9,109 | 0 |
Prior | 0 | 0 |
Revolving Loans Amortized Cost | 0 | 0 |
Total | 131,015 | 119,840 |
Commercial real estate loans | Construction | Pass and Watch | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Financing receivable, originated, year one | 2,708 | 31,269 |
Financing receivable, originated, year two | 30,721 | 70,528 |
Financing receivable, originated, year three | 79,544 | 8,935 |
Financing receivable, originated, year four | 8,933 | 9,108 |
Financing receivable, originated, year five | 9,109 | 0 |
Prior | 0 | 0 |
Revolving Loans Amortized Cost | 0 | 0 |
Total | 131,015 | 119,840 |
Residential loans | Home equity | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Financing receivable, originated, year one | 0 | 0 |
Financing receivable, originated, year two | 24 | 0 |
Financing receivable, originated, year three | 0 | 0 |
Financing receivable, originated, year four | 0 | 0 |
Financing receivable, originated, year five | 0 | 10 |
Prior | 690 | 645 |
Revolving Loans Amortized Cost | 87,378 | 88,091 |
Total | 88,092 | 88,746 |
Residential loans | Home equity | Pass and Watch | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Financing receivable, originated, year one | 0 | 0 |
Financing receivable, originated, year two | 24 | 0 |
Financing receivable, originated, year three | 0 | 0 |
Financing receivable, originated, year four | 0 | 0 |
Financing receivable, originated, year five | 0 | 10 |
Prior | 320 | 268 |
Revolving Loans Amortized Cost | 87,173 | 87,693 |
Total | 87,517 | 87,971 |
Residential loans | Home equity | Special Mention | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Financing receivable, originated, year one | 0 | |
Financing receivable, originated, year two | 0 | |
Financing receivable, originated, year three | 0 | |
Financing receivable, originated, year four | 0 | |
Financing receivable, originated, year five | 0 | |
Prior | 0 | |
Revolving Loans Amortized Cost | 66 | |
Total | 66 | |
Residential loans | Home equity | Substandard | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Financing receivable, originated, year one | 0 | 0 |
Financing receivable, originated, year two | 0 | 0 |
Financing receivable, originated, year three | 0 | 0 |
Financing receivable, originated, year four | 0 | 0 |
Financing receivable, originated, year five | 0 | 0 |
Prior | 370 | 377 |
Revolving Loans Amortized Cost | 139 | 398 |
Total | 509 | 775 |
Residential loans | Other residential | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Financing receivable, originated, year one | 5,249 | 15,800 |
Financing receivable, originated, year two | 15,690 | 31,981 |
Financing receivable, originated, year three | 31,776 | 25,529 |
Financing receivable, originated, year four | 24,342 | 15,411 |
Financing receivable, originated, year five | 14,848 | 7,964 |
Prior | 22,372 | 17,873 |
Revolving Loans Amortized Cost | 0 | 0 |
Total | 114,277 | 114,558 |
Residential loans | Other residential | Pass and Watch | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Financing receivable, originated, year one | 5,249 | 15,800 |
Financing receivable, originated, year two | 15,690 | 31,981 |
Financing receivable, originated, year three | 31,776 | 25,529 |
Financing receivable, originated, year four | 24,342 | 15,411 |
Financing receivable, originated, year five | 14,848 | 7,964 |
Prior | 22,372 | 17,873 |
Revolving Loans Amortized Cost | 0 | 0 |
Total | 114,277 | 114,558 |
Consumer loans | Installment and other consumer loans | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Financing receivable, originated, year one | 6,038 | 17,207 |
Financing receivable, originated, year two | 15,852 | 7,748 |
Financing receivable, originated, year three | 7,074 | 9,436 |
Financing receivable, originated, year four | 8,219 | 5,633 |
Financing receivable, originated, year five | 4,873 | 1,123 |
Prior | 7,119 | 6,620 |
Revolving Loans Amortized Cost | 1,828 | 1,766 |
Total | 51,003 | 49,533 |
Consumer loans | Installment and other consumer loans | Pass and Watch | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Financing receivable, originated, year one | 6,038 | 17,207 |
Financing receivable, originated, year two | 15,852 | 7,748 |
Financing receivable, originated, year three | 7,074 | 9,436 |
Financing receivable, originated, year four | 8,219 | 5,633 |
Financing receivable, originated, year five | 4,873 | 1,123 |
Prior | 7,103 | 6,620 |
Revolving Loans Amortized Cost | 1,828 | 1,766 |
Total | 50,987 | $ 49,533 |
Consumer loans | Installment and other consumer loans | Substandard | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Financing receivable, originated, year one | 0 | |
Financing receivable, originated, year two | 0 | |
Financing receivable, originated, year three | 0 | |
Financing receivable, originated, year four | 0 | |
Financing receivable, originated, year five | 0 | |
Prior | 16 | |
Revolving Loans Amortized Cost | 0 | |
Total | 16 | |
Consumer loans | Installment and other consumer loans | Gross current period charge-offs | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Financing receivable, originated, year one | 0 | |
Financing receivable, originated, year two | 0 | |
Financing receivable, originated, year three | 0 | |
Financing receivable, originated, year four | 0 | |
Financing receivable, originated, year five | 0 | |
Prior | 0 | |
Revolving Loans Amortized Cost | 2 | |
Total | $ 2 |
Loans and Allowance for Credit Losses on Loans - Outstanding and Aging Analysis (Details) |
3 Months Ended | ||||
---|---|---|---|---|---|
Mar. 31, 2022
USD ($)
branch
|
Mar. 31, 2021
USD ($)
|
Dec. 31, 2021
USD ($)
loan
|
Aug. 06, 2021
USD ($)
|
Jun. 30, 2021
USD ($)
|
|
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||
Loans at amortized cost | $ 2,201,854,000 | $ 2,255,645,000 | |||
Loans past due more than 90 days still accruing | 0 | ||||
Financing receivable, nonaccrual, earning interest on cash basis | 0 | 0 | |||
Financing receivable, nonaccrual, interest income | $ 0 | $ 0 | |||
Financing receivable, number of loans placed on nonaccrual status | branch | 1 | ||||
Financing receivable, nonaccrual, amortized cost | $ 16,000 | $ 0 | |||
Financing receivable, accrued interest, writeoff | 1,000 | ||||
Commercial loans | Commercial and industrial | |||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||
Loans at amortized cost | 248,625,000 | 301,602,000 | |||
Loans past due more than 90 days still accruing | 229,000 | ||||
Commercial loans | Commercial and industrial | SBA PPP | |||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||
Loans at amortized cost | 40,600,000 | $ 111,200,000 | $ 444,100,000 | ||
Number of loans | loan | 2 | ||||
Commercial loans | Commercial and industrial | American River Bank (ARB) | SBA PPP | |||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||
Loans at amortized cost | $ 18,600,000 | ||||
Commercial real estate loans | Commercial owner-occupied | |||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||
Loans at amortized cost | 391,924,000 | $ 392,345,000 | |||
Commercial real estate loans | Commercial investor-owned | |||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||
Loans at amortized cost | 1,176,918,000 | 1,189,021,000 | |||
Commercial real estate loans | Construction | |||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||
Loans at amortized cost | 131,015,000 | 119,840,000 | |||
Residential loans | Home equity | |||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||
Loans at amortized cost | 88,092,000 | 88,746,000 | |||
Residential loans | Other residential | |||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||
Loans at amortized cost | 114,277,000 | 114,558,000 | |||
Consumer loans | Installment and other consumer loans | |||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||
Loans at amortized cost | 51,003,000 | 49,533,000 | |||
Financial asset, other than financial asset acquired with credit deterioration | |||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||
Loans at amortized cost | 2,201,854,000 | 2,255,645,000 | |||
Non-accrual | 7,678,000 | 8,376,000 | |||
Non-accrual loans with no allowance | 7,678,000 | 8,376,000 | |||
Financial asset, other than financial asset acquired with credit deterioration | Total past due | |||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||
Loans at amortized cost | 2,643,000 | 2,314,000 | |||
Financial asset, other than financial asset acquired with credit deterioration | 30-59 days past due | |||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||
Loans at amortized cost | 2,130,000 | 1,536,000 | |||
Financial asset, other than financial asset acquired with credit deterioration | 60-89 days past due | |||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||
Loans at amortized cost | 443,000 | 461,000 | |||
Financial asset, other than financial asset acquired with credit deterioration | 90 days or more past due | |||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||
Loans at amortized cost | 70,000 | 317,000 | |||
Financial asset, other than financial asset acquired with credit deterioration | Current | |||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||
Loans at amortized cost | 2,199,211,000 | 2,253,331,000 | |||
Financial asset, other than financial asset acquired with credit deterioration | Commercial loans | Commercial and industrial | |||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||
Loans at amortized cost | 248,625,000 | 301,602,000 | |||
Non-accrual | 0 | 0 | |||
Non-accrual loans with no allowance | 0 | 0 | |||
Financial asset, other than financial asset acquired with credit deterioration | Commercial loans | Commercial and industrial | Total past due | |||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||
Loans at amortized cost | 776,000 | 625,000 | |||
Financial asset, other than financial asset acquired with credit deterioration | Commercial loans | Commercial and industrial | 30-59 days past due | |||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||
Loans at amortized cost | 435,000 | 2,000 | |||
Financial asset, other than financial asset acquired with credit deterioration | Commercial loans | Commercial and industrial | 60-89 days past due | |||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||
Loans at amortized cost | 341,000 | 394,000 | |||
Financial asset, other than financial asset acquired with credit deterioration | Commercial loans | Commercial and industrial | 90 days or more past due | |||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||
Loans at amortized cost | 0 | 229,000 | |||
Financial asset, other than financial asset acquired with credit deterioration | Commercial loans | Commercial and industrial | Current | |||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||
Loans at amortized cost | 247,849,000 | 300,977,000 | |||
Financial asset, other than financial asset acquired with credit deterioration | Commercial real estate loans | Commercial owner-occupied | |||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||
Loans at amortized cost | 391,924,000 | 392,345,000 | |||
Non-accrual | 7,272,000 | 7,269,000 | |||
Non-accrual loans with no allowance | 7,272,000 | 7,269,000 | |||
Financial asset, other than financial asset acquired with credit deterioration | Commercial real estate loans | Commercial owner-occupied | Total past due | |||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||
Loans at amortized cost | 324,000 | 0 | |||
Financial asset, other than financial asset acquired with credit deterioration | Commercial real estate loans | Commercial owner-occupied | 30-59 days past due | |||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||
Loans at amortized cost | 324,000 | 0 | |||
Financial asset, other than financial asset acquired with credit deterioration | Commercial real estate loans | Commercial owner-occupied | 60-89 days past due | |||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||
Loans at amortized cost | 0 | 0 | |||
Financial asset, other than financial asset acquired with credit deterioration | Commercial real estate loans | Commercial owner-occupied | 90 days or more past due | |||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||
Loans at amortized cost | 0 | 0 | |||
Financial asset, other than financial asset acquired with credit deterioration | Commercial real estate loans | Commercial owner-occupied | Current | |||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||
Loans at amortized cost | 391,600,000 | 392,345,000 | |||
Financial asset, other than financial asset acquired with credit deterioration | Commercial real estate loans | Commercial investor-owned | |||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||
Loans at amortized cost | 1,176,918,000 | 1,189,021,000 | |||
Non-accrual | 0 | 694,000 | |||
Non-accrual loans with no allowance | 0 | 694,000 | |||
Financial asset, other than financial asset acquired with credit deterioration | Commercial real estate loans | Commercial investor-owned | Total past due | |||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||
Loans at amortized cost | 0 | 0 | |||
Financial asset, other than financial asset acquired with credit deterioration | Commercial real estate loans | Commercial investor-owned | 30-59 days past due | |||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||
Loans at amortized cost | 0 | 0 | |||
Financial asset, other than financial asset acquired with credit deterioration | Commercial real estate loans | Commercial investor-owned | 60-89 days past due | |||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||
Loans at amortized cost | 0 | 0 | |||
Financial asset, other than financial asset acquired with credit deterioration | Commercial real estate loans | Commercial investor-owned | 90 days or more past due | |||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||
Loans at amortized cost | 0 | ||||
Financial asset, other than financial asset acquired with credit deterioration | Commercial real estate loans | Commercial investor-owned | Current | |||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||
Loans at amortized cost | 1,176,918,000 | 1,189,021,000 | |||
Financial asset, other than financial asset acquired with credit deterioration | Commercial real estate loans | Construction | |||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||
Loans at amortized cost | 131,015,000 | 119,840,000 | |||
Non-accrual | 0 | 0 | |||
Non-accrual loans with no allowance | 0 | 0 | |||
Financial asset, other than financial asset acquired with credit deterioration | Commercial real estate loans | Construction | Total past due | |||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||
Loans at amortized cost | 0 | 0 | |||
Financial asset, other than financial asset acquired with credit deterioration | Commercial real estate loans | Construction | 30-59 days past due | |||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||
Loans at amortized cost | 0 | 0 | |||
Financial asset, other than financial asset acquired with credit deterioration | Commercial real estate loans | Construction | 60-89 days past due | |||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||
Loans at amortized cost | 0 | 0 | |||
Financial asset, other than financial asset acquired with credit deterioration | Commercial real estate loans | Construction | 90 days or more past due | |||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||
Loans at amortized cost | 0 | 0 | |||
Financial asset, other than financial asset acquired with credit deterioration | Commercial real estate loans | Construction | Current | |||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||
Loans at amortized cost | 131,015,000 | 119,840,000 | |||
Financial asset, other than financial asset acquired with credit deterioration | Residential loans | Home equity | |||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||
Loans at amortized cost | 88,092,000 | 88,746,000 | |||
Non-accrual | 390,000 | 413,000 | |||
Non-accrual loans with no allowance | 390,000 | 413,000 | |||
Financial asset, other than financial asset acquired with credit deterioration | Residential loans | Home equity | Total past due | |||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||
Loans at amortized cost | 553,000 | 653,000 | |||
Financial asset, other than financial asset acquired with credit deterioration | Residential loans | Home equity | 30-59 days past due | |||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||
Loans at amortized cost | 399,000 | 498,000 | |||
Financial asset, other than financial asset acquired with credit deterioration | Residential loans | Home equity | 60-89 days past due | |||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||
Loans at amortized cost | 100,000 | 67,000 | |||
Financial asset, other than financial asset acquired with credit deterioration | Residential loans | Home equity | 90 days or more past due | |||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||
Loans at amortized cost | 54,000 | 88,000 | |||
Financial asset, other than financial asset acquired with credit deterioration | Residential loans | Home equity | Current | |||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||
Loans at amortized cost | 87,539,000 | 88,093,000 | |||
Financial asset, other than financial asset acquired with credit deterioration | Residential loans | Other residential | |||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||
Loans at amortized cost | 114,277,000 | 114,558,000 | |||
Non-accrual | 0 | 0 | |||
Non-accrual loans with no allowance | 0 | 0 | |||
Financial asset, other than financial asset acquired with credit deterioration | Residential loans | Other residential | Total past due | |||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||
Loans at amortized cost | 635,000 | 0 | |||
Financial asset, other than financial asset acquired with credit deterioration | Residential loans | Other residential | 30-59 days past due | |||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||
Loans at amortized cost | 635,000 | 0 | |||
Financial asset, other than financial asset acquired with credit deterioration | Residential loans | Other residential | 60-89 days past due | |||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||
Loans at amortized cost | 0 | 0 | |||
Financial asset, other than financial asset acquired with credit deterioration | Residential loans | Other residential | 90 days or more past due | |||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||
Loans at amortized cost | 0 | 0 | |||
Financial asset, other than financial asset acquired with credit deterioration | Residential loans | Other residential | Current | |||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||
Loans at amortized cost | 113,642,000 | 114,558,000 | |||
Financial asset, other than financial asset acquired with credit deterioration | Consumer loans | Installment and other consumer loans | |||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||
Loans at amortized cost | 51,003,000 | 49,533,000 | |||
Non-accrual | 16,000 | 0 | |||
Non-accrual loans with no allowance | 16,000 | 0 | |||
Financial asset, other than financial asset acquired with credit deterioration | Consumer loans | Installment and other consumer loans | Total past due | |||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||
Loans at amortized cost | 355,000 | 1,036,000 | |||
Financial asset, other than financial asset acquired with credit deterioration | Consumer loans | Installment and other consumer loans | 30-59 days past due | |||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||
Loans at amortized cost | 337,000 | 1,036,000 | |||
Financial asset, other than financial asset acquired with credit deterioration | Consumer loans | Installment and other consumer loans | 60-89 days past due | |||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||
Loans at amortized cost | 2,000 | 0 | |||
Financial asset, other than financial asset acquired with credit deterioration | Consumer loans | Installment and other consumer loans | 90 days or more past due | |||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||
Loans at amortized cost | 16,000 | 0 | |||
Financial asset, other than financial asset acquired with credit deterioration | Consumer loans | Installment and other consumer loans | Current | |||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||
Loans at amortized cost | $ 50,648,000 | $ 48,497,000 |
Loans and Allowance for Credit Losses on Loans - Schedule of Collateral-Dependent Non-Accrual Loans (Details) - USD ($) |
Mar. 31, 2022 |
Dec. 31, 2021 |
Mar. 31, 2021 |
Dec. 31, 2020 |
---|---|---|---|---|
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Allowance for credit losses | $ 22,547,000 | $ 23,023,000 | $ 19,958,000 | $ 22,874,000 |
Weighted average ratio of loans value to collateral dependent loans value | 69.00% | 67.00% | ||
Commercial Real Estate | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Non-accrual | $ 7,272,000 | $ 7,963,000 | ||
Residential Real Estate | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Non-accrual | 390,000 | 413,000 | ||
Other | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Non-accrual | 16,000 | 0 | ||
Collateral Pledged | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Non-accrual | 7,678,000 | 8,376,000 | ||
Allowance for credit losses | 0 | 0 | ||
Nonaccrual collateral dependent loans in process of foreclosure | 0 | 0 | ||
Commercial real estate loans | Commercial owner-occupied | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Allowance for credit losses | 2,622,000 | 2,776,000 | 2,304,000 | 2,778,000 |
Commercial real estate loans | Commercial owner-occupied | Commercial Real Estate | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Non-accrual | 7,272,000 | 7,269,000 | ||
Commercial real estate loans | Commercial owner-occupied | Residential Real Estate | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Non-accrual | 0 | 0 | ||
Commercial real estate loans | Commercial owner-occupied | Other | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Non-accrual | 0 | 0 | ||
Commercial real estate loans | Commercial owner-occupied | Collateral Pledged | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Non-accrual | 7,272,000 | 7,269,000 | ||
Allowance for credit losses | 0 | 0 | ||
Commercial real estate loans | Commercial investor-owned | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Allowance for credit losses | 12,301,000 | 12,739,000 | 10,856,000 | 12,682,000 |
Commercial real estate loans | Commercial investor-owned | Commercial Real Estate | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Non-accrual | 694,000 | |||
Commercial real estate loans | Commercial investor-owned | Residential Real Estate | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Non-accrual | 0 | |||
Commercial real estate loans | Commercial investor-owned | Other | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Non-accrual | 0 | |||
Commercial real estate loans | Commercial investor-owned | Collateral Pledged | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Non-accrual | 694,000 | |||
Allowance for credit losses | 0 | |||
Commercial real estate loans | Installment and other consumer loans | Commercial Real Estate | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Non-accrual | 0 | |||
Commercial real estate loans | Installment and other consumer loans | Residential Real Estate | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Non-accrual | 0 | |||
Commercial real estate loans | Installment and other consumer loans | Other | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Non-accrual | 16,000 | |||
Commercial real estate loans | Installment and other consumer loans | Collateral Pledged | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Non-accrual | 16,000 | |||
Allowance for credit losses | 0 | |||
Residential loans | Home equity | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Allowance for credit losses | 549,000 | 595,000 | $ 520,000 | $ 738,000 |
Residential loans | Home equity | Commercial Real Estate | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Non-accrual | 0 | 0 | ||
Residential loans | Home equity | Residential Real Estate | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Non-accrual | 390,000 | 413,000 | ||
Residential loans | Home equity | Other | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Non-accrual | 0 | 0 | ||
Residential loans | Home equity | Collateral Pledged | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Non-accrual | 390,000 | 413,000 | ||
Allowance for credit losses | $ 0 | $ 0 |
Loans and Allowance for Credit Losses on Loans - Troubled Debt Restructuring Narrative (Details) $ in Thousands |
3 Months Ended | ||
---|---|---|---|
Mar. 31, 2022
USD ($)
borrowingRelationship
loan
|
Mar. 31, 2021
loan
|
Dec. 31, 2021
USD ($)
|
|
Financing Receivable, Troubled Debt Restructuring [Line Items] | |||
Number of loans removed from TDR designation | 0 | 0 | |
Financing receivable, loan modifications under CARES Act, payment relief, number of borrowing relationships | borrowingRelationship | 2 | ||
Financing receivable, loan modifications under CARES Act, payment relief | 3 | ||
Financing receivable, modified under CARES Act, payment relief | $ | $ 23,600 | ||
Financing receivable, weighted average loan-to-value ratio, modified under CARES Act, remaining payment relief | 44.00% | ||
Unfunded commitments for TDR loans | $ | $ 241 | $ 441 | |
Number of modified TDR loans that defaulted | 0 | 0 |
Loans and Allowance for Credit Losses on Loans - Troubled Debt Restructuring by Class (Details) - USD ($) $ in Thousands |
Mar. 31, 2022 |
Dec. 31, 2021 |
---|---|---|
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Recorded investment in troubled debt restructurings | $ 9,492 | $ 9,510 |
Financing receivable, modifications, recorded investment, nonaccrual status | 7,400 | 7,400 |
Unfunded commitments for TDR loans | 241 | 441 |
Commercial loans | Commercial and industrial | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Recorded investment in troubled debt restructurings | 1,180 | 1,183 |
Commercial real estate loans | Commercial owner-occupied | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Recorded investment in troubled debt restructurings | 7,162 | 7,155 |
Commercial real estate loans | Commercial investor-owned | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Recorded investment in troubled debt restructurings | 175 | 179 |
Residential loans | Home equity | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Recorded investment in troubled debt restructurings | 379 | 386 |
Consumer loans | Installment and other consumer loans | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Recorded investment in troubled debt restructurings | $ 596 | $ 607 |
Loans and Allowance for Credit Losses on Loans - Allowance for Credit Losses on Loans (Details) - USD ($) $ in Thousands |
3 Months Ended | ||
---|---|---|---|
Mar. 31, 2022 |
Dec. 31, 2021 |
Mar. 31, 2021 |
|
Allowance for Loan and Lease Losses [Roll Forward] | |||
Beginning balance | $ 23,023 | $ 22,874 | |
Provision (reversal) | (485) | $ 600 | (2,929) |
Charge-offs | (2) | 0 | |
Recoveries | 11 | 13 | |
Ending balance | 22,547 | 23,023 | 19,958 |
Commercial loans | Commercial and industrial | |||
Allowance for Loan and Lease Losses [Roll Forward] | |||
Beginning balance | 1,709 | 2,530 | |
Provision (reversal) | 72 | (880) | |
Charge-offs | 0 | 0 | |
Recoveries | 3 | 4 | |
Ending balance | 1,784 | 1,709 | 1,654 |
Commercial real estate loans | Commercial owner-occupied | |||
Allowance for Loan and Lease Losses [Roll Forward] | |||
Beginning balance | 2,776 | 2,778 | |
Provision (reversal) | (154) | (474) | |
Charge-offs | 0 | 0 | |
Recoveries | 0 | 0 | |
Ending balance | 2,622 | 2,776 | 2,304 |
Commercial real estate loans | Commercial investor-owned | |||
Allowance for Loan and Lease Losses [Roll Forward] | |||
Beginning balance | 12,739 | 12,682 | |
Provision (reversal) | (438) | (1,826) | |
Charge-offs | 0 | 0 | |
Recoveries | 0 | 0 | |
Ending balance | 12,301 | 12,739 | 10,856 |
Commercial real estate loans | Construction | |||
Allowance for Loan and Lease Losses [Roll Forward] | |||
Beginning balance | 1,653 | 1,557 | |
Provision (reversal) | 56 | (254) | |
Charge-offs | 0 | 0 | |
Recoveries | 8 | 9 | |
Ending balance | 1,717 | 1,653 | 1,312 |
Residential loans | Home equity | |||
Allowance for Loan and Lease Losses [Roll Forward] | |||
Beginning balance | 595 | 738 | |
Provision (reversal) | (46) | (218) | |
Charge-offs | 0 | 0 | |
Recoveries | 0 | 0 | |
Ending balance | 549 | 595 | 520 |
Residential loans | Other residential | |||
Allowance for Loan and Lease Losses [Roll Forward] | |||
Beginning balance | 644 | 998 | |
Provision (reversal) | (16) | (241) | |
Charge-offs | 0 | 0 | |
Recoveries | 0 | 0 | |
Ending balance | 628 | 644 | 757 |
Consumer loans | Installment and other consumer loans | |||
Allowance for Loan and Lease Losses [Roll Forward] | |||
Beginning balance | 621 | 291 | |
Provision (reversal) | 22 | (36) | |
Charge-offs | (2) | 0 | |
Recoveries | 0 | 0 | |
Ending balance | 641 | 621 | 255 |
Unallocated | |||
Allowance for Loan and Lease Losses [Roll Forward] | |||
Beginning balance | 2,286 | 1,300 | |
Provision (reversal) | 19 | 1,000 | |
Charge-offs | 0 | 0 | |
Recoveries | 0 | 0 | |
Ending balance | $ 2,305 | $ 2,286 | $ 2,300 |
Loans and Allowance for Credit Losses on Loans - Pledged Loans (Details) - USD ($) $ in Millions |
Mar. 31, 2022 |
Dec. 31, 2021 |
---|---|---|
Financial Instruments Owned and Pledged as Collateral [Line Items] | ||
Residential loans pledged for FRB borrowings | $ 1,295.0 | $ 1,330.0 |
Other residential | ||
Financial Instruments Owned and Pledged as Collateral [Line Items] | ||
Pledged residential loan portfolio to secure borrowing with FRB | $ 102.2 | $ 106.2 |
Loans and Allowance for Credit Losses on Loans - Related Party (Details) - Directors, officers, principal shareholders and associates - USD ($) $ in Thousands |
Mar. 31, 2022 |
Dec. 31, 2021 |
---|---|---|
Related Party Transaction [Line Items] | ||
Related party loans | $ 5,100 | $ 7,900 |
Undisbursed commitment to related parties | $ 562 | $ 8,600 |
Borrowings and Other Obligations - Lines of Credit (Details) - Line of credit - USD ($) |
Aug. 26, 2021 |
Mar. 31, 2022 |
Dec. 31, 2021 |
Aug. 06, 2021 |
---|---|---|---|---|
Federal home loan bank borrowings | ||||
Line of Credit Facility [Line Items] | ||||
Lines of credit | $ 799,500,000 | $ 820,500,000 | ||
Federal home loan bank borrowings | American River Bank (ARB) | ||||
Line of Credit Facility [Line Items] | ||||
Lines of credit | $ 13,800,000 | |||
Repayments of Lines of Credit | $ 13,800,000 | |||
Federal home loan bank overnight borrowings | ||||
Line of Credit Facility [Line Items] | ||||
Amount of borrowings outstanding | 0 | 0 | ||
Federal reserve line of credit | ||||
Line of Credit Facility [Line Items] | ||||
Lines of credit | 57,300,000 | 70,800,000 | ||
Amount of borrowings outstanding | 0 | 0 | ||
Unsecured debt | Federal funds purchased | ||||
Line of Credit Facility [Line Items] | ||||
Lines of credit | 150,000,000 | 150,000,000 | ||
Amount of borrowings outstanding | $ 0 | $ 0 |
Borrowings and Other Obligations - Subordinated Debt (Details) - USD ($) $ in Thousands |
3 Months Ended | |||
---|---|---|---|---|
Mar. 15, 2021 |
Mar. 31, 2022 |
Mar. 31, 2021 |
Dec. 31, 2013 |
|
Debt Instrument [Line Items] | ||||
Accretion of discount on subordinated debenture | $ 0 | $ 1,347 | ||
Subordinated debenture | NorCal Community Bancorp Trust II | ||||
Debt Instrument [Line Items] | ||||
Contractual value of subordinated debt | $ 4,100 | |||
Repayments of debt | $ 2,800 | |||
Effective interest rate | 251.50% | |||
Accretion of discount on subordinated debenture | $ 1,300 |
Borrowings and Other Obligations - Other Obligations (Details) - USD ($) $ in Thousands |
Mar. 31, 2022 |
Dec. 31, 2021 |
Dec. 31, 2020 |
---|---|---|---|
Debt Disclosure [Abstract] | |||
Present value of net minimum lease payments (lease liability) | $ 388 | $ 419 | $ 419 |
Stockholders' Equity - Narrative (Details) - USD ($) |
3 Months Ended | 47 Months Ended | ||||||
---|---|---|---|---|---|---|---|---|
Apr. 22, 2022 |
Mar. 31, 2022 |
Mar. 31, 2021 |
Mar. 31, 2022 |
Oct. 22, 2021 |
Jul. 16, 2021 |
Jan. 24, 2020 |
Apr. 23, 2018 |
|
Class of Stock [Line Items] | ||||||||
Shares withheld for tax withholding and exercise of options (in shares) | 8,003 | 27,547 | ||||||
Amount of shares withheld for tax withholding and exercise of options | $ 278,000 | $ 1,100,000 | ||||||
Shares withheld for tax withholding and exercise of options, weighted average price (in usd per share) | $ 34.76 | $ 38.87 | ||||||
Share repurchase program, amount approved to repurchase | $ 57,000,000 | $ 25,000,000 | $ 25,000,000 | $ 25,000,000 | ||||
Stock repurchased, including commissions | $ 877,000 | $ 8,511,000 | ||||||
Subsequent event | ||||||||
Class of Stock [Line Items] | ||||||||
Dividends declared per common share (in usd per share) | $ 0.24 | |||||||
Common Stock | ||||||||
Class of Stock [Line Items] | ||||||||
Stock repurchased, including commissions | $ 877,000 | $ 8,511,000 | ||||||
Stock repurchased, including commissions (in shares) | 23,275 | 224,013 | 618,991 | |||||
Stock repurchased during period (in usd per share) | $ 36.04 | $ 36.04 | ||||||
Performance-based stock awards | ||||||||
Class of Stock [Line Items] | ||||||||
Vesting period of performance-based stock awards | 3 years | |||||||
Performance-based stock awards | Minimum | ||||||||
Class of Stock [Line Items] | ||||||||
Vesting percentage of performance-based awards | 0.00% | |||||||
Performance-based stock awards | Maximum | ||||||||
Class of Stock [Line Items] | ||||||||
Vesting percentage of performance-based awards | 200.00% |
Commitments and Contingencies - Off Balance Sheet Arrangements (Details) - USD ($) $ in Thousands |
Mar. 31, 2022 |
Dec. 31, 2021 |
---|---|---|
Total commitments and standby letters of credit | ||
Other Commitments [Line Items] | ||
Total commitments and standby letters of credit | $ 581,425 | $ 634,211 |
Commercial lines of credit | ||
Other Commitments [Line Items] | ||
Total commitments and standby letters of credit | 294,162 | 330,234 |
Revolving home equity lines | ||
Other Commitments [Line Items] | ||
Total commitments and standby letters of credit | 212,595 | 210,938 |
Undisbursed construction loans | ||
Other Commitments [Line Items] | ||
Total commitments and standby letters of credit | 61,554 | 78,381 |
Personal and other lines of credit | ||
Other Commitments [Line Items] | ||
Total commitments and standby letters of credit | 10,973 | 11,001 |
Standby letters of credit | ||
Other Commitments [Line Items] | ||
Total commitments and standby letters of credit | $ 2,141 | $ 3,657 |
Commitments and Contingencies - Narrative (Details) - USD ($) $ in Thousands |
3 Months Ended | 12 Months Ended | ||||
---|---|---|---|---|---|---|
Mar. 31, 2022 |
Dec. 31, 2021 |
Mar. 31, 2021 |
Dec. 31, 2012 |
|||
Loss Contingencies [Line Items] | ||||||
(Reversal of) provision for credit losses on unfunded loan commitments | $ (318) | $ 210 | $ (590) | |||
Litigation Matters | ||||||
Restricted cash and cash equivalents | [1] | 930 | 1,930 | |||
Visa Inc. | ||||||
Litigation Matters | ||||||
Settlement agreement amount | $ 4,000,000 | |||||
Restricted cash and cash equivalents | $ 882,000 | |||||
Minimum | ||||||
Loss Contingencies [Line Items] | ||||||
Weighted average remaining term (in years) | 7 months | |||||
Finance lease, initial contract terms (in years) | 3 years | |||||
Maximum | ||||||
Loss Contingencies [Line Items] | ||||||
Weighted average remaining term (in years) | 11 years | |||||
Finance lease, initial contract terms (in years) | 5 years | |||||
Total commitments and standby letters of credit | ||||||
Loss Contingencies [Line Items] | ||||||
Unfunded commitments credit loss (reversal) provision | $ 318 | $ 590 | ||||
Total commitments and standby letters of credit | Interest payable and other liabilities | ||||||
Loss Contingencies [Line Items] | ||||||
Allowance for off balance sheet commitments | $ 1,500 | $ 1,800 | ||||
|
Commitments and Contingencies - Lease Assets and Liabilities (Details) - USD ($) $ in Thousands |
Mar. 31, 2022 |
Dec. 31, 2021 |
Dec. 31, 2020 |
---|---|---|---|
Operating leases: | |||
Operating lease right-of-use assets | $ 23,544 | $ 23,604 | |
Operating lease liabilities | $ 25,351 | $ 25,429 | |
Finance leases: | |||
Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List] | Bank premises and equipment, net | Bank premises and equipment, net | |
Finance lease right-of-use assets | $ 499 | $ 499 | |
Accumulated amortization | (124) | (93) | |
Finance lease right-of-use assets, net | 375 | 406 | |
Finance lease liabilities | $ 388 | $ 419 | $ 419 |
Commitments and Contingencies - Noncash Investing and Financing Activities (Details) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Mar. 31, 2022 |
Mar. 31, 2021 |
|
Commitments and Contingencies Disclosure [Abstract] | ||
Right-of-use assets obtained in exchange for operating lease liabilities | $ 1,120 | $ 0 |
Commitments and Contingencies - Lease Cost (Details) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Mar. 31, 2022 |
Mar. 31, 2021 |
|
Commitments and Contingencies Disclosure [Abstract] | ||
Operating lease cost | $ 1,284 | $ 1,164 |
Variable lease cost | 0 | 0 |
Total operating lease cost | 1,284 | 1,164 |
Finance lease cost: | ||
Amortization of right-of-use assets | 31 | 27 |
Interest on finance lease liabilities | 1 | 0 |
Total finance lease cost | 32 | 27 |
Total lease cost | $ 1,316 | $ 1,191 |
Commitments and Contingencies - Lease Liability Maturity Schedule (Details) - USD ($) $ in Thousands |
Mar. 31, 2022 |
Dec. 31, 2021 |
Dec. 31, 2020 |
---|---|---|---|
Operating Leases | |||
2022 | $ 4,035 | ||
2023 | 4,745 | ||
2024 | 3,837 | ||
2025 | 3,328 | ||
2026 | 2,535 | ||
Thereafter | 8,468 | ||
Total minimum lease payments | 26,948 | ||
Amounts representing interest (present value discount) | (1,597) | ||
Present value of net minimum lease payments (lease liability) | $ 25,351 | $ 25,429 | |
Weighted average remaining term (in years) | 6 years 9 months 18 days | ||
Weighted average discount rate | 1.67% | ||
Finance Lease, Liability, Payment, Due [Abstract] | |||
2022 | $ 95 | ||
2023 | 117 | ||
2024 | 113 | ||
2025 | 66 | ||
2026 | 0 | ||
Thereafter | 0 | ||
Total minimum lease payments | 391 | ||
Amounts representing interest (present value discount) | (3) | ||
Present value of net minimum lease payments (lease liability) | $ 388 | $ 419 | $ 419 |
Weighted average remaining term (in years) | 3 years 3 months 18 days | ||
Weighted average discount rate | 0.62% |
Derivative Financial Instruments and Hedging Activities - Narrative (Details) - Fair value hedge - Designated as hedging instrument $ in Thousands |
Mar. 31, 2022
USD ($)
derivative
|
Dec. 31, 2021
USD ($)
|
---|---|---|
Derivatives, Fair Value [Line Items] | ||
Interest rate swaps accrued interest | $ | $ 10 | $ 11 |
Interest rate swap | ||
Derivatives, Fair Value [Line Items] | ||
Number of instruments held | derivative | 4 |
Derivative Financial Instruments and Hedging Activities - Information on Derivatives (Details) - USD ($) $ in Thousands |
3 Months Ended | ||
---|---|---|---|
Mar. 31, 2022 |
Dec. 31, 2021 |
Mar. 31, 2021 |
|
Derivatives, Fair Value [Line Items] | |||
Carrying Amounts of Hedged Assets | $ 12,979 | $ 13,976 | |
Cumulative Amount of Fair Value Hedging Adjustment Included in the Carrying Amount of the Hedged Loans | 187 | 939 | |
Interest and fees on loans | 23,677 | 25,495 | $ 20,661 |
Fair value hedge | Interest income | |||
Derivatives, Fair Value [Line Items] | |||
Increase in fair value of designated interest rate swaps due to LIBOR interest rate movements | 757 | 719 | |
Payment on interest rate swaps | (85) | (93) | |
Decrease in fair value hedging adjustment of hedged loans | (752) | (714) | |
Decrease in value of yield maintenance agreement | (3) | (3) | |
Net losses on fair value hedging relationships recognized in interest income | (83) | $ (91) | |
Fair value hedge | Designated as hedging instrument | Interest rate swap | Asset Derivatives | |||
Derivatives, Fair Value [Line Items] | |||
Interest rate contracts notional amount, asset derivatives | 3,082 | 0 | |
Interest rate contracts fair value, asset derivatives | 42 | 0 | |
Fair value hedge | Designated as hedging instrument | Interest rate swap | Liability Derivatives | |||
Derivatives, Fair Value [Line Items] | |||
Interest rate contracts notional amount, liability derivatives | 9,709 | 13,037 | |
Interest rate contracts fair value, liability derivatives | $ 370 | $ 1,085 |
Derivative Financial Instruments and Hedging Activities - Offsetting of Assets (Details) - USD ($) $ in Thousands |
Mar. 31, 2022 |
Dec. 31, 2021 |
---|---|---|
Derivative Instruments and Hedging Activities Disclosure [Abstract] | ||
Gross amounts of recognized assets | $ 42 | $ 0 |
Gross amounts offset in the statements of condition | 0 | 0 |
Net amounts of assets presented in the statements of condition | 42 | 0 |
Gross amounts not offset in the statements of condition, financial instruments | (42) | 0 |
Gross amounts not offset in the statements of condition, cash collateral received | 0 | 0 |
Net Amount | $ 0 | $ 0 |
Derivative Financial Instruments and Hedging Activities - Offsetting of Liabilities (Details) - USD ($) $ in Thousands |
Mar. 31, 2022 |
Dec. 31, 2021 |
---|---|---|
Derivative Instruments and Hedging Activities Disclosure [Abstract] | ||
Gross amounts of recognized liabilities | $ 370 | $ 1,085 |
Gross amounts offset in the statements of condition | 0 | 0 |
Net amounts of liabilities presented in the statements of condition | 370 | 1,085 |
Gross amounts not offset in the statements of condition, financial instruments | (42) | 0 |
Gross amounts not offset in the statements of condition, cash collateral pledged | (328) | (1,085) |
Net Amount | $ 0 | $ 0 |
Merger - Narrative (Details) - USD ($) |
3 Months Ended | |||
---|---|---|---|---|
Aug. 06, 2021 |
Mar. 31, 2022 |
Dec. 31, 2021 |
Mar. 31, 2021 |
|
Business Combination, Separately Recognized Transactions [Line Items] | ||||
Goodwill | $ 72,754,000 | $ 72,754,000 | ||
Core deposit intangible, net | 6,225,000 | 6,605,000 | ||
Amortization of core deposit intangible | 380,000 | $ 393,000 | $ 204,000 | |
American River Bank (ARB) Merger | ||||
Business Combination, Separately Recognized Transactions [Line Items] | ||||
Investment securities | $ 297,800,000 | |||
Loans | 419,400,000 | |||
Deposits | 790,000,000 | |||
Goodwill | 42,600,000 | |||
American River Bank (ARB) Merger | Core Deposits | ||||
Business Combination, Separately Recognized Transactions [Line Items] | ||||
Core deposit intangible, net | $ 3,900,000 | |||
Amortization of core deposit intangible | $ 184,000 | $ 0 | ||
Intangible useful life | 10 years | |||
Impairment loss intangible assets | $ 0 | |||
American River Bank (ARB) Merger | Bank of Marin | ||||
Business Combination, Separately Recognized Transactions [Line Items] | ||||
Merger agreement, shares exchange ratio (in shares) | 0.575 | |||
Business combination, number of common stock issued (in shares) | 3,441,235 |
Merger - Schedule of Consideration Paid for AMRB (Details) - AMRB $ / shares in Units, $ in Thousands |
Aug. 06, 2021
USD ($)
$ / shares
|
---|---|
Business Acquisition [Line Items] | |
Cash consideration for stock options | $ 63 |
Cash paid in lieu of fractional shares | 13 |
Total merger consideration | 124,477 |
Common Stock | |
Business Acquisition [Line Items] | |
Value of common stock consideration paid to shareholders (0.575 fixed exchange ratio, stock price $36.15) | $ 124,401 |
Fixed exchange ratio | 0.575 |
Business combination, common stock issuance price per share (in dollars per share) | $ / shares | $ 36.15 |
Merger - Schedule of Merger-Related One-Time and Conversion Costs (Details) - Bank of Marin - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Mar. 31, 2022 |
Mar. 31, 2021 |
|
Restructuring Cost and Reserve [Line Items] | ||
Total merger-related one-time and conversion costs | $ 547 | $ 0 |
Personnel and severance | ||
Restructuring Cost and Reserve [Line Items] | ||
Total merger-related one-time and conversion costs | 335 | 0 |
Professional services | ||
Restructuring Cost and Reserve [Line Items] | ||
Total merger-related one-time and conversion costs | 67 | 0 |
Data processing | ||
Restructuring Cost and Reserve [Line Items] | ||
Total merger-related one-time and conversion costs | 48 | 0 |
Other expense | ||
Restructuring Cost and Reserve [Line Items] | ||
Total merger-related one-time and conversion costs | $ 97 | $ 0 |
9<=,?''P&
MZTH;X-IMC[9]#Z-6Z;Z/RW79D!YRNX>'M?+: -9T5E(IOX_K]#&K72=_FA<.
M]XSFZN (!]?H,5 *"UHQ6];RP %.[D;GX.#-B)$]C\Q(8!K)X@RN?%J>>8[M
M29]3O5X _CNBZDGY,
M+#C)&(D17A:=[83)QV:+*3;&V401;) 'J@H2VWZB/ =VFPY@QJ)L)KZC\_K$
M7@&) P["BSQC$S5A8B$08X8#L" (+.2)LB3$ ?J;U!Y!YT!"P!ULB;_6"=)WBN@X1F7K AXD#%I_8>KQU'JMN\4CG
M\7@M(#4R_3.@B[]/,[(%-DG:VC:(UYXY O:V>.I ADE@&9@%)9L'Y2-;=B;B
M"92;P*1N Z7$KS8H,9T,D[$A[R\:1]Q 1X/4U4C [I
MZX 5F"N[L=W;A"0(ZS]=:C 21F%VT>"E_JJR 3?T5<]0=%S1+[8M&0ZF 8X)
M6 VI, (C/?32W[9I\R(((Y33^Z"87V "8, 5P;)N!YN2$)V^Z$4:=&^
M'TCD,^.-3H>-4&)&4,R+W:XKJ[ZL)=K:ML DN(E0_82P1KNFP3F B7$(][P$
M7$F;*NM]K035UH2LF(]8- 5,&@]3G-BM6<09GW%HN>-P;#U]\G*_1@"(Z7VL
M )@V"!LILW#+$&1%Z$=,HM^Y':^%Z0(R'!B#!0$
MTIT' ,*1;0XJI:;NN'ZR$'K:9F*:B>E7M77QLK;FCBB0-M?#70"CTTT!C"VF
MI\H94+2@& B52PN3ZVE+%[!VEN'K;/+/@-Z#8DT NI
M)Z9H'A1ELF-V%Q;I'95Q<#>3O?1MY;PQ,C,.\]\W3-Z<#ZCMV"Y.QA)%L8MW
M2SUL@:1G(6!4]D?;_0H.Q^IC,Q<*9V[SZE/?Y9H:>URLRST^E38*;)AW5R+G
MN">5QV <$!J620]UHOF"!R;\[0%*&MF?YU^,5Q?=+2(B_J?FWQ\DY1YP9=
M &@@C[F;Z[B=XBFN19,R_[E3]KH(@!N&V)H.U?&Q7V-?9PI3?+>&B$IWQ+M)
MG9V4'_?N7=1'2=/BL/S*>9HN350CU-^.QSU>JE'YD:U7A
MR<*Z4@9
$U(F[^-G*]AGMF%7*_]:_#=01#8
M C&CWMFD0=_9Y(0O3B<,RO'9VX'G)HGIV"*U#*5Z5JG_!+.ZXH#H8,KAY T]
MOBD60+75AS2&L[#T;AW,F&/C8:]DQ,FQUR"\R.[8772B33=K,0P
M!%2PKYVF8H)2/S4.>B /W77N?=7B:1L,/O%5^FQ9G&S#EMN_H6TOO]3]>%LZZ
MK%UDUYUQIND+IM4T.[EN:UM:XQY]_[BG>?#TXU+'O)0QSQ\8\TGVH6WZE I;=F 51
MJBF)1[2C?_V7%^?GIZ_N3 @(C$316.F*(SO?*G<$ 'SC,D*M7Z';D5>U&:B%'+2AQ_80AVV'>+X::CU!:
M:=/;90E.SV3^!DTY0Y'RQ$H*60[HSJ&N;#NYV"N&4QKURLP7#C1^%/*W' ")5A'RK#@^'M.UA-,:/0-D3C+AG]
MYSK-R5&_QWRS%%X_&3X/TB>,\Z9>I3/[[H2C9O5@3Z9B:MT%55X]V_0*VL1;
M64FAE.]P//4VC/W)IE4;^B#< AY89?4OHL)3D'Y)Z/T9@2FM\B>1SLL529T8
M>0!98"4V7OCM&I9>4?BJ!G5ZR"F;QZSJML @B2@1AT+-96 XYM&&G4S@ALDDGLLD/BRS2>7F/DCFBX+/"RT>Z/\,Y
M$L?/1)*/?ZNML^^I[F2D]U77AC1M2*T0W#XD?PO)?4@@;N@:YWJK@DA(,B3)
MQAC_'.V=4'3V#?U+8)+X?+4.*PLE>T;8(*H6U+4N-)HBJ<1UT2C>ZI;B%(V4
MKX3O<&M\:GU8,<6UJ7^Q[:ET2
M6P(@4<2AUKWM/@F6<1*^F"SILP:--Z#]0FNW7_@ W8?2XCM02P,$% @ VXJI5#+3Y;O@ P 5@P
M !D !X;"]W;W)KD/\S
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M)5SJ3;EJ[*]>3KW)#.5][8ABNHV%7J-8^DGX35GATU?&3%@I&D^V=1@]-N
M&I_@71>5D?!"FFX8G$#HVOO&MV,Q:/)N($E?DM[Y7I?T29("KX&^(+6OQ9'Y
MT31[,^+[3^[&IL?7RY""VK-:B?%]3Y"!-OL.R^0>WX]<1*TD@W\RX=0Q1? <
M]MX9BJ:6JYX>1W;X%LGID\G'=[?T@/#X)"S'H,U@A?8G[.[1(<,O:6GAEDM+
M8<=7S&_Q>M[=2H*L0E??1AB=BV@^:"0;%4>6Z0E3?"5 >>H0B>)W(=3\WLA"V1!;N3B
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M,S>%A*:MSS[IU5,SG-EU#YE;B:FX[X[Q=;@,P'O)SJ I7D,O*SU.'Z;T]%)
M#,@AM50K#H$%Q3)<]PS05-KFDJO#]O!UGH9"B$#D)L4\:2AUZ5MH!^G\!4#C
M*#*932P!8^AURR>765Z9GSCE3))*2$6QQ +)'X2@CK/@_N *1_)ZAX=6]%Z*
M8C]_%0,UZY)KKB0UI"U2>NXS7L" PX*@\,IGO&A''^I+9D3::PXG,J0*PK[
MD*YE>\Z8>ILH@5QHZ!W5X:KRJ]&&0K\;W]67(36JQA!\#V'6J/
XLLX
M38D0V/A]0_.@69(F=I]KZE=F[]C+;53&EWGZ6S*O%F\/] &;QW?1.JT^Y(\_
MQ)O]**(WR]/2_+)'.];W#]AL75;Y'?Q.^HQ1Z
M>6B*//0?(E9;VAUB=;"MXFS3(J0T,%((1"]X9 ^94N '3(04YI 6:40A+$3_
MGBF6@#2P@N>Z)@S:)5IZRA5@P4,P],!9"-P8 ,> +N:94@A!6\7-?X 0[L.Y
M>PCA/N"/ N2ML( 2U
M"YQ\:N"_K?#CX+%F6E.JU.=-UF[=SK)E*
M*/*?;M;!YDN;@?+KY]E_;I]>/,V(5?RNR'Y/)_7C]2 >H F?LF56?RR>_LF[
M)PJ;^<9%5K7_HJ=.UAN@\;*JBWDW6&@P3_/U_^ROSA+2 $QZ!OC= /_0 4$W
M(&@?=*U9^UCWK&8W5V7QA,I&6LS6O&AMTXX63Y/FC1\?ZE)\FHIQ]PL4,AZN-^WR_;8 N&N36\_6(9:#%Q@?%K.B0Q34)@ISW'.39>[).1Z
MDF'?+E=HQ/H4>F\7,CQ"\)C.N>DMY)S!D%V5C052&$U[.B=R(,:74T=H2TX-
MC5#[LNFYSHEL[A#'',X1QIC_\46&42C,J!?Y)K)QU(6P#QV3?F=H1/R34&3
MA=K!=8AQ(@>L.&6Q8U;J"HT8X<0OVQ +A8GUNW&&9YS(< 3Q$_--PPITZ!IG
M#]^TER\4
=
MF&DCD](8&20\+7[I8QF(FH$_:3'P2P/_N0%I,0A*@^"E'OJE01YJMY"2QV%%
M#9U/E3R"LJL1S3[DP